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1-AS-01-1 Proposal of Drug Rescuing
Yoshinori Fujiyoshi
Grad. Sch. Pharm. Sci./CeSPI, Nagoya Univ.
Pharmaceutical strategy was dramatically changed in 2000,
when Britain’s giant Pharmaceutical companies started to
discuss about a merger. They tried to change the traditional
approach to drug discovery, screening thousands of chemical
compounds to find one useful drug, to modern strategy,
namely evidence based drug development based on modern
biology. This change might be the dawn of the Structure
Guided Drug Development (SGDD). The success ratio of drug
development is, however, still very low and the cost is also up
to billion dollars. Many lead compounds have to be thrown
away because of adverse effects and/or other reasons. Struc-
tural information is very useful for designing chemical com-
pounds as SGDD. More importantly, structure analysis of the
target protein and its ligand complex could act as base camp
for challenging again to design better drug compounds avoid-
ing the adverse effects. We can find essential parts for phar-
macologic action as well as the parts giving no effect for the
action. We can modify these parts for challenging to rescue
the drug chemical avoiding the adverse effects. I named this
strategy “Drug Rescuing” and we are making efforts to de-
velop basic technologies for “Drug Rescuing”.
1-AS-01-3 Pharmacogenomics based
individualization of drug therapy
Taisei Mushiroda
RIKEN Center for Integrative Medical Sciences
Knowledge of pharmacogenomics (PGx) can help to improve
prediction of drug responses for establishment of individual-
ized drug therapy that aims to provide a right drug at appro-
priate dosage for each individual patient. In the USA, PGx in-
formation about genomic biomarkers that can predict risk of
adverse drug reactions (ADRs) and initial dosage setting is
available in labels of 166 FDA approved drugs. In particular,
the US FDA recommends genotyping of polymorphisms in
drug metabolizing enzymes and HLA prior to drug admini-
stration for prevention of severe ADRs for several drugs,
such as irinotecan, atomoxetine, carbamazepine and abacavir.
Genome wide association studies (GWAS) have been success-
ful in identifying genes/SNPs associated with drug responses
in the world. We have conducted and are conducting the
GWAS using DNA samples from Biobank Japan, which
started in 2003 for the collection of genomic DNA, serum and
clinical information from about 300,000 Japanese patients, and
revealed genomic biomarkers associated with drug efficacy
and risk of severe ADRs in Japanese. In order to apply the
identified genomic biomarkers to clinical therapeutics, fur-
ther prospective clinical trials will be necessary for valida-
tion of clinical utility.S141-AS-01-2 Development of software for
computer aided drug design―Easy
CADD system for all beginners―
Yoshifumi Fukunishi
molprof, AIST
We have been developing software for computer aided drug
design for 15 years. The computer software named myPresto
consists of compound database (including 42 million com-
pounds), molecular dynamics simulation, prediction of
ligand binding pocket of protein, protein compound docking
program, virtual screening programs, drug design tools, pre-
diction of LogS/LogP, and prediction of synthetic accessibil-
ity. The easy GUI programs of myPresto are available
(MoDesk [http : //www.moldesk.com/] and MF myPresto
[ http : / / www. fiatlux. co. jp / product / lifescience /
MFMYPRESTO/MFmyPresto index.html]). The integrated
system named MolSpace (http : //www.level five.jp/com-
pany/) is a workstation including the GUI software MolDesk
and a cloud computing controller MolGate and the users can
purchase chemicals, synthesize new design compounds and
examine them by in vtro assay through e mail. Among many
important aspects of CADD tools, I focus on the progress MD
simulation and the remained problems. One of the problems
is the halogen atoms. Halogen is negative charged atom, but
halogens bind oxygen atoms. The other problem is metal ions.
The metal ligand interaction is complexed. I will discuss
about these topics.
2-AS-01-1 Pharmaceutical regulatory
authority’s challenge for encouraging
innovative drug development
Kazuhiko Mori
The Ministry of Health, Labour and Welfare
In October 2015, The Ministry of Health, Labour and Welfare
designated 6 new investigational drugs (IND) which are being
developed by pharmaceutical company as “SAKIGAKE desig-
nated products”. These products are developed in Japan and
remarkable clinical effects is shown for the first time in the
world, are expected. The project which builds a disease reg-
istry centering on a national center and a clinical study core
hospital has started as an infrastructure building for effi-
ciency of clinical development of a new medicine. We expect
that the clinical study for which a disease registry was used
and clinical development of new drugs and new medical de-
vices are promoted. The world still has many patients wait-
ing eagerly for realization of a remarkable new medicine for
the disease which has no effective curatives. It’s requested
that industry academia government cooperate and work on
creation of a safer and more effective new drug more
promptly aggressively to respond to the expectation from a
patient. I’d like to introduce that the challenge in which the
Ministry of Health, Labour and Welfare also aids new drug
development innovation has been begun.
2-AS-01-2 AMED: Mission and vision for
medical innovation
Makoto Suematsu
Japan Agency for Medical Research and Development
AMED has been started in order to fast track medical R&D
and to improve a quality of life for people. Among a diversity
of different medical researches, AMED has chosen a field of
rare and intractable diseases to tackle with a number of ob-
stacles including rigid and inflexible funding systems, and
“Balkanization” of mindsets in academia and researchers.
There are several important reasons for launching Initiative
for Rare and Undiagnosed Diseases (IRUD), as the first na-
tional project, which aims to spread a concept of sharing of
data and expensive equipments, global phenotype coding for
saving patients in foreign countries, and microattribution
that should be recognized by all project leaders. AMED has
joined in International Rare Disease Consortium (IRDiRC) in
order to share many experiences in rare disease researches
which were accumulated over 40 years in Japan. In parallel
with IRUD, AMED has started up projects supporting ven-
ture companies developing orphan drugs and those aiming to
utilize patient derived iPS cells for mining new therapeutic
interventions. I would present an overview of our missions
and vision for medical innovations, and introduce drug dis-
covery innovation & screening consortium (DISC) and a new
project for activating regulatory sciences and big data sci-
ences.
2-AS-01-4 New strategy for evaluating
safety and effectiveness of drug
metabolites
Shinsaku Naito
Research and Development Center, Otsuka Pharmaceutical Factory, Inc.
A new strategy for assessing safety of metabolites is dis-
cussed to deliver high quality drugs to patients as quickly as
possible. In drug development, safety in humans is predicted
through methods such as metabolite profiling and pharma-
cological activity screening, clinical pharmacokinetic studies,
and sometimes safety studies using metabolite reference stan-
dards. In most cases, it is crucial to analyze metabolites using
human samples obtained in clinical studies and to determine
whether unique human metabolites are major metabolites.
However, these tasks often constitute a rate limiting factor
in drug development, and drug risk benefit considerations
may require selecting the optimal strategy, utilizing PMDA
consultations. In rare cases, risks associated with reactive
metabolites should be screened with human samples, which
would allow a comparison of the findings on reactivity in hu-
mans to those in animals. Safety evaluation of metabolites
cannot readily be based on a single theoretical framework,
and basically a case by case approach is called for. In sum-
mary, eliminating studies for unnecessary metabolite safety
assessment is essential for prompt supply of high quality
drugs to the medical frontline.S12-AS-01-3 Regulatory Science for
Translation of Cell BasedTherapeutic
Products
Yoji Sato
Div. Cell Based Thrp. Prod., National Institute of Health Science
Development of regenerative/cellular therapies using cell
based therapeutic products (CTPs) is keenly anticipated in
Japan, because of difficulties in securing human organs and
tissues in our country. To facilitate translation of novel
CTPs, the Japanese Diet recently passed the Regenerative
Medicine Promotion Act, as well as the Pharmaceuticals and
Medical Devices Act (the Revised Pharmaceutical Affairs
Law) and the Regenerative Medicine Safety Act. However,
the development of CTPs is still uncertain, because they in-
clude advanced and emerging technologies with little clinical
experiences. One of the biggest problems is that evaluation
tools and approaches to ensure their safety, efficacy and qual-
ity are lacking, which affects not only the risk assessment/
management of clinicians, developers and regulators, but also
their risk communication with the public. This is one of the
major reasons why regulatory science is needed for CTPs. At
the session, I would like to overview current scientific chal-
lenges for the development of CTPs, and introduce our study
to establish new methods for risk assessment of CTP derived
tumor formation, as an example of regulatory science re-
searches.
2-AS-02-1 A trend of the education of
nursing science and future problem
Shinobu Saito
Ministry of Education, Culture, Sports, Science and Technology Japan
The number of schools of nursing in Japan is 241 in 2015. And
the total of the entrance to school capacity is 20, 814 people.
Since the education such as the nurses who had high nature
was necessary, schools of nursing, graduate schools of nurs-
ing increased after the establishment of the law about the
promotion of the securing of talented people such as nurses in
1992. Ministry of Education, Culture, Sports, Science and
Technology was aimed for quality improvement of the nurs-
ing practice in March, 2011 and devised “nursing practice
ability and arrival target for first degree”. I will show some
examples of the curriculum of school of nursing. And I would
like to examine the knowledge that a student should learn for
nursing science education.5
2-AS-02-2 Pharmacology education and
research and human resource
development in nursing
Yumi Katano
Division of Theoretical Nursing, Yamagata University School of Medicine
Drugs can be a risk depending on their usage. Many nurses
handle drugs without fully realizing this fact. Currently,
more than 250 nursing colleges have been established in Ja-
pan, but colleges that treat pharmacology as a required
course are not common. Thus, enhancement of pharmacology
education is awaited. I would like to request the fostering of
personnel who have the capacity to provide pharmacology
education among graduates from nursing colleges and the
guarantee of positions to accommodate them. Based on my ex-
perience in teaching physiology and pharmacology at a nurs-
ing department, I will introduce pharmacology education and
research, as well as relevant human resource development,
that would foster nurses who are well versed in pharmaco-
therapy.
2-AS-02-4 Nursing Science from the
point of view of Pharmacology: what
can we do for Nursing Science
Toshihiko Yanagita
Dept. Clin. Pharmacol., Fac. Med., Miyazaki Univ.
The installation of nursing colleges/universities has rapidly
increased from the late 1990s, there are 248 institutions in Ja-
pan as of 2015 and it is expected to reach 280 institutions by
2021. Pharmacology and clinical pharmacology education in
undergraduate and postgraduate nursing colleges/universi-
ties is highly important, however, the lack of human re-
sources involved in pharmacology education due to the rapid
increase of nursing colleges/universities cannot be denied.
From the perspective of Pharmacological Society, (tradition-
ally) physicians and pharmacists has been main roles in Phar-
macology. Nurses give medicine directly to the patients and
observe the therapeutic effect or side effect at the bedside.
Therefore, nurses’ involvement in education and research of
pharmacology is expected to further development of pharma-
cological society.
In this topic, we would like to present mutual understanding
of the nursing colleges and Pharmacological Society, re ex-
amine the pharmacology education in nursing, as well as to
seek a nursing pharmacology education corresponding to the
needs of the new phase, the future of nursing education in
pharmacology and the development of human resource in
pharmacology education.S2-AS-02-3 Pharmacology from the point
of view of Nursing Science: what do we
make a request to Pharmacology
Keiko Yamaguchi
Dept. Nursing Nihon Fukushi Univ.
Nurses are responsible for carrying out the drug treatment
of the patients under the guidance of the doctor and they
monitor the patients how the drug takes an effect to the pa-
tients. Therefore, it is necessary that nurses are involved
with the subject under the correct understanding of drug
treatment.
Pharmacology education in nursing is a compulsory subject.
Even though students learn drug therapy in lectures, exer-
cise and training in each specialized courses in nursing, their
acquisition is not quite enough because they feel difficulty to
study pharmacology. They encounter many difficulties to
deal with the patients after they get a job as a nurse.
What kind of knowledge and assessment skills regarding
pharmacology in nursing will be required? How can we im-
plement pharmacology in basic nursing education? We would
like to discuss these matters in this symposium from the view
of pharmacology education.
2-AS-03-1 Intertissue communications
in glycometabolism and endothelial
function
Tsuneo Kobayashi, Kumiko Taguchi,
Takayuki Matsumoto
Dept. Physiol. and Morphol., Inst. Med. Chem., Hoshi Univ.
Recent studies have strongly implicated involvement of G
protein coupled receptor kinase 2 (GRK2) in the development
and/or progression of cardiovascular diseases and insulin re-
sistance. The hydrodynamic injection is an effective and sim-
ple method to control hepatic expression of transgenes in
mice (e.g., systemic administration of siRNA). Indeed, our
study demonstrated that the expression of GRK2 was de-
creased in liver but not in other organs including skeletal
muscle, heart, pancreas, and spleen of diabetic mice treated
with GRK2 siRNA by single hydrodynamic injection. The in-
jection of GRK2 siRNA in diabetic mice resulted in decreased
plasma levels of glucose, and improved the glucose/insulin in-
tolerance. The injection of GRK2 siRNA also could improve
the insulin induced relaxation associated with increased Akt
and eNOS activities in aortae from diabetic mice. Thus, he-
patic regulation of GRK2 plays an important role in normali-
zations of insulin resistance and endothelial dysfunction in
diabetes. In this symposium, we will describe the pathophysi-
ological role of GRK2, especially related to NO production, in
insulin resistance and diabetes, and provide novel insights
into the potential field of translational investigation to treat
diabetic complications.16
2-AS-03-2 Role of the inter organ neural
network from the liver in systemic
energy metabolism
Tetsuya Yamada, Hideki Katagiri
Dept. Metab. and Diabetes, Tohoku Univ. Sch Med.
The body equips inter organ system consisting of negative
feedback mechanism. For example, we found that neural
transmission from the PPARγ overexpressing fatty liver in-
creases energy consumption in brown adipose tissue (BAT)
through sympathetic activation (Science 2006). On the other
hand, mechanisms enabling (1) efficient storing of ingested
energy as fat ; and (2) minimum wasting of stored fat during
energy deprivation ; are necessary to maintain fat storage.
We have identified the mechanisms described in (1). When ex-
cess energy intake activates the hepatic glucokinase, the va-
gal transmission from the liver to the brain decreases energy
expenditure in BAT and leads to fat accumulation (Cell Me-
tab. 2012). As an example of (2), we recently discovered that
administration of SGLT2 inhibitors in mice decreased BAT
thermogenesis due to decreased sympathetic activity, which
was not present after selective hepatic vagotomy, indicating
that neural signals from the liver play an important role in
this mechanism. Neural networks from the liver to BAT en-
able appropriate fat storage and must be advantageous to
mammals experiencing frequent starvation, but may cause
obesity and make it difficult to recover from it in modern age
of plenty.
2-AS-03-4 Development of post
ischemic glucose intolerance induced by
cerebral neuronal damage through
communication system between brain
and peripheral tissues
Shogo Tokuyama
Dept. Clini. Pharm., Sch. Pharmaceu. Sci., Kobe Gakuin Univ.
The communication system between brain and peripheral tis-
sues through the autonomic nervous system is important for
maintaining glucose and energy metabolism. Recently, we
have found that the development of post ischemic glucose in-
tolerance is one of the triggers of ischemic neuronal damage.
In this symposium, I would like to discuss about the mecha-
nisms on the development of post ischemic glucose intoler-
ance focusing on communication system between brain and
peripheral tissues. Especially, we focused the effect of
orexin A, one of neuropeptides and well known as regulatory
factor of the communication between brain and peripheral
tissues, on the development of the post ischemic glucose in-
tolerance and neuronal damage through the activation of hy-
pothalamus medulla oblongata vagus nerve axis. In conclu-
sion, our evidences support valuable insight for the advanced
treatment of cerebral stroke and add to the existing litera-
ture about the role of post ischemic glucose intolerance and
the communication between the brain and peripheral tissues
as one of the new therapeutic target for use in ischemic
stroke patients.S12-AS-03-3 Brain heart kidney network
controls homeostasis and pathology in
the heart
Ichiro Manabe
Dept. Cardiovasc. Med., Univ. Tokyo Grad. Scho. Med.
Heart failure (HF) is a complex clinical syndrome character-
ized by cardiac function that is insufficient to meet systemic
demand. Nearly half of chronic HF (CHF) patients also have
chronic kidney disease (CKD), which increases their rate of
cardiovascular mortality, suggesting cardiorenal linkage via
mechanisms still poorly understood. We found that pressure
overload in the heart activates renal collecting duct (CD) epi-
thelial cells via sympathetic nerves. Within the kidneys, acti-
vated communication between CD cells, tissue macrophages
and endothelial cells leads to secretion of CSF2, which in turn
stimulates cardiac resident Ly6Clo macrophages essential
for the myocardial adaptive response to pressure overload.
We show that CD specific deletion of the transcription factor
Klf5, renal sympathetic denervation or adrenergic beta2 re-
ceptor blockade/deletion disrupts the renal response to car-
diac pressure overload. Our results clearly demonstrate that
dynamic interplay between the heart, brain and kidneys is
necessary for proper adaptation to cardiac stress, and high-
light the novel homeostatic functions of tissue macrophages
and the sympathetic nervous system, which represent poten-
tial targets for future CHF and CKD treatment strategies.
2-AS-04-1 Next generation cardiac
safety assessment using human iPS cell
technology: JiCSA activities
Yasunari Kanda 1,2
1Div. Pharmacol., NIHS, 2 JiCSA
Drug induced QT prolongation is a major cause of ventricu-
lar tachycardia such as torsade de pointes (TdP). The hERG
blockade potential has been used in the non clinical evalu-
ation of potential TdP risk. Human induced pluripotent stem
cell derived cardiomyocytes (hiPS CMs), which express mul-
tiple ion channels, are expected to assess cardiac safety. We
have organized Japan iPS Cardiac Safety Assessment (JiCSA)
to generate functional iPS CMs and validate the usage of
iPS CMs. We have evaluated cardiac differentiation protocol
to overcome line to line variability. We also successfully
generated mature hiPS CMs by overexpressing KCNJ2, that
are responsible for stabilizing the resting membrane poten-
tials. Furthermore, we prepared standardized protocol to
measure field potential of iPS CM sheet with multielectrode
array. The hERG blockerE4031 resulted in field potential
prolongation and early afterrepolarization. We are now as-
sessing proarrhythmic potential of 60 compounds to examine
the TdP predictivity using iPS CMs. In the symposium, we
will present our strategy for the fit for purpose cells and the
standardized protocol, and discuss proarrhythmic risk using
iPS CMs.
This research is supported by AMED 15mk0104053h0101 (to
Yuko Sekino).7
2-AS-04-2 Progress in applications of
iPSC derived neurons for neuronal
maturation
Tomoaki Shirao
Dept. Neurobiology＆ Behavior, Gunma Univ. Grad. Sch. Med.
Differentiated neurons from human induced pluripotent stem
cells (hiPSC derived neurons) are expected to be useful for
developing novel methods of treatment for various neurologi-
cal diseases or drug discovery. However, the detailed process
of functional maturation of hiPSC derived neurons remains
poorly understood. In this talk, I will first introduce the study
comparing hiPSC derived neurons with rat primary cul-
tured neurons. Morphological development of rat and human
neurons before axonal polarization was similar. However, ax-
onal growth speed was slower in the hiPS neurons. We eluci-
dated that glial conditioned medium contained a factor accel-
erating the axonal growth. The latter half of my talk, I will
introduce the recent advancement in the application of
hiPSC derived neurons for the safety pharmacology.
2-AS-04-4 3 Case studies where
merging plastics sciences with
microfabrication to serve biomedical
applications we have contributed to
platform technologies in life cell
isolation, imaging and cultivation
Georg Bauer
Sony DADC BioSciences GmbH
Microfluidic chips often are composed of a clear polymer
about the size of a credit card, and contain microfluidic chan-
nels, valves and filters replacing a whole workflow in the
laboratory. They may be coated by iPS cells allowing re-
searchers to recapitulate the physiological and mechanical
functions of the organs, and to observe what happens in real
time. The environment of iPS cultivation contributes
strongly to the degree to which the iPS reactivity is repre-
sentative for the physiological context. In other applications
the target is to identify and monitor biomarkers and to speed
up the pharmaceutical development process by providing
more predictive and useful measures of the efficacy and
safety of new drugs in humans and at a fraction of the time
and costs associated with traditional lab automation or animal
testing. We will present three case studies where we have
contributed to the development of novel platform technolo-
gies for life cell isolation, cultivation and imaging or pro-
vide the sample prep for DNA sequencing.S12-AS-04-3 Fabrication of iPSC derived
Cardiomyocyte construct by Scaffold
free Bio 3D Printer
Koichi Nakayama 1, Ken ichi Arai 1, Atsuko Ojima 2
1Dept. Regenerative Medicine and Biomedical Engineering, Faculty of Medicine,
Saga Univ., 2 iPS Portal, inc
Inspired from bone fracture treatments in orthopedic sur-
gery, we have established a simple method to fabricate 3D
scaffold free cell construct.This method use spheroids and
temporal fixator which enable placement of various types of
three dimensional cells into desired xyz positions without
need of hydrogels or biochemical reactive materials. We also
developed a robotic system for scaffold free cell construc-
tion, named “Bio 3D Printer”. With this system, we already
successfully fabricated living cell only construct such as car-
tilage, liver, cardiomyocyte, blood vessel, and so on. In this
symposium,we`d like to introduce our “Heart PJ”, which use
iPSC Derived Cardiomyocyte and the Bio 3D Printer to fab-
ricate cell only construct,which may useful for cardio drug
research tool and also future heart regeneration.
3-AS-01-1 Basics and practices of
genome editing examples from
development to application ofTALEN
and CRISPR systems
Tetsushi Sakuma
Dept. of Math. and Life Sci., Grad. Sch. of Sci., Hiroshima Univ.
Programmable nucleases such as TALENs and CRISPR/Cas9
have enabled next generation techniques for genetic engi-
neering, called “genome editing”. G “genome editing”.
Genome editing technology is based on the introduction of
site specific DNA double strand break (DSB), followed by
various DSB repair mechanisms including non homologous
end joining (NHEJ), homologous recombination (HR), and mi-
crohomology mediated end joining (MMEJ). Basically, er-
ror prone NHEJ or MMEJ induces short insertions and dele-
tions at the target site, resulting in gene knockout. On the
other hand, HR mediated incorporation of exogenous donor
DNA results in gene knockin. However, rapidly moving re-
search field of genome editing has made this innovative tech-
nology extremely diverse and complex. In this talk, I provide
basic and practical information on genome editing by show-
ing a variety of examples from development to application of
TALEN and CRISPR systems.8
3-AS-01-2 Development of methods for
reproducing disease causing mutations
using genome editing techniques in
mice
Shuji Takada
Dept. of Systems BioMed., NCCHD
Genome editing technology enables us to produce knockout
mice easily and quickly. Since this technology is more flex-
ible than methods based on homologous recombination using
ES cells, knockout mice can be produced for a gene which is
surrounded by repetitive elements and designed at a single
nucleotide level. In addition, production of knockout mice can
be applied for the functional screening of mutations found in
genomic analysis of patients by next generation sequencer to
identify disease causing mutations. Using genome editing
technique, we have been constructing various application
methods to reproduce disease causing mutation identified in
our institute in living mouse. In this talk, I will explain some
of the methods we are using in my lab such as introduction of
point mutation, production of KO mice for genes surrounded
by repetitive elements, double KO mouse production of
closely located genes and deletion of more than 25 kb genomic
sequence. In addition, I will talk about generation of nested
deletion mutants in mice to map disease causing sequence.
3-AS-01-4 Single step seamless CFTR
gene correction in CF iPSCs and their
directed differentiation into cells
responsible for CF pathophysiology
Shingo Suzuki 1,2, R. Geoffrey Sargent 2,
Keisuke Chosa 2,4, Beate Illek 3, Horst Fischer 3,
Alaleh Eamaeili Shandiz 2, Tsuyoshi Shuto 4,
Hirofumi Kai 4, Yuet. W Kan 1,5,6, Dieter. C Gruenert 2,6,7
1Dept. of Medicine, UCSF, 2Dept. of OHNS, UCSF, 3CHORI, 4Dept. of Mol.
Med., Kumamoto Univ. Pharm. Sci., 5Dept. of Lab. Med., UCSF, 6 Institute for
Human Genetics, UCSF, 7Regen. Med. and Stem Cell Res., Comprehensive Cancer
Center, Cardiovasc. Res. Institute, UCSF
Sequence specific modification via homologous recombination
(HR) in mammalian genomic DNA is an attractive, potentially
therapeutic, strategy for inherited diseases. Sequence specific en-
donucleases, such as the ZFNs, the TALENs and the CRISPR/Cas
9, significantly improves HR through introduction of double strand
DNA breaks in the target genomic DNA. Combined with the in-
duced pluripotent stem cells (iPSCs) technology these two tech-
nologies has advanced the potential of a personalized cell and gene
therapy for genetic diseases. Here, we show single step seamless
CFTR gene correction in cystic fibrosis (CF) patient derived
iPSCs using small/short DNA fragments comprised of wild type
donor DNA in conjunction with TALENs. Corrected iPSCs were
clonally isolated by cyclic enrichment strategy that resulted in an
~100 fold enrichment of the corrected CF iPSCs after 6 enrich-
ment cycles. The corrected CF iPSCs showed wild type airway
epithelial cell cAMP dependent Cl ion transport when differenti-
ated into airway like epithelial cells. The potential and challenges
involved in achieving a comprehensive therapy for inherited dis-
eases like CF, using gene corrected iPSCs, will be discussed.S13-AS-01-3 Cloning free CRISPR/Cas
system
Tomomi Aida
Lab. Mol. Neurosci., MRI, TMDU
Recent development of CRISPR/Cas mediated genome edit-
ing technology has provided us the way to manipulate the
genome of nearly any species freely and easily. Although this
revolutionary technology enables the one step production of
knockout animals, several challenges still remain to be over-
come such as transgene knock in and specificity of editing in
the animals. The use of Cas9 protein may be a key technology
to these issues. We show cloning free CRISPR/Cas system
based on the direct nuclear delivery of Cas9 protein complex
with chemically synthesized dual RNAs, which facilitates
rapid one step generation of transgene knock in mice with
high specificity. Our method expands the range of in vivo ap-
plication of CRISPR/Cas technology.
3-AS-01-5 Study on tissue specific and
developmental stage specific roles of
ubiqutin ligases using CRISPR/Cas9
system
Masayuki Kaneko
Dept. Biochem., Inst. Biomed.＆ Health Sci, Hiroshima Univ.
Studies on endoplasmic reticulum (ER) associated degrada-
tion (ERAD), in which unfolded proteins accumulated in the
ER are selectively transported to the cytosol for degradation
by the ubiquitin proteasome system, have been focused on
molecular mechanisms in yeast. In human, disruption of the
ER quality control system causes various diseases. Further-
more, ER stress has become more important because it is also
involved in cellular differentiation and tissue development.
We have identified human 37 ubiquitin ligases with trans-
membrane domain, which are potentially involved in ERAD.
As reason for so many genes in mammals compared with the
yeast 2 ubiquitin ligases, they are assumed to have tissue spe-
cific and/or developmental stage specific roles. However,
physiological roles of these 37 transmembrane ubiquitin li-
gases remain largely unkown. To address this issue, we used
the next generation gene targeted editing tool, CRISPR/Cas9
system, to generate knock out mise and stem cells. Here, we
introduce current findings on the involvement of the
ubiquitin ligases in novel biological functions.9
3-AS-02-1 Drug discovery in big data era
Yasushi Okuno
Kyoto Univ. Grad. Sch. Med.
According to accelerating computing power such as super
computers, the importance of “Simulation science” and “Big
data science” is growing rapidly as modern sciences, second
only to experimental science and theoretical science. In the
life science field, along with the significant progress of equip-
ment of measurement and observation and ICT technology in
recent years, it is said to have entered the big data era. Espe-
cially, research and development of big data analysis tech-
niques for personal genome is an urgent need. In the clinical
medicine and epidemiology, big data is called as real world
data, and the analysis of clinical real world data has attracted
attention as a new approach which can reveal true fact that is
happening in actual clinical site.For application of big data
approaches to drug discovery, we have been developing the
methods to predict compound protein interactions, lead com-
pound structures and clinical adverse drug reactions using
artificial intelligence. In this presentation, we would like to
discuss the potential of the big data approaches for pharma-
cology (especially systems pharmacology) and drug discov-
ery.
3-AS-02-3 Molecular dynamics
simulation study on protein small
molecule interaction
Takefumi Yamashita
RCAST, Univ. Tokyo
The advancement of computational power and methodology
has extended the range of application of molecular dynamics
(MD) simulation. In particular, the MD simulation has been
widely used to clarify the mechanism of protein function,
which usually involves dynamic structural change not only of
protein but also of hydrogen bond network of water mole-
cules in the cavity (e.g., Yamashita and Voth, JACS 2012). In
the context of pharmacology, protein small molecule interac-
tion is of special interest : the resulting molecular recogni-
tion in the cell is directly related to the drug efficacy and side
effect minimization. Because an excellent property to repre-
sent the binding interaction between a protein and small
molecule is the binding free energy, the accurate prediction
of the binding free energy is critical to succeeding in the
computer assisted drug design. Recently, we tried to im-
prove the prediction accuracy by introducing the MD simula-
tion based binding free energy calculation method with the
huge computational power of “K”, which is one of the fastest
computers in the world (e.g., Yamashita et al., Chem. Pharm.
Bull. 2015). We discuss the possibility that the accurate MD
simulation makes the drug development more efficient and
rational.S23-AS-02-2 Particle simulations of
epidermal growth factor response
pathway
Koichi Takahashi
RIKEN QBiC
We have constructed a predictive model of epidermal growth
factor (EGF) response pathways in mammalian cells at the
molecular resolution usingK computer. Cells take advantage
of network structural,spatial, and temporal dimensions in de-
sign space to achieve and optimizetheir signaling functions.
Building blocks where correlations betweennetwork, space
and time are most evidently exhibited include clusteringand
localization of receptor proteins, multi site covalent modifi-
cationsof proteins such as double phosphorylation of mito-
gen activated proteinkinases (MAPK), and scaffold proteins
which tether kinases andsubstrates in close proximity. An in-
triguing question is howcells respond to the signal differ-
ently. This phenomena called cellresponse heterogeneity is
suggested to be relevant to some higherfunctions such as cell
differentiation, development and immunology. Wefound that,
among many possible factors, extrinsic noise (cell to cell
variance in protein expression) can cause this heterogene-
ityin cellular response in a way that is consistent with experi-
mentalobservations.
3-AS-02-4 Theory of Dynamical
Network Biomarkers and Mibyou and
Preemptive Medicine
Kazuyuki Aihara
IIS, Univ. Tokyo
In this talk, I will review our recent research of dynamical
network biomarkers theory and its possible application to
mibyou and preemptive medicine. Dynamical network
biomarkers (DNB) are a new concept of biomarkers that de-
tect a predisease or mibyou state rather than a disease state.
DNB is derived mathematically on the basis of bifurcation
theory, and can be used to identify early warning signals for
an imminent bifurcation point from a healthy state to a dis-
ease state, namely a predisease state. Due to this diagnosis of
the mibyou state, preemptive treatment can be started early
enough beforeemergence of disease symptoms. Further, I
will discuss possible pharmacological research for such pre-
emptive medicine from the viewpoint of DNB.0
3-JPS-1 NMDA receptor function and
human disease
Stephen Traynelis
Dept. Pharmacol., Emory Univ. Sch. Med.
NMDA receptors are ligand gated channels that mediate a
slow, Ca2+ permeable component of excitatory synaptic trans-
mission in the central nervous system. The receptors are te-
trameric assemblies typically comprised of two GluN1 and
two GluN2 subunits, encoded by a family of five genes (GRIN
1 , GRIN2A , GRIN2B , GRIN2C , GRIN2D ). De novo and inher-
ited mutations within this receptor family identified in pa-
tients with neurological disease but absent from the healthy
population are most commonly associated with epilepsy. The
GRIN2A gene harbors more of these rare variants than other
GRIN genes, and thus has been considered a locus for child-
hood epilepsy. Despite the identification of hundreds of
NMDA receptor mutations, there are less than a dozen vari-
ants for which functional data exist. We have sought to ad-
vance our understanding of the role of these mutations in neu-
rological disease by comprehensively obtaining functional
data on all variants currently in the literature as well as new
cases identified by our collaborators. These studies have re-
vealed patient populations that may be amenable to therapeu-
tic treatment. These studies have also provided new informa-
tion about how the NMDA receptor works by highlighting
key residues involved in channel gating.
3-JPS-3 Cognitive improvement
through CaMKII activation by the
hippocampalT type calcium channels
Kohji Fukunaga
Dept. Pharmacol. Tohoku Univ. Grad. Sch. Pharm. Sci.
We here introduce a novel Alzheimer disease (AD) therapeu-
tics candidate, which has potential to enhance of CaMKII ac-
tivity in the hippocampus and prefrontal cortex. We first de-
fine the mechanism underlying cognitive enhancement of a
novel AD drug candidate, ST101 which stimulates T type
calcium channel in mouse cortical slices (Moriguchi et al., J
Neurochem 2012 ; 121 : 44 53). ST101 finished the Phase II
trial in U.S.A. (J Alz Dis 2015 ; 48 : 473). We then successfully
synthesized more potent spiroimidazopyridine derivatives
(SAK3), which markedly enhanced CaMKII activity, thereby
promoting LTP induction and maintenance in the hippocam-
pus. Interestingly, SAK3 stimulated T type calcium channels
in neuro2A cells transfected with CACNA1G (Cav3.1) and
CACNA1I (Cav3.3), but not CACNA1H (Cav3.2). The CaMKII
activation is associated with increases in ACh and glutamate
release in the hippocampus. The enhancements of ACh and
glutamate release were completely blocked by pre admini-
stration of T type calcium channel blocker NNC 55 0396.
Furthermore, Cav3.1 channel was highly expressed in the
terminal of ACh neurons in the hippocampus, suggesting that
SAK3 improves memory deficits via stimulation of T type
calcium channels.S23-JPS-2 Glutamate receptors,
synapse organizers and intellectual
disability
Masayoshi Mishina
Brain Sci. Lab., Res. Org. of Sci. Tech., Ritsumeikan Univ.
Acquiring new knowledge is one of the most important func-
tions of our brain. Disturbance of learning and memory af-
fects our cognitive capabilities and thus our quality of life,
such as intellectual disabilities (ID) and Alzheimer disease.
We have been studying the molecular basis of learning and
memory focusing on the glutamate receptor (GluR), the key
molecule of information transmission between neurons. We
showed that the NMDA receptor GluRε1/GluN2A determines
the thresholds of hippocampal synaptic plasticity LTP and
contextual learning. Cerebellar synaptic plasticity LTD and
optokinetic response adaptation are facilitated in mutant
mice lacking GluRδ2 interacting protein Delphilin. We also
found that the NMDA receptor GluRε2/GluN2B is essential
for sensory map formation in the brain and GluRδ2 regulates
cerebellar synapse formation by trans synaptic interaction
with presynaptic neurexins through Cbln1. Synapse forma-
tion of cortical neurons is mediated by IL1 receptor acces-
sory protein like 1 (IL1RAPL1), responsible for nonsyndro-
mic ID and autism. Impairments of synapse formation and
maturation are implicated in the pathogenesis of mental dis-
orders. Thus, we are beginning to uncover the molecular ba-
sis of brain functions and mind.
3-JPS-4 Tea polyphenols inhibit rat
osteoclast formation and differentiation
Yoshiomi Oka
Dept. Orthopaedic Surg. Showa Univ. Sch. Med
Regulation of osteoclast activity is essential in the treatment
of bone disease. Polyphenols in green tea, particularly epigal-
locatechin 3 gallate (EGCG), inhibit MMPs expression and
activity. However, the effects of the black tea polyphenol,
theaflavin 3,3’ digallate (TFDG), on osteoclast and MMP ac-
tivity are unknown. Therefore, we examined whether TFDG
and EGCG affect MMP activity and osteoclast formation and
differentiation in vitro. TFDG or EGCG (10 and 100 μM) was
added to cultures of rat osteoclast precursors cells and ma-
ture osteoclasts. Numbers of multinucleated osteoclasts and
actin rings decreased in polyphenol treated cultures relative
to control cultures. MMP 2 and MMP 9 activities were
lower in TFDG and EGCG treated rat osteoclast precursor
cells than in control cultures. MMP 9 mRNA levels declined
significantly in TFDG treated osteoclasts in comparison to
control osteoclasts. TFDG and EGCG inhibited the formation
and differentiation of osteoclasts via inhibition of MMPs.
TFDG may suppress actin ring formation more effectively
than EGCG. Thus, TFDG and EGCG may be suitable agents
for the treatment of bone resorption diseases.1
3-JPS-5 Nicotine and tar free
cigarette smoke extract induces cell
damage through reactive oxygen
species newly generated by PKC
dependent activation of NADPH oxidase
Hiroshi Asano
Dept. Cell. Pharmacol. Hokkaido Univ. Grad. Sch. Med.
We examined cytotoxic effects of nicotine/tar free cigarette
smoke extract (CSE) on C6 glioma cells. The CSE induced
plasma membrane damage and apoptosis. The cytotoxic ac-
tivities decayed with half life of approximately 2 h at 37℃,
and were abolished by N acetyl L cysteine and reduced glu-
tathione. The membrane damage determined by LDH leak-
age and propidium iodide uptake was prevented by catalase
and edaravone (a scavenger of ・OH) but not by superoxide
dismutase, indicating involvement of ・OH. In contrast, the
apoptosis determined by MTS assay and DNA fragmentation
was resistant to edaravone, but induced by either authentic
H2O2 or O2 generated by xanthine/xanthine oxidase system,
indicating involvement of H2O2. Diphenyleneiodonium (NOX
inhibitor) and bisindolylmaleimide I abolished membrane
damage, whereas they partially inhibited apoptosis. These re-
sults demonstrate that 1) stable components in the CSE acti-
vate PKC, which stimulates NOX to generate reactive oxygen
species (ROS), causing membrane damage and apoptosis ; 2)
different ROS are responsible for membrane damage and
apoptosis ; 3) part of the apoptosis is caused by oxidants gen-
erated independently of PKC and NOX.
2-CS-2 SGLT2 Inhibitor
(Luseogliflozin):A NewMechanism for
TreatingType 2 Diabetes Mellitus and
Therapeutic Potential to Prevent the
Progression of Diabetic Complications
Naoki Kojima 1, Yoshishige Samukawa 2,
Teisuke Takahashi 1
1 Pharmacology 2, Taisho Pharmaceutical Co., Ltd., 2 Research＆ Development
Headquaters, Taisho Pharmaceutical Co., Ltd.
SGLT2 inhibitor has the unique mechanism of action on blood
glucose lowering effect.
In Zucker fatty rats, luseogliflozin as SGLT2 inhibitor in-
creased urinary glucose excretions and lowered the increase
in blood glucose levels on oral glucose tolerance test. Fur-
thermore, luseogliflozin suppressed the increase in plasma in-
sulin levels after glucose loading.
In Japanese patients with type 2 diabetes, luseogliflozin in-
creased urinary glucose excretion and lowered the mean 24
hours blood glucose levels measured by continuous glucose
monitoring. The proportion of time during 24 hours with glu-
cose levels of 70 180 mg/dL was increased without hypogly-
cemia. The decrease in blood glucose levels was accompanied
by reduction in serum insulin levels throughout the day.
These results suggest that luseogliflozin could lead to favor-
able improvement in glycemic control independent of insulin
secretion in diabetic animals and also type 2 diabetic patients.
Moreover, luseogliflozin prevented the progression of renal
injury in animal models of diabetic nephropathy. Further in-
vestigation of SGLT2 inhibitors on diabetic complications
would be expected to be innovative therapeutic options.S2-CS-1 Mode of SGLT inhibition by
an SGLT2 inhibitor, canagliflozin and
implication in renal and small intestinal
effects
Chiaki Kuriyama
Research Unit C, Sohyaku. Innovative Research Division
SGLT2 inhibitors reduce blood glucose levels through in-
creasing urinary glucose excretion. SGLT2 is expressed in
the proximal tubules in the kidney, whereas SGLT1 is located
also in the small intestine. Both SGLTs localize in the luminal
but not the basolateral side of epithelial cells. We analyzed
the sidedness of inhibition of SGLTs by canagliflozin (Cana)
to clarify exact PK/PD profiles. Cana inhibited SGLT2 from
the extracellular side but not from the intracellular side, and
the inhibition of glucose transport was competitive and de-
pended on the extracellular Cana concentration. SGLT1 was
also inhibited by Cana at higher concentration range in a
similar manner. PK analysis revealed that the plasma level of
Cana is sufficient to inhibit SGLT2 but not SGLT1, whereas
intestinal luminal concentration is expected to be high
enough to inhibit SGLT1 after oral treatment. In OGTT in ro-
dents, Cana improved blood glucose excursion, probably by
inhibiting intestinal SGLT1 as well as renal SGLT2. A recent
clinical study of Cana also found the delayed intestinal glu-
cose absorption accompanied by increased plasma GLP 1 lev-
els. These results indicate that oral Cana transiently inhibits
intestinal SGLT1 in addition to renal SGLT2.
2-CS-3 Pharmacological analysis of
SGLT2 inhibitor (tofogliflozin) using in
vivo glucose clamp and titration
protocols in rats and cynomolgus
monkeys
Masanori Fukazawa, Takumi Nagata,
Masayuki Suzuki, Yoshiyuki Suzuki, Yoshiki Kawabe
Fuji Gotemba Research Labs. Chugai Pharm.
Using the highly specific SGLT2 inhibitor tofogliflozin
(TOFO) and the SGLT1 and 2 (SGLT1/2) inhibitor phlorizin
(PHZ), we evaluated : 1) the ratio of contribution of SGLT2
vs. SGLT1 to renal glucose reabsorption (RGR),2) the risk of
hypoglycemia from urinary glucose excretion (UGE), and 3)
the effects on TmG (transport maximum for glucose) and
splay of the glucose titration curve. Under hyperglycemic
conditions in rats, TOFO and PHZ achieved>50% inhibition
of RGR when plasma levels were sufficient to inhibit SGLT2
completely and SGLT1 to different degrees. Under hypogly-
cemic conditions, RGR was reduced by 20 50% with PHZ and
by 1% 5% with TOFO. Under normoglycemic conditions, en-
dogenous glucose production (EGP) increased to compensate
for TOFO induced UGE, resulting in normal plasma glucose
(PG) levels, but higher UGE and a greater EGP induced by
PHZ resulted in lower minimum PG. Fitting of the titration
curve in cynomolgus monkeys showed that TOHO and PHZ
extend the splay without affecting TmG. These results sug-
gest that the contribution of SGLT1 to RGR is greater under
lower glycemic conditions, and that SGLT2 selective inhibi-
tors pose a lower risk of hypoglycemia than SGLT1/2 inhibi-
tors.22
2-CS-4 Visualization of mechanism
of action, and a further therapeutic
potential of ipragliflozin, a selective
SGLT2 Inhibitor
Toshiyuki Takasu, Shoji Takakura, Kaori Hamada,
Minori Saitoh
Drug Discovery Research, Astellas Pharma Inc.
In this session, the presenter will introduce the recent find-
ings of ipragliflozin (ipra), the first C glycoside SGLT2 se-
lective inhibitor synthesized in cooperation with Kotobuki
Pharmaceuticals Co. Ltd. Using positron emission tomogra-
phy, the mechanism of action of ipra in rat kidney was visual-
ized directly and dynamically. In order to investigate phar-
macological potential by inhibiting SGLT2, we examined the
effect of ipra on body composition of diet induced obese
(DIO) rats. Further, effect on the development of non alco-
holic fatty liver disease (NAFLD) was studied in choline defi-
cient L amino acid defined (CDAA) diet rats. As a result, it
was revealed that ipra reduced visceral and subcutaneous fat
masses but not lean mass or bone mineral content in DIO rats,
which was accompanied with enhanced lipolysis and fatty
acid oxidation. In CDAA diet fed rats, ipra prevented both
hepatic TG accumulation and large lipid droplet formation,
and exerted a prophylactic effect on liver fibrosis.
These findings suggest a variety of pharmacological action of
SGLT2 inhibitors caused by enhanced urinary glucose excre-
tion.
3-CS-2 A strategy to improve the
success rate of CNS drug development:
TAK 063, a novel PDE10A inhibitor, as a
case study
Haruhide Kimura
CNS Drug Discovery Unit, Pharmaceutical Research Division, Takeda
Pharmaceutical Company Limited
Principal mechanisms of current medications for psychiatric
diseases were primarily discovered by serendipity. The suc-
cess rate for central nervous system (CNS) drug development
is still low for several reasons, including a lack of knowledge
of disease pathophysiology and poor predictive validity of ani-
mal models. This presentation describes a strategy of CNS
drug development using a phosphodiesterase 10A (PDE10A)
inhibitor, TAK 063, as an example. By careful consideration
of the biology of the target and detailed biochemical studies,
we hypothesized that off rates of PDE10A inhibitors charac-
terize their pharmacological profile via the differential acti-
vation of the direct and indirect pathways in the stratum.
Based on this hypothesis, we discovered the PDE10A selec-
tive inhibitor TAK 063 with balanced activation of these
pathways via a faster off rate profile. Several biomarkers, in-
cluding PDE10A occupancy by positron emission tomogra-
phy, electroencephalogram, and pharmacological magnetic
resonance imaging, were used to bridge preclinical and clini-
cal studies. Original strategies to find differentiated drugs
and integration of translational studies will be a key to im-
proving the success rate for CNS drug development.S23-CS-1 Translating novel
therapeutics for neurodegenerative
disorders
Masanori Hizue
Drug Safety R＆D, Pfizer Inc.
As the world’s population continues to age, neurodegenera-
tive disorders such as Alzheimer’s and Parkinson’s diseases
represent significant unmet medical needs that require trans-
formational therapies. Without effective therapies, these dis-
orders will present significant societal, economic, and ethical
challenges. Significant effort within the pharmaceutical in-
dustry is focusing on delivering efficacious therapies that
could potentially modify the course of disease progression as
well as provide novel symptomatic treatment paradigms. By
utilizing a deep understanding of disease pathogenesis our
success at delivering innovative medicines should improve.
The application of human genetics informs target discovery,
validation and identification of pathways involved in disease
pathogenesis and focuses opportunities to utilize a precision
medicine based approach. We are currently focusing on novel
mechanisms rooted in human genetics to discover small mole-
cule disease modifying therapies for Alzheimer’s disease in
addition to focusing on agents that target specific domains as-
sociated with neuropsychiatric disorders. In this presenta-
tion, two case studies utilizing these approaches will be dis-
cussed.
3-CS-3 How to improve success rates
of the compounds acting on CNS using
biomarkers
Seishi Katsumata
Dis. Res. Lab. I, Dept. of Biology＆ Pharmacology ONO Pharmaceutical Co., Ltd
Regardless of the huge R&D investments, less than 10% of
the CNS drug candidates have been approved in US. The low
success rate is attributed to lack of efficacy in the late phases
of clinical trial. Genetic, blood, CSF, electrophysiological, and
imaging biomarkers are expected to contribute to identifying
right patients, selecting doses and deducing efficacy. Among
them, PET is often used for go/no go decision making.
In the phase 3 trial of anti Aβ antibody for Alzheimer’s dis-
ease, Aβ PET is used for identifying the patients with Aβ de-
posits in the brain. In the phase 1 trial of TSPO antagonist,
ONO 2952, relationship between plasma concentration and
TSPO occupancy was determined to select optimal doses in
the phase 2 trial for IBS. ONO 2952 could improve visceral
pain and bowel habits in female diarrhea predominant IBS pa-
tients with the predicted doses. Lack of efficacy of aprepitant
in several phase3 trials for depression with the doses in
which it occupies more than 80% of the NK1 receptor in the
brain suggests that NK1 receptor could not be appropriate
target for antidepressant.
These challenges indicate that biomarkers can contribute to
improving success rates of CNS drug candidates and early de-
cision making for further development.3
1-YS-1 Comprehensive cell analysis
of whole organ/body for the organism
level systems biology
Etsuo A. Susaki 1,2,3
1Dept. Systems Pharmacol., Grad. Sch. Med., UTokyo, 2 PRESTO, JST, 3 Lab.
synthetic biol., RIKEN QBiC
The multicellular organism is compose of various types of
cells inside, where they connect with each other and work in
a coordinated manner. The mechanism of an organism level
biological function, such as the sleep wake behavioral
rhythm, is implemented in the multicellular circuitry or the
multicellular system. In this talk, we will introduce a compre-
hensive cell and cell circuit analysis pipeline, termed CUBIC
(Clear, Unobstructed Brain/Body Imaging Cocktails and
Computational analysis). This includes an efficient and repro-
ducible whole organ and body clearing method, a rapid imag-
ing with light sheet fluorescence microscopy and computa-
tional image informatics, and supports the realization of the
organinsm level systems biology . This technology thus can
be applicable to the wide range of life science and medical re-
searches, and will facilitate our system level understanding
of the multicellular organism. References : Susaki et al. Cell
157 : 726 739, 2014Tainaka et al. Cell 159 : 911 924, 2014Susaki
et al. Nature Protocols 10, 1709 1727, 2015.
1-YS-3 Optogenetic fMRI for the
study of BOLD signal induction by
astrocytes
Norio Takata
Dept. Neuropsych., Keio Univ. Sch. Med.
Functional magnetic resonance imaging (fMRI) to localize
brain area responding to drug challenges is called pharma-
cological MRI (phMRI). fMRI measures blood oxygenation
level dependent (BOLD) signal, which has been used as a sur-
rogate marker of neuronal activities. Astrocyte, another ma-
jor component in the brain, has been assigned a subsidiary
role in BOLD signal generation ; responding to neuronal ac-
tivities, astrocytes dilate blood vessel diameter, resulting in
BOLD signal increase by changing oxy and deoxy hemoglo-
bin ratio. We hypothesized that astrocytes might also con-
sume oxygen and induce BOLD signal, which has been diffi-
cult to test because conventional methods stimulate both neu-
rons and astrocytes. To this end, we combined recent techno-
logical breakthroughs : optogenetic activation of astrocytes
in vivo (Cell Rep. 2 : 397 406, 2012) and mouse specific MRI
receiver (CryoProbe). We first prepared a transgenic mouse
whose astrocytes express a light sensitive cation channel,
channel rhodopsin 2. CryoProbe enabled us to perform fMRI
from a small brain of a mouse. We observed BOLD signal
upon the optogenetic activation of astrocytes without appar-
ent modulation of neuronal activities. Our results may sug-
gest astrocytes as a new pharmacological target in phMRI.S21-YS-2 Neural CircuitTracing with
Glycoprotein Deleted RabiesViruses
Fumitaka Osakada 1,2,3,4
1 Lab. Cell. Pharmacol., Grad. Sch. Pharm. Sci., Nagoya Univ., 2 Lab. Neural
Information Processing, Inst. Adv. Res., Nagoya Univ., 3 PRESTO, JST, 4 Systems
Neurobiol. Lab., Salk Inst.
The processing of neural information in neural circuits plays
a key role in brain functions. To gain mechanistic insights
about brain functions and to treat diseases of the nervous sys-
tem, it is crucial to understand what the neural circuits are
computing and how they achieve these computations. How-
ever, studying a specific neural circuit is extremely difficult
because most nervous system structures contain many types
of neurons with intertwined axons and dendrites. Here I will
describe rabies virus based system that makes it possible to
resolve connectivity with high resolution, to correlate con-
nectivity with function, and to manipulate the activity of de-
fined circuit components. Rabies viruses have been used for
anatomical studies because they spread transsynaptically in
the retrograde direction and only between connected neurons
Our system is based on rabies viruses whose glycoprotein
gene has been deleted from the genome, making it possible to
control the transsynaptic spread of the virus and to select
specific neurons or neuron types for primary infection. This
also allows circuits of specific neurons to be more directly
linked to function for physiological and behavioral studies.
1-YS-4 Visualization of Ca2+
dynamics within the endoplasmic
reticulum for the investigation of
neuronal and astrocytic functions
Yohei Okubo 1, Junji Suzuki 1, Kazunori Kanemaru 1,
Naotoshi Nakamura 2, Tatsuo Shibata 2, Masamitsu Iino 1
1Dept. Pharmacol., Grad. Sch. Med., Univ. of Tokyo, 2 Lab. for Phys. Biol., RIKEN
QBiC
Ca2+ is a key messenger that regulates neuronal and astro-
cytic functions in the brain. Although the endoplasmic reticu-
lum (ER) plays indispensable roles as a source and sink of
Ca2+, technical difficulties have impeded analysis of Ca2+ dy-
namics within the ER. In this study, we have used a geneti-
cally encoded ER Ca2+ indicator, G CEPIA1er to visualize
Ca2+ dynamics within ER. We found that Ca2+ mobilizing syn-
aptic inputs locally decreased the ER Ca2+ concentration, fol-
lowed by Ca2+ replenishment by intraluminal Ca2+ diffusion
throughout the ER of dendrites and spines. Furthermore, Ca2+
spike inducing synaptic inputs cumulatively increased the
ER’s Ca2+ content. Thus our study indicates that the ER func-
tions both as a tunnel to redistribute stored Ca2+ and as a
leaky integrator of synaptic inputs in neurons. We also found
ER Ca2+ dynamics in astrocytes induced by behavior and drug
treatment. Collectively, these ER Ca2+ visualization studies
provide important new insights to ER Ca2+ dynamics in neu-
rons and astrocytes.4
2-YS-1 Pharmacogenetics to study
synapse competition
Ryuta Koyama
Lab. Chem. Pharmacol., Grad. Sch. Pharmaceut. Sci., Univ. Tokyo
The formation of mature neural circuits requires selective
pruning of inappropriate synapses and strengthening of ap-
propriate synaptic connections, i.e., synapse competition. A
longstanding question in neurobiology is what determines
which synapses will be eliminated? While the role of sponta-
neous and experience driven synaptic activity in develop-
mental synaptic pruning is well established, surprisingly lit-
tle is known about the molecules and mechanisms that link
neural activity with the physical elimination of specific syn-
apses. In order to dissect the mechanisms that drive the elimi-
nation of specific CNS synapses, a reliable in vitro model is
necessary. In this talk, I will introduce a novel retinogenicu-
late co culture system in which the activity of axons from
retinal ganglion cells can be modulated by pharmacogenet-
ics : we used the DREADD (Designer Receptors Exclusively
Activated by Designer Drugs) system, in which the activa-
tion of G protein coupled receptors (Gq, Gi, and Gs) engi-
neered from muscarinic receptors can be precisely con-
trolled by a ligand named clozapine N oxide (CNO) which is
otherwise pharmacologically inert.
2-YS-3 Multi unit recording with
microgenetic manipulation for studying
hippocampal information processing
Takuma Kitanishi 1, Sakiko Ujita 2,
Mehdi Fallahnezhad 1,3,4, Naomi Kitanishi 1,
Yuji Ikegaya 2,5, Ayumu Tashiro 1,3,4
1 Kavli Inst. for Systems Neurosci., Norwegian Univ. of Sci. and Tech., 2 Lab. Chem.
Pharmacol., Grad. Sch. Pharmaceut. Sci., Univ. Tokyo, 3Warwick NTU Neurosci.
Programme, Sch. Biol. Sci., Nanyang Technological Univ, 4Warwick NTU
Neurosci. Programme, Sch. Life Sci., Univ. Warwick, 5 Center for Information and
Neural Networks
Firing patterns of individual neurons are determined by the
interaction of synaptic inputs with cellular mechanisms. To
investigate the cellular mechanism mediating a specific fir-
ing pattern, interfering with the cellular machinery of inter-
est under intact input activity is crucial. To achieve this, we
devised a virus mediated approach to perform extracellular
unit recording from genetically manipulated neurons in the
intact brain environment, and examined a role of synaptic
plasticity for hippocampal firing activity. We showed that
synaptic plasticity dependent on the GluR1 subunit of AMPA
receptor mediates two dynamic changes in neuronal firing in
the hippocampal CA1 area during novel experiences : (i) the
establishment of phase locked firing to slow gamma oscilla-
tions, which is thought to originate from the CA3 area, and
(ii) the rapid formation of the spatial firing pattern of place
cells. The results suggest a series of events potentially under-
lying the acquisition of new spatial information : slow
gamma oscillations induce the two GluR1 dependent changes
of CA1 neuronal firing, which in turn determine information
flow in the hippocampal entorhinal system.S22-YS-2 In vivo analysis of reward
signal based on flex system: mode of
action in D1R MSNs
Taku Nagai 1, Mutsuki Amano 2, Kiyofumi Yamada 1,
Kozo Kaibuchi 2
1Dep. Neuropsychopharmacol. Hosp. Pharm., Nagoya Univ. Grad. Sch. Med.,
2Dept. Cell Pharmacol., Nagoya Univ. Grad. Sch. Med.
It is well known that dopamine (DA) is necessary for motor
function, motivation, working memory and reward. The prin-
cipal target of DA is medium spiny neurons (MSNs), which
are a special type of GABAergic inhibitory cell that repre-
sents 95% of the neurons within the striatum, including the
nucleus accumbens (NAc). There is a distinct class of spa-
tially intermixed MSNs that express DA type 1 or 2 receptors
(D1R MSNs or D2R MSNs, respectively). D1R is coupled to
adenylate cyclase through Golf to activate protein kinase A
(PKA), whereas D2R inhibits adenylate cyclase through Gi.
Although PKA has been implicated in reward signals down-
stream of D1Rs by pharmacological approaches, there is no
direct evidence indicating that PKA in D1R MSNs regulates
neuronal excitability and reward related behaviors. We es-
tablished the system in which wild type PKA (wtPKA) or
constitutively active mutant PKA (caPKA) was expressed in
the NAc under the control of specific promoters for D1R
MSNs using adeno associated virus (AAV) mediated condi-
tional transgenic techniques. In this symposium, I will discuss
in vivo analysis of reward signal based on flex system to elu-
cidate mode of action in D1R MSNs.
2-YS-4 FAST: a new block face serial
microscopy tomography for high speed
imaging and an unbiased comparative
analysis
Atsushi Kasai 1, Hitoshi Hashimoto 1,2,3
1 Lab. Mol. Neuropharmacol., Grad. Sch. Pharmaceut. Sci., Osaka Univ., 2 iPS Cell
based Res. Project on Brain Neuropharmacol. and Toxicol., Osaka Univ., 3Mol. Res.
Center for Children’s Mental Dev., United Grad. Sch. Child Dev., Osaka Univ.
Recent remarkable progress in optical microscopy has facili-
tated whole brain imaging to systemically understand ana-
tomical and functional brain networks. However, whole
brain imaging at a resolution sufficient to discriminate all of
the cells in the brain is still challenging due to trade offs be-
tween imaging speed and spatial resolution. Here we have de-
veloped a new automated imaging system, named FAST
(block f ace s erial microscopy t omography), that consists of
a confocal microscope and a built in tissue slicer system.
FAST system provides whole brain images at subcellular
resolution with unprecedented speed. In combination with
fluorescence labeling methods, FAST system enables the
visualization of neural activities and neural circuits in the
whole brain. In addition, we achieved unbiased and quantita-
tive comparisons of the whole brain images. The quantitative
comparison detected cell loss and neural activities induced by
various stressors. Thus, FAST system can provide not only
detailed brain mapping, but also comprehensive information
about structural and functional changes in the brain, which
contribute to a solid understanding of brain systems.5
1-PMS-1 Immunology cures diverse
rheumatic diseases: a perspective on
immunopharmacology
Masaru Ishii
Dept. Immunol. Cell Biol., Osaka Univ. Grad. Sch. Med.
Drugs targeting the immune system have been widely ex-
ploited in the treatment of inflammatory, allergic and autoim-
mune disorders during the second half of the 20th century.
The recent advances in immunopharmacological research
made available new classes of clinically relevant drugs, com-
prising protein kinase inhibitors and biologics, such as mono-
clonal antibodies that selectively modulate the immune re-
sponse not only in cancer and autoimmunity but also in a
number of additional human pathologies. The newly formed
ImmuPhar is the Immunopharmacology Section of the Inter-
national Union of Basic and Clinical Pharmacology, providing
a unique international expert-lead platform aiming to dissect
and promote the growing understanding of immune system
as well as to challenge the identification and validation of
drug targets and lead candidates for the treatment of many
forms of debilitating diseases including, among others, can-
cer, allergies, autoimmune and metabolic diseases. In this
symposium I will outline the current movement on immuno-
pharmacology in Japan as well as in the world, focusing on
the activity of ImmuPhar, and discuss future perspectives in
this promising field.
1-PMS-3 Significance of Clinical
Pharmacology in Development of Drugs
forAutoimmune Diseases.
Shinichi Kawai
Div. Rheumatol., Dept. Intern Med., Toho Univ. Sch. Med.
Clinical pharmacology is an academic field of investigating
clinical use of drugs. It is tightly linked to the basic pharma-
cology, with special focus on the application of pharmacologi-
cal theory to the actual clinical therapeutics. Clinical pharma-
cology includes wide spectra from clinical development of
drugs against new target molecules, to the practical informa-
tion of how to use drugs. The etiology of autoimmune dis-
eases remains unclear at present, but advances have been
made in the elucidation of its pathophysiology based on pro-
gress in molecular biology and related fields. As a conse-
quence, many attempts have been made to develop new meth-
ods of treatment. Especially, recent treatment of rheumatoid
arthritis has been advanced dramatically.In this presentation,
I will introduce the current drug development for autoim-
mune diseases. In addition, I will also introduce our recent
clinical studies conducted to elucidate the ethnic differences
in pharmacokinetics of several drugs among the east Asian
populations and Caucasians.S21-PMS-2 Inflammatory mediators that
regulate immune cells and therapeutic
targets
Masataka Majima
Dept. Mol. Pharmacol., Grad. Sch. Med. Sci. Kitasato Univ.
Inflammation is a set of complex biological responses to
harmful stimuli such as pathogens, damaged cells, and irri-
tants. Inflammation is a protective response that involves im-
mune cells, blood vessels, and molecular mediators, and its
purpose is to eliminate the initial cause of cell injury, to clear
out tissues damaged from the original insults, and to initiate
tissue repair. We had shown that authentic inflammatory me-
diators, arachidonic acid metabolites including prostagland-
ins (PGs) and leukotrienes (LTs) regulated immune cells and
became good therapeutic targets. A PGE receptor, EP signal-
ing enhanced chronic inflammation via inducing isoforms of
vascular endothelial growth factors that regulate angiogene-
sis and lymphangiogenesis. Further, it also facilitated tumor
lymph node metastasis via formation of premetastatic niche
affecting dendritic cells and regulatory T cells. A LT recep-
tor, BLT1 signaling exhibited the chemotactic activity on
mast cells to form the proangiogenic microenvironment.
These indicate that the field of arachidonic acid metabolites
is quite rich with therapeutic candidates that modulate im-
mune cell functions.
1-PMS-4 A novel direction of human
immunology research and its relevance
to drug discovery
Kazuhiko Yamamoto
Dept. Allergy and Rheumatology, The Univ. Tokyo, Sch. Med
Although basic concept of immunology has been greatly pro-
gressed using mouse system, understanding human immune
system remains unsatisfactory. One of the advantages of mice
is knockout technology, which clearly indicates targeted gene
is the cause of phenomena. In human, it is impossible to util-
ize such technology. However, gene polymorphisms are in-
herited prior disease. Therefore, disease risk polymorphisms
indicate the causality of disease.Recent genome wide associa-
tion studies (GWAS) have uncovered numerous risk genes.
We conducted a trans-ethnic GWAS meta-analysis for rheu-
matoid arthritis (RA) through international collaboration and
identified 101 RA risk loci. A systematic evaluation of the
overlap between RA risk genes and the target genes of ap-
proved drugs suggest that disease risk genes are promising
resources for drug discovery. Forty four out of 100 non-HLA
SNPs were found in cis-acting expression quantitative trait
loci (cis-eQTL). This indicates that majority of disease-
causing variants affect the expression of genes. Using these
findings, we believe that we can construct pathway interac-
tions of genes and cells, which will unravels complex re-
sponses of immune related genes and cells and will give novel
insights into human immune system.6
2-PPS-1 Optogenetic control of
descending noradrenergic system and in
vivo analysis of its antinociceptive
action
Hidemasa Furue
Dept Information Physiol., Nat. Inst. Physiol. Sci.
Locus coeruleus (LC) neurons in the brain stem send norad-
renergic projections throughout the neuroaxis and are impli-
cated in the control of many homeostatic functions such as
arousal, cardio respiratory control. In addition, the LC is also
a major source of noradrenergic projections to the spinal su-
perficial dorsal horn which play an important role in pain
modulation. Clinically alpha 2 adrenoceptor agonists are
widely used as sedative agents, and LC is also principal site
for their sedative action. We have examined how descending
noradrenergic neurons inhibit spinal nociceptive transmis-
sion by using in vivo recordings of spinal nociceptive synap-
tic transmission and optogenetic control of LC neurons. Op-
toactivation of the LC neurons expressing ChR2 elicited a
barrage of spinal inhibitory GABAergic synaptic responses.
This activation was mediated by alpha 1 receptors expressed
in spinal GABAergic neurons. Systemic administration of al-
pha 2 agonist also enhanced the descending noradrenergic
control of spinal GABAergic transmission at low doses that
produce minimal sedative action. This novel analgesic mecha-
nism may provide new targets for intervention allowing anal-
gesic actions to be dissociated from unwanted sedation.
2-PPS-3 New approach for elucidating
neuropathic allodynia using
optogenetics
Makoto Tsuda
Dept Life Innov., Grad. Sch. Pharmaceut. Sci., Kyushu Univ.
A cardinal symptom of neuropathic pain is characterized by
tactile allodynia (pain hypersensitivity evoked by innocuous
mechanical stimuli). Effective therapy for this pain is lack-
ing, and the mechanisms are unclear. Since myelinated pri-
mary afferent Aβ fibers transmit innocuous mechanical in-
formation from the skin to the spinal dorsal horn (SDH), it
has been hypothesized that pathological altered signaling
from Aβ fibers might be implicated in tactile allodynia. How-
ever, there is no tool to selectively stimulate Aβ fibers in
vivo , and thus whether stimulation of Aβ fibers causes pain
after PNI remains unknown. In this talk, I will show our re-
cent findings using optogenetics. After PNI, blue light stimu-
lation of the plantar skin of transgenic rats (ChR2V) that had
expressed channelrhodopsin 2 mainly in Aβ fibers among
primary afferent populations, exhibited pain like withdrawal
responses. Electrophysiological studies revealed the exis-
tence of excitatory inputs from Aβ fibers to lamina I SDH
neurons in PNI ChR2V rats, implying a conversion of Aβ fi-
ber mediated innocuous information to pain. Thus, this
might provide a new approach for investigating the mecha-
nisms underlying neuropathic allodynia and evaluating the
analgesic effects of drugs.S22-PPS-2 Role of orexin neurons on
pain sensation
Akihiro Yamanaka, Ayumu Inutsuka,
Akira Yamashita
Dept. Neurosci. II, Res. Inst. Env. Med. Nagoya Univ.
Orexin is a neuropeptide synthesized small number of neu-
rons located in the hypothalamus. Recent study revealed that
sleep disorder Narcolepsy is caused by specific loss of orexin
neurons. This fact suggests that orexin neurons have an im-
portant role in the regulation of sleep/wakefulness. However,
narcolepsy patients show not only abnormality of sleep/wake-
fulness but also abnormality of metabolism. Additionally, nar-
colepsy patients showed increase in chronic pain suggesting
role in pain sensation. Here we generated Narcolepsy model
mice which orexin neurons are specifically ablated at desired
timing. Orexin ablated mice showed decreased in pain thresh-
old means sensitive to pain. Conversely, activity of orexin
neurons are activated by using pharmacogenetics. Activation
of orexin neurons increased pain threshold indicates that
mice showed analgesia. Finally, we measured the activity of
orexin neurons in free behaving mice by using fiber photome-
try. Calcium probe, GCaMP6, was exclusively expressed in
orexin neurons. Mice were applied by mechanical pain and
heat pain. The activity of orexin neurons was increased by
applying mechanical or heat pain. Taken together, we re-
vealed that the activity of orexin neurons have an important
role in the sensing pain.
2-PPS-4 Analysis of “pain activated
network” and “pain ON cells” for
identification of the mechanism of
chronic pain
Minoru Narita 1,2
1Dept. Pharmacol., Hoshi Univ., 2 L StaR, Hoshi Univ.
Chronic pain, especially, neuropathic pain, often has a nega-
tive effect on the patient’s quality of life, can act as a stressor
and increases the incidence of anxiety and depression. How-
ever, the molecular mechanism of such refractory pain is not
fully understood. An optogenetic approach and a designer re-
ceptor exclusively activated by designer drug (DREADD)
system have emerged as powerful tools for studying the
“pain activated network”. As well as the neuronal network
analysis, the “pain ON cell” sorting and its multi Omics pro-
filing are useful for identifying the molecular mechanism of
chronic pain. Additionally, more recent advances using
highly reproducible and sensitive detection methods have im-
proved our ability to document cellular phenotypic variation
of “pain ON cells”. In this symposium, I will introduce our re-
cent multi analysis for the “pain activated network” and
“pain On cells”.7
2-PTS-1 Progress in Gas Phamacology
Akio Matsumoto
Dept. Pharmacol., Chiba Univ. Grad. Sch. Med.
Although it has been known that a various gases are pro-
duced particularly in the gut by microbes, an endogenous gas
production such as NO and CO in mammalian cells has estab-
lished entirely new principle for intercellular signaling since
gaseous molecule can easily travel through membrane and
migrate into adjacent cells. These small molecules activate
mainly cGMP pathways ; furthermore, they utilize thiol re-
activity to exert their biological functions in all classes of sig-
naling pathways. Biochemical modifications on thiol by these
molecules usually compete with O2. Thus, gas signaling has to
consider O2 concentration at the site of action. Much attention
has been paid to the chemical properties of thiol modification
to segregate the mode of action by each molecule. Recent
findings on poly sulfur modification have provided variable
clues on the accumulated knowledge. Although it has not
been clarified the molecular mechanism to exert the biologi-
cal action, molecular hydrogen is coming into the field. Be-
sides the anti oxidative activity to eliminate OH・, molecular
hydrogen potentiates β receptor signal and transfer the ac-
tivity. This session will provide basic concepts of thiol based
modifications with gaseous molecules and their clinical impli-
cations from the point of view in gas pharmacology.
2-PTS-3 Increase in cardiac risk by
electrophile mediated activation of
dynamin related protein 1
Motohiro Nishida 1,2,3
1Div. Cardiocirc. Signal., Okazaki Inst. Integr. Biosci., 2Dept. Translat. Pharm.
Sci., 3 PRESTO, JST
Covalent modification of GTP binding protein by endogenous
electrophiles, such as 8 nitro guanoshine 3’,5’ monophos-
phate (8 nitro cGMP), promotes myocardial early senes-
cence. Exogenous treatment with NaHS improved heart fail-
ure by eliminating 8 nitro cGMP accumulation. However,
using a novel techniques to measure intracellular reactive
sulfur species, we found that NaHS per se hardly eliminates
electrophiles in vitro, and formation of more nucleophilic sul-
fur species, such as Cys persulfide/polysulfide in proteins,
predominatly eliminates endogenous electrophilies in the
heart. We also revealed that hypoxic stress or exogenous
treatment with an electrophile, such as methylmercury
(MeHg), induces mitochondrial hyper fission via electro-
philic modification of rodent dynamin related protein 1 (Drp
1). Polysulfide detection assay revealed that endogenous Drp1
forms Cys persulfide in rat cardiomyocytes, and persulfide
level is dramatically reduced by MeHg exposure. Treatment
with NaHS for 24 hrs completely suppresses MeHg induced
activation of Drp1 and mechanical stress induced cardiac in-
jury. These results strongly suggest that S polythiolation of
Drp1 underlies suppression of eletrophile mediated cardiac
vulnerability to hemodynamic overload.S22-PTS-2 Molecular mechanism of ER
dysfunction triggered by nitric oxide
Takashi Uehara
Dept. Med. Pharmacol., Grad. Sch. Med., Dent.＆ Pharm. Sci., Okayama Univ.
Treatment with high concentration or prolonged exposure of
nitric oxide (NO) results in neuronal cell death or neurode-
generative disorders such as Parkinson’s or Alzheimer’s dis-
ease. We have demonstrated that NO induces S nitrosylation
of protein disulfide isomerase (PDI) which specifically exists
in the lumen of endoplasmic reticulum (ER). The protein S
nitrosylation contributes to the accumulation of immature un-
folded proteins due to the inactivation of PDI enzymatic ac-
tivity via that reaction. In general, the specific signals in re-
sponse to ER stress are activated via the sensors including
IRE1, PERK, and ATF6, located in the ER membrane. We
are attempting to resolve how the sensors are activated by
NO in neuronal cells. Using a specific detection system for
unfolded protein response (UPR) signal, we recently found
that IRE1 XBP1 branch is preferentially inactivated by
treatment with NO donors. Our findings reveal that nitrosa-
tive stress leads to dysfunctional UPR, thus contributing to
neuronal apoptosis/neurodegenerative diseases.
2-PTS-4 Capture of reactive sulfur
species by environmental electrophiles
Yoshito Kumagai
Fac. Med. Univ. Tsukuba
Environmental electrophiles covalently modify protein thiols,
resulting in protein adducts formation. For example, meth-
ylmercury (MeHg) activates some redox signal transduction
pathways through covalent modification of sensor proteins at
nontoxic concentrations. It is therefore recognized that acti-
vation of the signaling pathways associated with cellular pro-
tection causes elevation of the threshold for environmental
electrophile mediated cell damage. We isolated an unknown
metabolite of MeHg from SH SY5Y cells exposed to MeHg
and from the liver of rats given MeHg, which we identified as
(MeHg)2S. Our recent findings indicate that (MeHg)2S is pro-
duced as a result of the capture by MeHg of a mobilized sul-
fur atom from endogenous reactive sulfur species (RSS) such
as GSH persulfide (GSSH), its polysulfide (GSSSG) and even
protein bound RSS. Because RSS have high nucleophilicity
and antioxidant capability, substantial (MeHg)2S formation is
associated with a reduction in nucleophilic and/or reductive
cellular status. Thus, we propose a new concept : RSS pro-
tect cells from electrophilic insults, and excessive exposure
to electrophilic species appears to deplete these RSS, which
leads to greater susceptibility to electrophile dependent tox-
icity.8
2-PTS-5 Formation mechanisms and
redox regulatory functions of reactive
persulfide and protein polysulfur species
Takaaki Akaike
Dept. Envrion. Sci. Molecular Toxicol., Tohoku Univ. Grad. Sch. Med.
Cysteine persulfide is known to be a physiological metabolite
formed ubiquitously in various organisms. We recently iden-
tified appreciable generation of cysteine persulfide in cul-
tured cells and in vivo. These reactive sulfur species like per-
sulfides and related species (e.g., hydropolysulfides) were po-
tent scavengers for reactive oxygen species and showed a
strong redox signaling regulatory function via electrophile
thiolation. The best example is a chemical and biological in-
teraction of persulfide species with the endogenously gener-
ated electrophile 8 nitro cGMP. The biological relevance of
cysteine persulfides/polysulfides is now increasingly recog-
nized as essential structural residues or prosthetic compo-
nents of many proteins and enzymes, which may include
metal ligands most typically observed with iron sulfur clus-
ters. Surprisingly, a clear translation coupled cysteine poly-
sulfuration is revealed herein and its incorporation into pro-
teins ubiquitously occurs among different organisms. Clarifi-
cation of molecular mechanisms of biosynthesis and physi-
ological functions of polysulfur proteins may potentially pro-
mote a paradigm shift of molecular and chemical biology,
opening up to a new era of innovation in the redox biology.
1-S-01-1 The regulatory functions of
microglia in brain development and their
application possibility in the drug
development and therapeutics
Kaoru Sato
Lab. Neuropharmacol., Div. Pharmacol., NIHS
CNS microglia have long been considered as resident immune
cells, which are activated in response to pathological events.
In pathological conditions, they change their morphology to
an amoeboid shape, acquiring activation specific phenotypes,
such as chemotaxis, phagocytosis, and secretion of inflamma-
tory cytokines in the surrounding environment, thereby de-
termining the extent of inflammation. However, There is in-
creasing evidence that microglia also play diverse roles in
brain development. For example, we recently clarified that
activated microglia accumulate in the subventricular zone
and enhanced neurogenesis and oligodendrogenesis during
the early postnatal period. After P14, they dispersed to white
matter where they became more ramified. More recently, we
clarified that microglia significantly enhanced the functional
maturation of blood brain barrier. In both situations, micro-
glia reveal their regulatory effects through regulating the cy-
tokine/chemokine dynamics of surrounding environments.
We may therefore achieve more efficient therapeutic effects
if we clarified the combinations of cytokine/chemokines es-
sential for the regulatory functions of microglia in brain de-
velopment.S22-PTS-6 Mutual redox modification of
NO and reactive sulfur species
Yasuo Watanabe
Dept. Pharmacol., Showa Pharmaceutical Univ.
Hydropersulfides on protein Cys residues (S sulfhydration)
play important roles for modulation of protein structure and
functions. The reactive sulfur species like cysteine hydroper-
sulfides is generated by cystathionine γ lyase (CSE), which in
turn may contribute to other cysteine hydropersulfides de-
rivatives of proteins in cells. Indeed, a large number of S
sulfhydrated proteins have been identified using proteomic
methods in CSE operated cells. Recent results have identi-
fied Ca2+/calmodulin dependent protein kinases (CaMKs) and
nitric oxide synthases (NOSs) as S sulfhydrated enzymes. In-
terestingly, treatment of CSE or CaMKs with S nitrosocyste-
ine results in an inactivation of each enzyme activity via its
S nitrosylation. Thus, reactive sulfur and NO signaling are
mutually regulated through the S sulfhydrated and S nitro-
sylated modification of specific proteins. To clarify impor-
tant biological function of hydropersulfides in cells, the fluo-
rescent probes are useful tools for their visualization. Recent
research has assigned redox dependent functions to specific
hydropersulfides including biosynthesis, control of enzyme
activity, and role as redox sensor.
1-S-01-2 Regulation ofTissue Stem
Cells in Hair Follicle Regeneration and
Aging
Emi Nishimura, Nan Liu
Dept. Stem Cell Biol., Medical Research Institute, Tokyo Med. Dent. Univ.
The hair follicle is a mini-organ of the skin that is specialized
to grow hair. Somatic stem cells including hair follicle stem
cells and melanocyte stem cells and their progeny interact
and regulate each other to grow a pigmented hair. To under-
stand the mechanisms of senescent baldness and hair graying,
we have studies the aging-associated changes in murine and
human hair follicles and found that the fate of somatic stem
cells becomes dys-regulated by aging thereby causing the ag-
ing phenotypes. Furthermore, we found that the control of
the key step can prevent the expression of the hair follicle ag-
ing. In this symposium, mechanisms of tissue and organ aging
and potential strategies for anti-aging will be discussed.9
1-S-01-3 Modeling human
neurological diseases using iPSC
derived neural stem cells with subtype
specificity
Wado Akamatsu
Center for Genomic and Regenerative Medicine
Although in vitro disease models employing human pluripo-
tent stem cells (PSCs) have great potential to clarify the asso-
ciation of neuronal subtypes with disease, it is currently diffi-
cult to compare various PSC derived subtypes due to variety
of cultivation procedures. Here, we report a culture system
to control the regional identity of PSC derived neurons along
the anteroposterior (A P) and dorsoventral (D V) axis just
adding several small molecules and growth factors. In the
ALS iPSC derived neurons, neurite swellings were observed
preferentially in neurons with the characteristics of the ven-
tral spinal cord. In contrast, the numbers of p tau+spots are
increased in neurons with forebrain characteristics derived
from Alzheimer’s disease (AD) patients. These data sug-
gested that specific brain regions are preferentially damaged
in most neurological diseases and regional specificity of neu-
ral stem cells must be an important factor for neural disease
modeling with iPSCs.
1-S-02-1 Development of endothelial
dysfunction induced aortic dissection
model and search for a preventive
strategy
Yuki Izawa Ishizawa 1, Masaki Imanishi 2,
Yoshitaka Kihira 1, Licht Miyamoto 3,
Yoshito Zamami 2,4, Yasumasa Ikeda 1,
Koichiro Tsuchiya 3, Toshiaki Tamaki 1,
Keisuke Ishizawa 2,4
1Dept. Pharmacol, Inst. Biomed. Sci., Tokushima Univ. Grad. Sch., 2Dept. Pharm.,
Tokushima Univ. Hosp., 3Dept. Med. Pharmacol., Inst. Biomed. Sci., Tokushima
Univ. Grad. Sch., 4Dept. Clin. Pharm., Inst. Biomed. Sci., Tokushima Univ. Grad.
Sch.
Aortic dissection (AD) is considered to be based on hyperten-
sion and degradation of media. Endothelial dysfunction also
might be necessary for AD onset. However, the detailed mecha-
nism of AD is still unknown. We have tried to develop a novel
mice model showing a high incidence of AD based on pharma-
cologically induced endothelial dysfunction. In our recent
study, it was revealed that pitavastatin, a HMG CoA reductase,
showed endothelial protective effect and anti inflammatory ef-
fect. Therefore we have also assessed the effect of pitavastatin
on our novel AD model.C57Bl/6J mice were treated with Nω
nitro L arginine methyl ester (L NAME), a nitric oxide (NO)
synthase inhibitor, to induce endothelial dysfunction, and fol-
lowed by the administration of angiotensin II (Ang II) and β
aminopropionitrile (BAPN). Incidence of AD and lethal rupture
was significantly increased in L NAME, Ang II, and BAPN
(LAB) group compared with Ang II and BAPN (AB) alone. Ad-
ministration of pitavastatin significantly increased NO produc-
tion in aorta and suppressed AD onset compared to LAB group.S1-S-01-4 Direct Cardiac
Reprogramming for Heart Regeneration
Masaki Ieda 1, Takeshi Suzuki 2
1Dept. Cardio, Keio Univ. Sch. Med., 2 Faculty Parmacy, Keio. Univ.
Despite recent progress in cardiovascular biology and medi-
cine, heart failure remains a leading cause of death and new
therapies are highly demanded. Due to the limited regenera-
tive capacity of cardiomyocytes, regenerative therapy has
emerged as an attractive approach for the treatment of heart
failure, and direct cardiac reprogramming from fibroblasts
might be a powerful strategy toward this goal. We first re-
ported that a combination of three cardiac specific transcrip-
tion factors, Gata4, Mef2c, and Tbx5 (GMT), could directly
reprogram mouse fibroblasts into cardiomyocyte like cells in
vitro (Ieda et al. Cell, 2010). Subsequently, we and others dem-
onstrated that gene transfer of the cardiac reprogramming
factors in the mouse infarct hearts could directly convert en-
dogenous cardiac fibroblasts into cardiomyocyte like cells in
vivo (Inagawa et al. Circ Res, 2012). In human, addition of
Myocd and Mesp1 to GMT (GMTMM) reprogrammed human
cardiac fibroblasts into cardiomyocyte like cells (Wada et al.
PNAS, 2013, Muraoka et al. EMBO J, 2014). Although more
refinements are needed, these findings might inform new re-
generative strategies for the treatment of heart failure (Sada-
hiro et al, Circ Res, 2015).
1-S-02-2 Underlying mechanisms for
arteriosclerosis in Intermittent hypoxia
or biomechanical stretch
Yoji Kyotani 1, Shin Takasawa 2, Jing Zhao 1,
Kentaro Ozawa 1, Masanori Yoshizumi 1
1Dept. Pharmacol., Nara Medical Univ. Sch. Med., 2Dept. Biochem., Nara Medical
Univ. Sch. Med.
Atherosclerosis is caused by several factors, such as diabetes,
hypertension and dyslipidemia. Among these factors, ob-
structive sleep apnea characterized by intermittent hypoxia
(IH) during sleep, is well known as a risk factor, but its
mechanisms have not been elucidated. Recently, we have
shown that IH directly induces rat aortic smooth muscle cells
(RASMCs) proliferation which is important step in progres-
sion of atherosclerosis with up regulation of several epider-
mal growth factors and erbB2 receptor mRNAs. In addition,
erbB2 receptor inhibitor suppressed IH induced RASMC
proliferation.
It is thought that acute aortic dissection is accompanied by
vascular smooth muscle cell death, because aortic dissection
is characterized by aortic medial degeneration. We investi-
gated the effects of mechanical stretch, which mimics an
acute rise in blood pressure, on RASMC death. Mechanical
stretch induced RASMC death and activation of c Jun N ter-
minal kinase and p38. In addition, mechanical stretch in-
duced RASMC death was suppressed by azelnidipine.
Further investigation of the effects of IH and mechanical
stretch on vascular smooth muscle cells may be clews for es-
tablishing treatments or prophylaxes of atherosclerosis and
acute aortic dissection.30
1-S-02-3 A new strategy for the
treatment of metabolic disease, with a
focus on MGAT inhibitor
Chihiro Okuma 1,2, Takeshi Ohta 1, Shinichi Kume 2,
Hironobu Tadaki 1, Hiromi Hamada 1, Tomohiro Oda 1,
Hideyuki Taniuchi 1, Yukihito Ishii 1,
Tatsuya Ishigure 1, Shohei Sakata 1, Jun Nishiu 1,
Makoto Kakutani 1
1 CPRI. JT, 2 Lab. Auimal Physiol. and Funct. Anat., Dept. Agric., Kyoto Univ.
Atherosclerosis is accelerated by metabolic diseases. From
this point of view, to efficiently and effectively manage the
risk factors is regarded as important for prevention of athe-
rosclerosis.Monoacylglycerol acyltransferases (MGATs)
catalyze in the first step of triglyceride synthesis and are in-
volved in dietary fat absorption. Recently, it has been shown
that MGATs are closely associated with metabolic diseases
such as obesity, type2 diabetes and nonalcoholic fatty liver
disease, which are risk factors of atherosclerosis.JTP 103237
is a novel MGAT2 inhibitor generated in our institute. In
studies with diet induced obesity mice, JTP 103237 de-
creased body weight gain in a dietary fat dependent manner
and improved glucose tolerance. In addition, it decreased he-
patic TG contents and partly increased energy expenditure.
In the studies with high sucrose diet fed mice, JTP 103237
decreased TG contents, de novo lipogenesis and SREBP1c ex-
pression in liver. Moreover, it decreased plasma cholesterol
levels.Although there is room for further investigation in-
cluding prevention study in atherosclerosis models, JTP
103237 is expected to be a unique drug for the treatment of
metabolic diseases and new option for management of athero-
sclerosis.
1-S-03-1 New functions of reactive
astrocytes
Schuichi Koizumi
Dept. Neuropharmacol., Interdiscip. Grad. Sch. Med., Univ. Yamanashi
Astrocytes become reactive in the several inflammatory and
neurodegenerative diseases, which control a big variety of
brain functions including excitability and morphology of neu-
rons. “Reactive astrocyte” is a well used term in several
pathological conditions, many of which are thought to be cor-
related to pathogenesis of the diseases. However, reactive as-
trocytes have a big variety of forms, some of which are
thought to be rather beneficial for the brain functions. Here,
we show that two types of reactive astrocytes after brain
ischemia using middle cerebral artery occlusion (MCAO)
model of mice. After a brief non lethal MCAO (precondition-
ing), astrocytes become reactive and express P2X7 receptors
that induced ischemic tolerance. This astrocytic P2X7 recep-
tor was a required for the induction of ischemic tolerance. In
addition, we previously showed that an increase in Ca2+ ex-
citability in astrocytes in the primary somatosensory cortex
is a primary cause of synaptic remodeling in a model of neu-
ropathic pain in mice. Unlike preconditioning evoked ones,
these astrocytes are different form PC induced neuroprotec-
tive reactive astrocytes, but rather synapse forming pheno-
type. We also discuss molecular based mechanisms underly-
ing distinct phenotype of reactive astrocytes.S1-S-02-4 Progression of
arteriosclerosis from a point of view of
ROCK: a translational study
Kensuke Noma 1,2, Yasuki Kihara 3, Yukihito Higashi 1,2
1Dept. Regene. and Med., Med. Cent. for Transp. and Cli. Res., Hiroshima Univ.
Hosp., 2Dept. Cardiovasc. Regene. and Med., Res. Cent for Rad. Genome Med.,
RIRBM, Hiroshima Univ., 3Dept. Cardiovasc. Med., Hiroshima Univ.
Recently, there is accumulating evidence that the increase on
Rho associated coiled coil forming kinase (ROCK) activity
could evoke the onset and progression of cardiovascular dis-
ease. Therefore, we sought to determine the clinical signifi-
cance of vascular and leukocyte ROCK activity in humans
and roles of ROCK1 and/or ROCK2 in cardiovascular dis-
eases using ROCK1 and ROCK2 knockout mice. We have
found in clinical studies that ROCK activity is increased in
smokers, a human model of oxidative stress, ROCK activity
substantially correlates with endothelial dysfunction, and ag-
ing related increase on aortic stiffness is mediated via vascu-
lar ROCK activity. We further found several mechanisms of
ROCK mediated atherosclerosis by in vitro and in vivo stud-
ies. Indeed, recent studies have shown the functional differ-
ence between the two isoforms, hence, we have focused on the
downstream signaling pathway on ROCK1 and/or ROCK2 us-
ing not only ROCK1 and ROCK2 knockout mice but also cells
isolated from these mice. In addition, we are working on
ROCK related translational study including cellular, animal,
and clinical studies, viz. bench to bedside study. In this sym-
posium, we would show the data of our translational study.
1-S-03-2 Sexual dimorphism in
immune neuronal signaling in pain
hypersensitivity
Michael Salter
Northbridge Chair in Paediatric Res., Hosp. Sick Children; Dept. Physiol, Univ.
Toronto
Neuron microglial interactions are recognized as key for
physiological and pathological processes in the CNS. Micro-
glia have been found to play a causal role in neuropathic pain
resulting from peripheral nerve injury, and a core neuron
microglia neuron signaling pathway has been elucidated.
Within the spinal cord, microglia suppress neuronal inhibi-
tion by a cascade involving activation of microglial P2X4 re-
ceptors causing the release of brain derived neurotrophic fac-
tor (BDNF). BDNF acts on trkB receptors which leads to a
rise in intracellular [Cl ] in dorsal horn nociceptive output
neurons, transforming the response properties of these neu-
rons. This core signaling pathway has been extensively char-
acterized, in studies using male mice. We have recently dis-
covered that microglia neuron signaling is dispensable in fe-
male mice. Rather, pain hypersensitivity in female mice de-
pends upon the adaptive immune system, likely upon T cells.
Despite this profound difference in cellular mechanisms, pain
hypersensitivity in female mice is as robust as that in male
mice. Taking into consideration sex differences in the spinal
immune neuronal signaling has important implications rang-
ing from diagnostics, to therapeutics, to prevention of
chronic pain.31
1-S-03-3 A crucial role of spinal
astrocytes in chronic itch
Makoto Tsuda
Dept Life Innov., Grad. Sch. Pharmaceut. Sci., Kyushu Univ.
Chronic itch is an intractable symptom of inflammatory skin
diseases, such as atopic dermatitis. Recent studies have re-
vealed the selective neuronal pathways for itch sensations ;
however, the mechanisms by which itching turns into a
pathological chronic state are poorly understood. In my talk, I
will show our findings indicating that astrocytes are mark-
edly activated in the dorsal horn (SDH) of spinal segments
corresponding to the regions of itchy skin. STAT3 was selec-
tively activated in SDH astrocytes and that conditional dis-
ruption of astrocytic STAT3 activation prevented the astro-
cytic activation and chronic itching. Pharmacological inhibi-
tion of STAT3 in the SDH ameliorated the fully developed
chronic itch. Furthermore, atopic dermatitis mice exhibited
an increase in scratching elicited by intrathecal administra-
tion of gastrin releasing peptide, and this enhancement was
normalized by suppressing STAT3 mediated reactive astro-
cytes. Moreover, we identified lipocalin 2 (LCN2) as an astro-
cytic STAT3 dependent upregulated factor that was crucial
for chronic itch. Therefore, reactive astrocytes in the SDH
with activated STAT3 play a pivotal role in chronic itch by
enhancing spinal itch signaling by LCN2 and may represent a
previously unrecognized target for treating chronic itch.
1-S-04-2 In vivo real time
measurement of local drug
concentrations by using diamond
microelectrode
Genki Ogata 1,2, Yuya Ishii 3, Kai Asai 3, Yamato Sano 4,
Fumiaki Nin 1,2, Takamasa Yoshida 1,5,
Shizuo Komune 5,6, Madoka Takai 7,
Hiroyuki Kusuhara 4, Yasuaki Einaga 3,8,
Hiroshi Hibino 1,2
1Dept Mol Physiol, Niigata Univ Sch Med, 2Ctr for Transdisciplinary Res, Niigata
Univ, 3Dept of Chem, Faculty of Sci and Tech, Keio Univ, 4 Lab of Mol
Pharmacokinet, Grad Sch of Pharm Sci, The Univ of Tokyo, 5Dept Otolaryngol,
Grad Sch Med, Kyushu Univ, 6Div of Otolaryngol Head＆ Neck Surg, Yuaikai
Oda Hospital, 7Dep of Bioeng, Grad Sch of Eng, The Univ of Tokyo, 8 JST ACCEL
For pharmacological studies, it is important to analyze local
concentrations of systemically administered drugs in in vivo
various organs and tissues. Conventional methods do not ac-
complish this because they require considerable analyte quan-
tities and have low sampling rates. They also cannot address
how change of drug concentrations correlates with target cell
or tissue functions over time. Therefore, we designed a sys-
tem equipped with two different sensors. One is a boron
doped diamond microsensor, which semi quantitatively de-
tected change of concentrations of vascularly applied ototoxic
diuretic, bumetanide, in the extracellular fluid of the cochlea
of live guinea pigs. The time resolution ranged within several
seconds. The other, a glass microelectrode simultaneously
monitored the endocochlear potential underlying hearing.
This multi sensing system can be applied to monitor other
drugs and electrophysiological functions in numerous tissues
and organs and promote the pharmacological researches.S31-S-04-1 Chemical concentration
profile imaging using scanning
electrochemical microscopy and
scanning ion conductance microscopy
hybrid system
Yasufumi Takahashi 1,2, Hiroki Ida 3, Yuanshu Zhou 4,
Hitoshi Shiku 3, Tomokazu Matsue 3,4
1Div. of Electrical Eng. and Computer Sci., Kanazawa Univ., 2 JST PREST, 3Grad.
school of enviromental, Tohoku niversity, 4Advanced institude for material reseach,
Tohoku university
Scanning electrochemical microscopy (SECM), a type of scan-
ning probe microscopy, has been used to characterize and im-
age the local chemical concentration and flux by scanning
sample surfaces with an ultra micro electrode (UME). It is ef-
fective to evaluate a single cell respiration activity and neu-
rotransmitter release, but the resolution is related with the
electrode size and electrode sample distance. To improve the
resolution of SECM, we adopted distance control system of
scanning ion conductance microscopy (SICM) and fabricated
SECM SICM probe. SICM is a promising technique for non-
contact topography imaging under physiological conditions.
SICM uses a nanopipette as a scanning probe to detect ionic
current between an electrode inside the pipette and that lo-
cated in a bath. We have developed an extremely quick (2
min) and simple process with a high success rate for making
SECM SICM probe. The method allows fabrication of SECM
SICM probe with a radius ranging from 10 nm to 1 um. In this
presentation, we will discuss about cell membrane permeabil-
ity measurement and local neurotransmitter detection using
SECM SICM.
1-S-04-3 Microfluidic devices for cell
culture and cell based assay in drug
discovery
Shinji Sugiura, Taku Satoh, Kazumi Shin,
Toshiyuki Kanamori
Biotech. Res. Inst., AIST
Microfluidic devices are expected to create a new opportu-
nity in drug discovery owing to their advantageous charac-
teristics, including precise fabrication of small structures,
easy replication of the fabricated structure, precise manipu-
lation of small volume liquid, and usage of small amounts of
expensive reagents. Generally, cell culture in a microfluidic
device is carried out by medium perfusion using syringe
pumps. However, liquid handling using syringe pump is cum-
bersome. To address this issue, we developed a pressure
driven perfusion culture system, in which multiple liquids
could be handled by simply applying pressure in the liquid
reservoir. This is a convenient system to create different cul-
ture conditions in a single microfluidic device. We have ap-
plied pressure driven perfusion culture system to drug dose
response assay, circulation culture system, and multi organs
culture system.2
1-S-04-4 Integration of in vitro data
using pharmacokinetic model
Hiroyuki Kusuhara
Grad. Sch. of Pharm. Sci., the Univ. of Tokyo
Because of its difficulty, bridging from preclinical to clinical
studies is referred to as Devil River. Species difference in the
pharmacokinetics between animals and humans is one of the
obstacles. Measurement of human kinetic parameters will
bridge the gap in the pharmacokinetics of drugs. Physiologi-
cally based pharmacokinetic (PBPK) model, where the ana-
tomical and physiological structure of the body is considered,
is frequently used for pharmacokinetic prediction of drugs.
We demonstrated that combining in vitro data measured us-
ing human derived materials, and scaling factors could suc-
cessfully describe the plasma concentration time profiles of
pravastatin following intravenous and oral administration in
humans using PBPK model. Furthermore, we newly intro-
duced a newly developed parameter estimation method, clus-
ter newton method (CNM) which automatically prepares mul-
tiple initial parameter sets when the researchers just set the
rages of the parameters, and provides multiple sets of fitted
parameters as solution. We applied this method to the quanti-
tative analysis of clinically reported drug drug interactions
using PBPK model. PBPK model is a good plat home for bot-
tom up and top down approaches in the pharmacokinetic
analysis of drugs.
1-S-05-2 Lifestyle related diseases
improved by functional food
Susumu Yoshino, Riyo Awa, Yasuo Miyake,
Nobuaki Ohto, Hiroshige Kuwahara
Maruzen Pharmaceuticals Co., Ltd.
As Lifestyle related diseases, particularly obesity and the al-
lied diseases continue increasing significantly around the
world, the development of effective prophylaxis and its en-
lightenment are important issues. Since the utilization of food
component, addition to daily physical exercise, is considered
to be an effective countermeasure against obesity, the devel-
opment of functional food collects big attention recently.
Kaempferia parviflora (KP), known as black ginger or
krachai dum, is a plant that belongs to the Zingiberaceae
family and has been used as a folk medicine for long time. KP
includes polymethoxyflavone, which has a variety of benefi-
cial activity.We previously demonstrated that KP suppresses
the weight gain and fat accumulation and increase the energy
consumption in mice fed high fat diet. We also demonstrated
that KP increased the energy consumption in human. These
results suggest that KP is a useful functional food in order to
prevent obesity.In this symposium, I will outline the anti obe-
sity effect and the mechanism of KP as an example of func-
tional food, and further discuss the benefits and future chal-
lenges of functional food.S31-S-05-1 Health foods and weight
management
Yi Wen Chien
School of Nut. and Health Sciences, Taipei Med. Univ., Taipei, Taiwan
Many different dietary approaches have been studied in an
attempt to achieve healthy, sustainable weight loss among in-
dividuals with overweight and obesity. Meal replacement,
low carbohydrate low glycemic index (GI) diet, high protein
intake, and moderate fat consumption have shown some posi-
tive effects on weight maintenance. However, the results are
controversial. Some findings from our studies demonstrate
that weight loss related to dairy product intake is due to the
combination of an energy restricted diet with consumption of
dairy products. Using milk or yogurt contained conjugated li-
noleic acid (CLA) on weight loss program had more signifi-
cantly reduced in body weight, body mass index (BMI), and
body fat percentage. A new supplement with hydroxycitric
acid (HCA) and chromium (Cr) significantly reduced weight
gain and body fat accumulation in diet induced obesity rats.
Further, the commercial product containing garcinia cambo-
gia extract, yerba mate extract and guarana extract, can be
helpful in weight control along with nutrition education and
maintaining high density lipoprotein cholesterol level. Our
results can provide more information about a proper choice
of health foods for weight loss or maintain programs.
1-S-05-3 Improvement of bone
metabolism by functional foods
Nobuo Izumo, Yasuo Watanabe
General Health Medical Center, Yokohama University of Pharmacy.
In the life related diseases, it has been well documented that
the hypertension, hyperlipidemia and hyperglycemia cause
the sudden death and the chronic severe diseases. However,
the dysfunctions of bone metabolism induced by life style
have not been fully understood. And also it has been reported
that such dysfunctions can be caused by not only aging but
also lack of exercises. Moreover, interestingly, the young
sportswomen have several types of less developing of bone
growth due to the deviation of nutrition. In our recent stud-
ies, we examined the effects of several functional foods and
water on bone metabolism. Then we evaluated that some sub-
stances (e.g. hydrogen water and lactoferrin) significantly
stimulated the ossification and attenuated osteoclastic. These
substances also inhibited the steroid induced bone dysfunc-
tions. Furthermore, these substances did not show any severe
adverse evidences. These results indicate that the daily taken
healthy substances can prevent the bone metabolic dysfunc-
tion induced by irregular life style. We also discuss about the
protection of bone metabolic dysfunction based on the
pharma food interaction in this symposium.3
1-S-05-4 Dietary supplements for
hepatoprotection
Jane Chao
School of Nut. and Health Sciences, Taipei Med. Univ., Taipei, Taiwan
The mortality rate for liver and intrahepatic bile duct cancer
was 34.9 per 100,000 in2014. Therefore, hepatoprotection is a
major approach to prevent the development liverdisease and
hepatocellular carcinoma in Taiwan. Some dietary supple-
ments, such as fish oil,nicotinic acid, flaxseed, and active com-
ponents in herbs, have been considered to be potentialfor he-
patoprotection via antioxidant, anti inflammatory, and antifi-
brotic activities. The n 3polyunsaturated fatty acids, such as
eicosapentaenoic and docosahexaenoic acids rich in fishoil,
showed hepatoprotective activity against the development of
non alcoholic fatty liverdisease by modulating lipogenesis
and lipolysis. Supplementation with nicotinic acid andflax-
seed showed to protect liver damage against oxidative stress
via the improvement ofantioxidant defense. Ginseng extract
and ginsenosides are shown to attenuate liver fibrosis
byregulating fibrogenesis. Hot water extracted Lycium bar-
barum and Rehmannia glutinosa protectedagainst necrotic
damage in the liver and suppressed liver fibrosis. Therefore,
appropriate dietarysupplements with hepatoprotective activ-
ity could improve liver damage and inhibit the developmen-
tof liver disease.
1-S-06-2 Multiphoton Imaging of
Renal Function
Daisuke Nakano
Department of Pharmacology, Kagawa University, Kagawa
Urine output is widely used as a criterion for acute kidney in-
jury (AKI) diagnosis. Although a number of investigations
have identified potential mechanisms of AKI, regulation of
urine flow has not been evaluated. We have developed the
methods to evaluate changes of urine flow as well as multiple
renal function by intravital imaging to enable real time
monitoring by multiphoton microscopy. The tubular flow
rate was measured by freely filtered dye (FITC inulin or Lu-
cifer yellow) that was time dependently declined in the ex-
perimental acute kidney injury models ; it was already
slower at 2 h in LPS injected mice compared with saline in-
jected mice, while the blood pressure and GFR were normal.
Mitochondrial membrane potential in the tubules depends on
the peritubular capillary flow rather than tubular flow.
These analysis could be the useful tool to evaluate the renal
function in the live animals, and shed light on the black box in
the renal physiology.S31-S-06-1 Kidney and amino acids in
blood pressure regulation, with special
attention on dopamine, GABA and salt
intake
Midori Yatabe, Junichi Yatabe, Atsuhiro Ichihara
Dept. Endocrinology and Hypertension, Tokyo Women’s Med. Univ.
Amino acids and metabolites can serve as signaling mole-
cules. Dopamine is a metabolite of amino acid tyrosine via L
dopa. In the kidney, dopamine is synthesized in the proximal
tubule and increases sodium excretion during dietary NaCl
load. Renal antihypertensive effects of dopamine are exerted
mostly via D1 receptor. GRK4, a receptor kinase, modifies re-
nal dopaminergic signaling, and genetic polymorphisms of
GRK4 are implicated in the pathogenesis of salt sensitivity in
humans. Another amino acid related signaling molecule is
gamma aminobutyric acid (GABA). GABA is a non proteino-
genic amino acid, has antihypertensive properties, and is syn-
thesized in the kidney. A part of anti hypertensive effect of
GABA may be due to its renal actions because GABA recep-
tors are identified on renal tubules, and GABA induces natri-
ureis and diuresis. Salt increases urinary excretion of various
amino acids, and plasma concentrations of some amino acids
are shown to be different in hypertensive models. Advances
in technology has made amino acid research more active in
recent years, and new findings can be expected to unravel
novel mechanisms of renal blood pressure regulation.
1-S-06-3 Kidney as a sensor and a
regulator of internal mileu
Tatsuo Shimosawa
Dept. Clinical Lab. Univ. Tokyo Hospital
Physiological function of kidney is not only excrete waste but
sense the changes of chemical signals and mechanical signals
and regulate CNS and cardiovascular functions. In this sym-
posium, I focus on sympathetic regulation of kidney function
and kidney derived regulation of sympathetic tone. Catecho-
lamine regulate renin angiotensin axis in the kidney to regu-
late glomerular pressure as well as ion exchanges in the tu-
bules. Recently I clarified that catecholamine regulate so-
dium reabsorption via beta 2 receptor and sodium chloride
co transporter independent from angiotensin II. Moreover,
we observed cardiac diastolic dysfunction in high salt loaded
rat. In this rat model, denervation of both afferent and effer-
ent sympathetic nerve in the kidney reversed cardiac dys-
function independent from blood pressure or cardiac remod-
eling. These data suggest that renal efferent sympathetic
nerve regulate sodium homeostasis in contrast afferent nerve
sense sodium level to convey signal to the heart possibly via
CNS. It is well known that kidney senses blood pressure, ion
mileu, oxygen pressure and other signals and regulate homeo-
stasis. Taken together, kidney could be a center for giant
data of whole body and control tower of the homeostasis.4
1-S-06-4 WNK signaling and KLHL3/
Cullin3 ubiquitin ligase complex in salt
sensitive hypertension
Eisei Sohara
Dept. Nephrology, Tokyo Medical and Dental Univ.
Pseudohypoaldosteronism type II (PHAII) is a hereditary dis-
ease characterized by salt sensitive hypertension. Mutations
in with no lysine kinase 1 (WNK1) and WNK4 genes are
found to cause PHAII. It was demonstrated that WNK kinases
constitute a signaling cascade with OSR1, SPAK, and the SLC
12a transporter family, including thiazide sensitive NaCl co-
transporter (NCC). The WNK OSR1/SPAK SLC12a signal-
ing cascade exist in the kidney and vascular smooth muscle
cells, and physiologically regulates salt sensitivity, i.e., uri-
nary sodium excretion and arterial tone by a various hormo-
nal and dietary factors. In 2012, two additional genes respon-
sible for PHAII, Kelch like 3 (KLHL3) and Cullin 3 (CUL3),
were identified. WNK1 and WNK4 was shown to be sub-
strates of KLHL3 CUL3 E3 ubiquitin ligase complex. The
loss of interaction between KLHL3 and WNK4 induces in-
creased levels of WNK kinases due to impaired ubiquitina-
tion, resulting in PHAII. These results implicated that WNK
signaling is physiologically regulated by KLHL3/CUL3 me-
diated ubiquitination. In this session, we would like to present
the pathophysiological roles of the WNK signaling cascade in
the kidney and vascular smooth muscle cells and the regula-
tion of WNK signaling by KLHL3 and CUL3.
1-S-07-2 Involvement of semaphorins
in immunological disorders.
Atsushi Kumanogoh
Dept. Resp. Med., Grad. Sch. Med., Osaka Univ.
Semaphorin was originally identified as neural guidance fac-
tors. Recent research on semaphorins demonstrated that
these proteins play pleiotropic functions in immunological
regulation, angiogenesis, tumor metastasis, and bone metabo-
lism. In particular, semaphorins involved in various phases of
immune responses are referred to as “immune semaphorins”.
Accumulating evidence demonstrates that immune sema-
phorins play important roles in the pathogenesis of autoim-
mune diseases. We here present the pathological involvement
of semaphorins and their receptors in immunological disor-
ders, including the roles of Semaphorin 4D in rheumatoid ar-
thritis.S31-S-07-1 Intracellular signaling of
Sema3A through phosphorylation
cascade
Fumio Nakamura, Yoshio Goshima
Dept. Mol. Pharmacol. Sch. Med. Yokohama City Univ.
Sema3A, one of vertebrate secreted semaphorins, is a repul-
sive axon guidance molecule. Sema3A inhibits the neurite
outgrowth of dorsal root ganglion neurons and hippocampal
axons. Sema3A also regulates the dendritic formation of cor-
tical and hippocampal neurons. The receptor for Sema3A is
the complex of Neuropilin 1 and Plexin A. This complex ac-
tivates three different intracellular signaling : small G pro-
tein cascade, phosphorylation cascade, and oxidation signal-
ing. We will introduce our recent findings of the phosphoryla-
tion cascade and discuss therapeutic targets of this signaling.
1-S-07-3 The regulation of bone
remodelling by semaphorin
Tomoki Nakashima
Dept. of Cell Signaling, Grad. Sch. Med., Tokyo Med. Dent. Univ.
Bone is constantly renewed by the balanced action of bone
formation and bone resorption. This restructuring process
called “bone remodeling” is important not only for normal
bone mass and strength, but also for mineral homeostasis.
Bone remodeling is stringently regulated by communication
between bone component cells such as osteoclasts, osteoblasts
and osteocytes. An imbalance of this process is often linked to
various bone diseases. Recently, we identified that sema-
phorin molecules have a crucial role in the regulation of bone
remodeling. The regulatory mechanisms provide a scientific
basis for future therapeutic approaches to bone diseases.5
1-S-07-4 Revisiting the structure
activity relationship of semaphorin 3A
Junichi Takagi, Yukiko Matsunaga, Emiko Mihara
Inst. Protein Res., Osaka Univ.
Semaphorin 3A (Sema3A) is a prototypic soluble semaphorin
that activates A type plexin on cell surface, with a help of its
high affinity co receptor neuropilin 1 (Nrp 1). Although a
crystal structure exists for a ternary complex containing
minimum fragments of these three components (Sema3A,
Plexin A2, and Nrp 1), we still don’t know exactly how Sema3
A activates Plexin on cell surface. In addition, although it has
been known since 1997 that Sema3A undergoes complex pro-
teolytic processing that regulates its activity, the molecular
mechanism underlying such regulation has not been rational-
ized in the context of the structure. In order to reinvestigate
the structure activity relationship of Sema3A, we established
a high throughput cell collapse assay system using non neu-
ronal cells. Systematic evaluation of various mutant Sema3A
proteins revealed a presence of multiple “active sites” dis-
tributed over the entire molecule, enabling us to design a
Sema3A variant that is highly active and more stable than the
wild type protein. Combined with plexin A1 ectodomain
structures deduced from electron microscopic molecular im-
aging, a revised model of Sema3A induced plexin activation
on cell surface is constructed.
1-S-08-2 Roles of signal network
during the endothelial to mesenchymal
transition (EndMT)
Tetsuro Watabe
Sect. Biochem., Grad. Sch. Med. Dent., Tokyo Med. Dent. Univ.
Endothelial cells undergo differentiation into mesenchymal
cells during various physiological and pathological processes
including heart valve formation and cancer progression, re-
spectively. However, the molecular mechanisms that regu-
late such endothelial to mesenchymal transition (EndMT)
remain to be elucidated. Here we show that TGF β plays im-
portant roles during mesenchymal differentiation of endothe-
lial cells. By addition of TGF β2, MS 1 endothelial cells un-
derwent mesenchymal transition characterized by increased
expression of various mesenchymal markers such as SMA.
We found that TGF β2 induced EndMT of MS 1 cells is de-
pendent on the activation of Rho signals. We found that TGF
β2 induces the expression of myocardin related transcription
factor A (MRTF A) and its nuclear accumulation in MS 1
cells and that MRTF A is required and sufficient for TGF β
2 induced SMA expression. These results indicate that acti-
vation of Smad signals by TGF β2 have dual effects on the ac-
tivation of Rho signals and MRTF A leading to the mesen-
chymal transition of MS 1 endothelial cells. Taken together,
these findings suggest that TGF β2 activates multiple tran-
scriptional and signaling networks during mesenchymal tran-
sition of endothelial cells.S31-S-08-1 The collecting lymphatic
vasculature: regulation and roles in
pathophysiology
Gwendalyn Randolph
Dept. Pathology＆ Immunology, Washington Univ. Sch. Med.
Studies in mice recently revealed that infection induced tis-
sue damage in the mesentery causes hyperpermeable, leaky
lymphatic collecting vessels and consequent persistent altera-
tions in tolerance and immunity normally programmed by
mesenteric lymph nodes. To address whether analogous
changes might occur in human IBD, we established a
multistep, 3D imaging approach to characterize mesenteric
tissue from Crohn’s disease resections or non IBD subjects.
In Crohn’s disease specimens, lymphocyte rich aggregates
were observed to markedly constrict the contractile collect-
ing lymphatic vessels that drain to and from lymph nodes.
These were associated with a striking intimal hypertrophy of
adjacent veins. In other literature, collecting vessel constric-
tion has been experimentally shown to promote leaky collect-
ing vessels and venous collapse. Thus, the imaging data in
Crohn’s disease tissue are consistent with the possibility that
lymph and venous outflow from the intestinal wall may be
sufficiently altered in Crohn’s disease to promote leaky col-
lecting vessels that might in turn prevent normal lymph
node mediated regulation of immunity. Data will be pre-
sented that implicates IRF4+ CCR7+ dendritic cells in con-
trol of collecting vessel permeability.
1-S-08-3 Platelet activation blocks
misconnection of lymphatic to blood
vessels in mouse peripheral tissues via
TGF β signals
Masanori Hirashima
Div. Vasc. Biol., Kobe Univ. Grad. Sch. Med.
Lymphatic endothelial cells (LECs) are derived from venous
endothelial cells during embryogenesis and subsequently
form a vasculature separate from blood vessels in peripheral
tissues. Recent studies indicated a critical role of platelets ac-
tivated by LECs in proper separation between these two vas-
cular systems. However, how platelets keep lymphatic ves-
sels separate from blood vessels remains unknown. Here, we
show that abnormal lymph blood connections randomly oc-
cur in embryonic back skin of Plcg2 / mice lacking platelet
activation, suggesting a critical role of platelets during lym-
phatic vessel elongation. In vitro analysis showed that plate-
lets or activated platelet conditioned medium inhibits LEC
migration and proliferation in a Syk or Plcg dependent
manner and also induces an immediate filopodial retraction of
LECs. These effects were inhibited by an inhibitor of TGF β
signals, while TGF β induced a filopodial retraction of LECs.
In vivo analysis indicates the role of TGF β in keeping lym-
phatic vessels separate from blood vessels. These results in-
dicate a novel role of platelets in partitioning blood and lym-
phatic vascular compartments by promoting LEC retraction
in mouse peripheral tissues.6
1-S-08-4 Roles of Prostaglandins in
regulation of plasticity of lymphatics
and lymph nodes
Masataka Majima, Kanako Hosono, Hideki Amano,
Tomoe Fujita
Dept. Phamacol., Kitasato Univ. Sch. Med.
Angiogenesis is upregulated by prostaglandins (PGs), how-
ever, little is known about their involvement in lymphangio-
genesis. In chronic inflammation, lymphangiogenesis de-
tected by double immunostaning of VEGFR 3 and LYVE 1
was upregulated via COX 2 and EP3/4 signaling during the
development of granulation tissues. The lymphatic system is
an important route for cancer dissemination, and lymph node
metastasis (LNM) serves as a critical prognostic determinant
in cancer patients. A murine model of Lewis lung carcinoma
(LLC) cell metastasis revealed that COX 2 is expressed in
dendritic cells (DCs) from the early stage in the lymph node
subcapsular regions, and COX 2 inhibition markedly sup-
pressed mediastinal LNM. Stromal cell derived factor 1
(SDF 1) was elevated in DCs before LLC cell infiltration to
the lymph nodes, and a COX 2 inhibitor, an SDF 1 antago-
nist, and a CXCR4 neutralizing antibody all reduced LNM.
LNM was reduced in mice lacking EP3, and stimulation of
cultured DCs with an EP3 agonist increased SDF 1 produc-
tion. Accumulation of regulatory T cells and lymph node lym-
phangiogenesis was also COX 2/EP3 dependent. These re-
sults indicate that COX 2 and EP signaling modulate plastic-
ity of lymphatics and lymph nodes in pathological settings.
1-S-09-2 Establishment of a model
mouse of food allergic enteropathy
Haruyo Nakajima Adachi, Erika Hiraide,
Satoshi Hachimura
Research Center for Food Safety and Dept. Applied Biol. Chem., The Univ. Tokyo
Food allergy induces uncomfortable symptoms and in some
cases may be a life threatening disease. Our interests have
concentrated on clarifying its detailed mechanisms of estab-
lishment of inflammation and of its recovery. To study the
mechanism, we established a food allergic mouse model using
OVA23 3 mice, which express OVA specific T cell receptor
transgenes. OVA23 3 mice show severe enteropathy, weight
loss, and increase of serum OVA specific IgE by only feeding
with EW based diet without adjuvant. By further continuous
feeding with the diet, they recover from inflammation, al-
though in mesenteric lymph nodes, inflammatory responses
are maintained. These results suggest that our model has
unique characteristics to enable us to investigate the mecha-
nism from start of food allergic enteropathy to attenuation of
the inflammation developed in whole body upon feeding with
OVA. Thus, we have analyzed roles of both intestinal and sys-
temic tissues of EW fed OVA23 3 mice throughout the ex-
perimental period monitoring IL 4 producing OVA specific
CD4+ T cells responses as a causative factor. We found each
tissue played different roles in inflammatory or regulatory
responses. We are now examining relation between intestinal
and cutaneous responses to OVA using this model.S1-S-09-1 A murine model of Japanese
cedar pollinosis for studying
mechanisms and potential biomarkers
of allergen specific immunotherapy
Soichi Tofukuji
Allergy Group, Oncology＆Immunology, Shionogi＆ Co., LTD.
<Objective>Sublingual immunotherapy (SLIT) is considered
as a potentially curative treatment for allergic diseases such
as Japanese cedar pollinosis (JCP), in which patients were ex-
posed with JC pollen every spring. However, the mechanisms
and biomarkers involved remain to be elucidated. In this
study, we established a murine model of JCP and evaluated
the efficacy of SLIT. <Methods>BALB/c mice were intrana-
sally sensitized and challenged with Japanese cedar pollen
crude extract (JC) and were challenged every 5 weeks to in-
duce allergic nasal responses, which mimics the JCP. The
mice were treated with JC SLIT between the challenges and
then the therapeutic effect was assessed by number of
sneezes, antigen specific T cell responses, antibodies, and
histology of nasal mucosa.<Results>JC SLIT significantly
reduced the JC specific allergic reactions, with long lasting
effect even after completion of treatment (carry over effect).
<Conclusion>We have generated a mouse model of JCP that
is useful for studying mechanism and biomarkers of SLIT.
1-S-09-3 Analyses of asthma
pathogenesis by focusing on IL 33
Takeshi Nabe 1, Nobuaki Mizutani 2
1Dept. Immunopharmacol., Setsunan Univ. Fac. Pharm. Sci., 2Dept. Pharmacol.,
Kobe Pharm. Univ.
IL 33, one of damage associated molecular patterns
(DAMPs), is extracellularly released when cells such as air-
way epithelial cells are damaged. Because IL 33 is detected
in asthma lung in large amounts, and IL 33 activates various
leukocytes including not only Th2 cells but also type 2 innate
lymphoid cells (ILC2), IL 33 could be involved in asthma
pathogenesis by orchestrating the innate and acquired immu-
nity. It is expected that strategies to suppress IL 33 produc-
tion may lead to regulation of asthma. However, production
mechanisms of IL 33 have not been unclear. Using murine
models of ovalbumin induced airway inflammation, we have
reported that IL 33 was involved in airway inflammation and
remodeling, and Th2 cytokine production. We found that the
IL 33 production from the airway epithelial cells was gluco-
corticoid sensitive, and induced by not only the innate but
also acquired immune mechanisms. Because anti IgE neutral-
izing antibody suppressed the IL 33 production, the specific
antigen may be recognized by IgE molecule followed by IL
33 production from the epithelial cells. However, mast cell/
basophil depleting antibody did not affect the IL 33 produc-
tion. Further analyses of cellular and molecular mechanisms
of IL 33 production may lead to new pharmacotherapy of
asthma.37
1-S-09-4 Rapid development of house
dust mite induced allergic inflammation
Osamu Kaminuma
Allergy Immunol. Proj., Tokyo Metropol. Inst. Med. Sci.
To investigate the pathogenesis of and to develop new treat-
ments for allergic diseases, tons of animal models have been
established so far. In general, topical application of allergens
to target tissues of animals previously immunized with sys-
temic administration of corresponding allergens induces tis-
sue specific inflammatory responses. However it has been
difficult to reproduce the developmental process of human al-
lergy in which clinical symptoms are induced only by re-
peated allergen provocation to the target tissues without the
systemic immunization. Although several models of airway
inflammation elicited by repeated provocation of house dust
mite to naive mice were reported recently, a long term aller-
gen challenge process was required to establish them. We
here reported a new murine model in which obvious allergic
airway inflammation could be induced simply by a couple of
allergen application.
1-S-10-2 Hyaluronan dependent
regulation of glutamate transporters
Mariko Hayashi 1, Masato Yasui 1, Kaoru Sato 2
1Dept. Pharmacol., Keio Univ. Sch. Med., 2NIHS
Glutamate released to synapses must be removed after synap-
tic activation to terminate the signal and to protect neurons
from excitotoxicity. Astrocytes are mostly responsible for
the glutamate clearance. They extend thousands of thin cellu-
lar processes to approach synapses for this purpose.We found
that the trimeric transmembrane transporter domain of glu-
tamate transporters has a property to localize to filopodia
tops, while their N and C terminal cytoplasmic tails are not
required. This is a common property of trimeric transporter
family members. Neither transporter activity nor astrocyte
specific protein was required for this filopodia tip localiza-
tion. Furthermore, the transporter core within filopodia tips
strengthened the attachment of filopodia to external sub-
strates, thereby stabilizing the filopodia. Recently we found
that the process tip localization of glutamate transporter is
hyaluronan dependent. For the localization, CD44, a represen-
tative hyaluronan receptor, was not required. Instead,
hyaluronan synthase showed hyaluronan dependent interac-
tion with glutamate transporters. Glutamate uptake activity
was reduced by loss of process tip localization by hyaluroni-
dase treatment, and as a result, neurons were activated gluta-
mate dependently.S31-S-10-1 Neuronal axon regeneration
and sulfated glycans
Kenji Kadomatsu
Dept. Biochem. Nagoya Univ. Grad. Sch. Med.
Axons in the central nervous system cannot regenerate after
injury. It is due to low intrinsic capacity of regeneration and
emerging inhibitory molecules upon injury. Therapeutics for
neuronal injuries are not currently available and have long
been awaited. Chondroitin sulfate (CS) is one of the strongest
inhibitors, while heparan sulfate (HS) promotes axon growth.
Both CS and HS are glycosaminoglycans, which are long sul-
fated glycans with repeating disaccharide units, and thus
have similar structures. Therefore, it is a big question why
CS and HS show opposite effects on axon growth. We ad-
dressed this question to understand molecular mechanisms
underlying the axon regeneration inhibition. Through identi-
fication of critical structures of CS and HS for axon growth,
we found a“chance and necessity” rule of functional domains
of CS and HS in their receptor organization. Natural CS has a
short functional domain which monomerizes its receptor
RPTPσ (receptor-type protein tyrosine phosphatase σ),
blocks the autophagy flux, leads to dystrophic endball forma-
tion, and consequently suppress axon regeneration. Natural
HS harbors a long functional domain that oligomerizes
RPTPσ and reverses this pathway.
1-S-10-3 Bisecting GlcNAc
modification promotesAlzheimer’s
disease
Yasuhiko Kizuka, Shinobu Kitazume,
Naoyuki Taniguchi
Disease Glycomics Team, Global Research Cluster, RIKEN
Alzheimer’s disease (AD) is the most common dementia and a
serious issue all around the world. Recently, we found that
GnT III, a glycosyltransferase for the biosynthesis of a
unique sugar modification “bisecting GlcNAc”, plays a patho-
logical role in AD. GnT III KO mice show a dramatic de-
crease in production of amyloid β (Aβ), a hallmark and the
causative peptide of AD, resulting in improvement of cogni-
tive function. We found that BACE1, an essential protease for
Aβ generation, is a novel target for bisecting GlcNAc and
that BACE1 is relocated from early endosomes to lysosomes
without loss of its catalytic activity in GnT III KO cells (Ki-
zuka et al., (2015) EMBO Mol. Med.). This indicates that bi-
secting GlcNAc regulates Aβ production by controlling sub-
cellular localization of BACE1.
We also revealed that bisecting GlcNAc is required for BACE
1 upregulation under oxidative stress. BACE1 protein is
upregulated under various stress conditions such as aging or
Aβ accumulation, and such BACE1 upregulation was abol-
ished in GnT III KO cells where BACE1 is degraded faster in
lysosomes than wild type cells. These data indicate that bi-
secting GlcNAc regulates BACE1 protein level by preventing
its lysosomal degradation under stress conditions (Kizuka et
al., (2015) Biochem. J.).8
1-S-10-4 How we overcome blood
brain barrier?The challenge in
chemotherapy against brain
malignancies.
Motohiro Nonaka 1,2, Misa Suzuki Anekoji 2,
Jun Nakayama 3, Michiko Fukuda 1,2
1Drug Discovery Lab, AIST, 2Cancer Center, Sanford Burnham Prebys Med. Dis.
Inst., 3Dept. Mol. Pathology, Shinshu Univ. Grad. Sch. Med.
The blood brain barrier (BBB) generally blocks penetration
of chemotherapeutics into brain stroma, which is the main ob-
stacle in treating brain malignancies. Previously we reported
that carbohydrate mimetic peptide IF7 targets to tumor vas-
culature through annexin A1 and delivers anticancer drug to
tumor stroma. Since IF7 crosses the endothelial cells by ac-
tive transcytosis, we hypothesized that IF7 overcomes the
BBB. When FITC tagged IF7 was injected intravenously into
C6 glioma tumor bearing mice, fluorescence signals were
clearly seen in the brain tumors, whereas a FITC tagged
control peptide (RQ7) with reversed IF7 sequence was not de-
tected. When IF7 conjugated to the anti cancer drug SN 38
(IF7 SN38) was injected intravenously into mice harboring
two tumors, one subcutaneous and the other in brain, growth
of both tumors was suppressed. Furthermore, IF7 SN38 sup-
pressed brain tumor growth more effectively than that of
subcutaneous tumors, regardless of cancer cell line or host
mouse strain. Taken together, these results suggest that con-
jugates of IF7 and anticancer drug could become a novel
therapeutics against brain malignancies with little side ef-
fect.
1-S-11-2 Development of a H2S
fluorescence probe and its application to
inhibitor screening for H2S producing
enzymes
Kenjiro Hanaoka
Grad. Sch. Pharm. Sci., Univ. Tokyo
For detailed studies of the physiological functions of sulfur
compounds such as H2S and sulfane sulfur, a new method to
measure their concentration in biological samples is re-
quired. For example, the existing methylene blue method and
the sulfide ion selective electrode method for measuring H2S
are destructive, requiring homogenization of samples. There-
fore, we designed and synthesized a novel fluorescence probe
for H2S, HSip 1 (Hydrogen Sulfide Imaging Probe 1) (J. Am.
Chem. Soc. 2011, 133, 18003). Further, HSip 1 showed a large
and immediate fluorescence increment (by 50 fold) upon addi-
tion of 10 μM H2S, whereas almost no fluorescence increment
was observed upon addition of 10 mM GSH. We also applied
HSip 1 to the inhibitor high throughput screening (HTS) of a
chemical library containing 160,000 compounds from The
University of Tokyo, Drug Discovery Initiative, and found se-
lective inhibitors for 3MST and CSE. Recently, we designed
and synthesized a novel fluorescence probe for sulfane sulfur,
SSip 1 (Sulfane Sulfur Imaging Probe 1) and this probe
showed a large fluorescence increment in both cuvette and
microscope measurements upon addition of 50 μM Na2S4
based on the intramolecular spirocyclization of the probe.S31-S-11-1 The physiological roles of
hydrogen sulfide and polysulfides
Hideo Kimura
Dept. Mol. Pharm. Natl. Inst. Neurosci. NCNP
We demonstrated that cystathionine beta synthase (CBS) is a
H2S producing enzyme in the brain and that H2S facilitates
the induction of hippocampal long term potentiation (LTP) in
1996. The following year we demonstrated another role of
this molecule, smooth muscle relaxation with its producing
enzyme cystathionine gamma lyase (CSE). We also found the
neuroprotective effect of this molecule. This finding led to
the identification of the protection of various tissues/organs
against ischemia reperfusion injury. We added a novel path-
way, which produce H2S from D cysteine, to three authentic
pathways which metabolize L cysteine. We recently found
polysulfides (H2Sn) in the brain, and it activates transient re-
ceptor potential ankyrin 1 (TRPA1) channels much more po-
tently than H2S. TRPA1 channels mediate various physi-
ological responses including the sensory transduction, but its
endogenous ligand has not been identified. H2Sn also regu-
lates the translocation of Nrf2 transcription factor to the nu-
cleus to upregulate aitioxidant genes. In this symposium we
discuss the producing pathways of polysulfides, their physi-
ological roles and the importance of the balance between H2S
and H2Sn to regulate the activity of their target proteins.
1-S-11-3 Insulin secretion and cellular
stress protection in pancreatic beta cells
Toshihide Kimura
Dept. Pharmacol., Oita Univ.
We previously reported that hydrogen sulfide inhibited glu-
cose induced insulin release from pancreatic islets. Underly-
ing mechanisms for the inhibition seems to be multiple. We
also demonstrated that hydrogen sulfide protected islet cells
from apoptotic cell death induced by high glucose. hydrogen
sulfide increased total glutathione levels and decreased the
production of reactive oxygen species in the mouse beta cell
line MIN6. Finally, we found that the expression of the hydro-
gen sulfide producing enzyme cystathionine gamma lyase
(CSE) was induced by stimulation with glucose in islets. This
supports an idea that hydrogen sulfide may be produced in an
inducible manner just like the other two gasotransmitters NO
and CO. Together with our recent report that a lack of CSE
induced apoptotic beta cell death and promoted the develop-
ment of HFD induced diabetes, these findings also tempt us
to suggest that hydrogen sulfide produced by CSE may be an
intrinsic brake equipped within the pancreatic beta cell to in-
hibit insulin release and reduce cellular stress evoked by glu-
cose, possibly via its anti oxidant actions.9
1-S-11-4 The spatial distribution of
glutathione persulfide in the mouse lens
Mayumi Kajimura, Takafumi Yoshioka,
Makoto Suematsu, Akiko Kubo, Takako Hishiki
Dept. Biochem., Keio Univ. Sch. Med.,
Although glutathione (GSH) is known as the principal antioxi-
dant in the lens, glutathione hydropersulfide (GSSH) has been
recently recognized as a more effective reductant which can
donate a hydrogen atom to one electron oxidants more read-
ily than the thiol. However, the spatial distribution and the
quantification of GSSH remain to be determined. To examine
spatial distributions of GSSH, we took advantage of a unique
nature of an atmospheric pressure MALDI imaging mass
spectrometry (IMS) where the ionization of tissue metabolites
occurs in the presence of molecular oxygen. Under such a
condition, GSSH can be readily oxidized to derive glutathione
S sulfonate (GSSO3H) whose ionization efficiency is much
higher than its native form, making it possible to detect this
trace amount metabolite. We found that mass intensities of
GSSO3H are high in both the epithelium and the outer cortex
of the lens. These results imply that hydropersulfide oxida-
tion states might control protein functions necessary for lens
transparency.
1-S-12-2 The emerging role of
interleukin 19 as inflammatory
mediators
Yasu Taka Azuma, Tadayoshi Takeuchi
Lab. of Vet. Pharmacol., Division of Vet. Sci., Grad. Sch. Life Env. Sci., Osaka
Prefecture Univ.
It has long been appreciated that an immune response must
be tightly regulated to avoid the fatal consequences of an
overwhelming or inappropriate inflammation. Conversely,
exposure to foreign organisms such as LPS, a cell wall com-
ponent of Gram negative bacteria, triggers the host release
of inflammatory mediators that can promote the life threat-
ening tissue damage. Interleukin 19 (IL 19) is a member of
the IL 10 family of cytokines. The last 10 years from the find-
ing of IL 19, investigations have underlined the role of IL 19
in the immunological diseases. It is known that expression of
IL 19 is increased in the epidermis of patients with psoriasis,
which is a Th1 dominant disease. Increased concentration of
IL 19 has also been found in the serum of patients with
asthma, which is a Th2 dominant disease. Moreover, there is
an increasing body of data demonstrating that IL 19 is associ-
ated with the pathogenesis of immune responses in various
organs. In this symposium, we will report the recent ad-
vances in the role of IL 19 as inflammatory mediators in coli-
tis, intimal hyperplasia and neuroinflammation.S41-S-12-1 The Role of Ser/Thr Protein
Phosphatases in intestinal inflammation
and cancer
Takashi Ohama
Dept. Vet. Pharmacol., Yamaguchi Univ.
In this symposium, I present a current picture of phosphatase
targeting anti cancer strategy. Protein Phosphatase 2A (PP2
A) plays a central role in phosphorylation dependent signal-
ing pathways and is implicated as an important tumor sup-
presser. SET/I2PP2A is a potent inhibitor of PP2A and in-
creased SET expression has been suggested to correlates
with the poor prognosis of chronic myeloid leukemia. How-
ever, the role of SET in gastrointestinal cancer remains un-
known. We found increased SET protein levels in the cancer
tissues of Gan mice, which spontaneously develop gastric ade-
nocarcinoma in an inflammation dependent manner. We util-
ized lentivirus to stably express shRNA targeting SET in hu-
man gastric cancer cell lines, MKN45 and MKN74, and found
that the suppression of SET expression leads to significant
decrease in colony numbers in soft agar assay and inhibits tu-
mor growth in mouse xenograft model. SET over expression
in mouse gastric organoid model suggested SET maintains
the stemness of epithelial cells. SET inhibitors effectively
killed gastric cancer cells. Our results suggest that increased
SET expression plays the important role in the aggravation
of gastric cancer, and the possibility for SET targeting anti
cancer drugs.
1-S-12-3 The role of mast cell in food
allergy
Takahisa Murata, Tatsuro Nakamura, Yuki Fujiwara
Animal Radiology, Univesity of Tokyo.
Food allergy is an abnormal immune response to food pro-
teins. The number of patients with food allergies is now in-
creasing especially in developed countries. Symptoms affect-
ing the skin, lung, and gastrointestinal tract include eczema,
labored breathing, and diarrhea. In serious cases, hypersensi-
tivity against food antigens may lead to systemic anaphylaxis
reactions, thus threatening the life of the patient. There is no
effective treatment available for these reactions. Mast cells
are major players in this disease. Upon antigen consumption,
mast cells release a large number of inflammatory mediators,
including histamine, platelet activator factor (PAF) and
prostaglandin D2 (PGD2). Mast cells strongly express hema-
topoietic PGD synthase (H PGDS) and produce a large
amount of the arachidonic acid metabolite prostaglandin D2
(PGD2). Although PGD2 has been emerged as a mast cell de-
rived allergic mediator, there is uncertainty about its contri-
bution to allergic inflammation. We have been investigating
the role of prostaglandin D2 in food allergy using genetically
modified mice. In this symposium, we introduce the implica-
tion of mast cell derived PGD2 for food allergy and anaphy-
laxis, and suggest its efficacy for therapeutic application.0
1-S-12-4 Roles of novel serine/
threonine kinases that regulate the
pathogenesis of hypertension through
inflammatory reactions
Hideyuki Yamawaki
Lab. Vet. Pharmacol., Kitasato Univ. Sch. Vet. Med.
Hypertension is often associated with inflammatory reactions
through several organs including kidney, brain, heart and
vasculature. However, the underling mechanisms still re-
main to be fully determined. Protein kinases regulate critical
cellular functions including proliferation, migration, cell
death and inflammation, that are important for maintaining
the homeostasis of living organism. Recently, our group has
discovered several protein kinases, expression of which are
specifically upregulated in the tissues from experimental hy-
pertensive animal models. In this symposium, I introduce
functions of the serine/threonine kinases, namely eukaryotic
elongation factor 2 kinase (also known as CaMK III) and zip-
per interacting protein kinase (also known as DAPK3) espe-
cially focusing on inflammation, discuss their roles in the
pathogenesis of hypertension, and propose their potential
therapeutic application.
1-S-13-2 Inhibition of Parkin opposing
Deubiquitination Enzyme USP14 as a
therapeutic approach to enhance
clearance of misfolded proteins in PD
Elena Ziviani
Dept. Biol. Univ. Padua
USP14, mammalian homologue of fly gene CG5384, was identi-
fied following a Deubiquitination Enzyme (DUB) based RNAi
screening as a novel regulator of ubiquitination of mitochon-
drial Mitofusin (Mfn). Our data show that USP14 is opposing
Parkin in the ubiquitination of Mfn and USP14 suppression is
sufficient to promote mitophagy in the absence of Parkin, via
stabilization of Mfn ubiquitinated forms. We propose that
suppression of USP14 activity might be instrumental for the
activation of mitochondria clearance pathway downstream of
Parkin and can be beneficial in ameliorating locomotor defi-
cits in animal models of PD.S41-S-13-1 Functional role of a novel
protein inhibiting mitochondrial fusion
Naoki Inoue 1, Norihito Shintani 1,2, Akemichi Baba 1,3,
Hitoshi Hashimoto 1,4
1Grad. Sch. Pharmaceut. Sci., Osaka Univ., 2Dept. Biol., Univ. Padua, 3 Fuc.
Pharmaceut. Sci., Hyogo Univ. Health Sci., 4United Grad. Sch. Child Dev., Osaka
Univ. Kanazawa Univ. Hamamatsu Univ. Sch. Med. Chiba Univ.＆ Univ. Fukui
Several lines of evidences have revealed the possible roles of
mitochondrial quality control in the pathogenesis of neurode-
generative diseases. For example, perturbation of mitophagy
(mitochondrial degradation by autophagy) promotes the accu-
mulation of the damaged mitochondria, a main source of reac-
tive oxygen species. Mitochondria are highly dynamic organ-
elles, and their quality is controlled by not only mitophagy
but also mitochondrial dynamics (fission and fusion). Mito-
chondrial dynamics is crucial for mitochondrial renewal, dis-
tribution and proliferation, however, its regulatory mecha-
nism in neurodegeneration remains poorly understood. Re-
cently, we identified a novel 13 kDa protein (p13) whose ex-
pression is decreased in the pancreatic islets with oxidative
stress. Further studies have revealed that p13 is also ex-
pressed in several brain regions, and affects mitochondrial
dynamics by inhibiting their fusion process. We will present
our data indicating the relation between p13 and Parkinson’s
disease, and propose that further functional analysis of p13
contribute to mitochondrial dynamics based drug discovery
for neurodegenerative diseases.
1-S-13-3 Alpha synuclein
conformational states and their impact
on vesicle trafficking
Luigi Bubacco
Dept. Biol. Univ. Padua
Alpha synuclein (aS) is one of the emerging molecular play-
ers in synaptic function. This 140 aa protein localized at pre-
synaptic terminals, and several studies are characterizing aS
as protein that binds synaptic vesicle membranes and likely
assists vesicle trafficking and SNARE complex formation.
Wild type aS has also been reported to bind actin, slowing
down its polymerization and accelerating its depolymeriza-
tion, probably by sequestration of monomers that leads to an
alteration of exo and endocytic traffic. The peculiarity of aS
is that simply an increase in its expression levels leads to ab-
normal aggregation and neuronal degeneration both in vitro
and in vivo. A paradigm of this behaviour is found in multipli-
cation mutations that increase expression levels by 50 100%
and cause Parkinson’s disease or dementia with Lewy bodies.
To unravel its physiological role we started from a charac-
terization of the tightly regulated equilibrium between
water soluble and membrane bound and the posttransla-
tional modifications that may control aS competence to inter-
act with other cellular partners. To account for the Janus like
quality of aS, the complex sequence of events that starts with
aS aggregation and leads to its action as endotoxin will be dis-
cussed.1
1-S-13-4 SUMOylation Pathways in
Synaptic Development and
Neurodegeneration
Shinsuke Matsuzaki 1,2,3,4,5, Hironori Takamura 1,2,5,
Taiichi Katayama 1, Paul Fraser 4,5
1Dept. Mol Brain Sci, United Grad. Sch. of Child Development, Osaka Univ.,
2Mol. Res. Cent. for Children’s Mental Development, United Grad. Sch. of Child
Development, Osaka Univ, 3Anatomy and Neuroscience, Grad. Sch. of Medicine,
Osaka Univ.,
4Dept. Medical Biophyscs, Univ. of Toronto, 5 Tanz Centre for Res.
Neurodegenerative Diseases, Univ. of Toronto
Small ubiquitin like modifier 1 (SUMO1) plays a number of
roles in cellular events and recent evidence has given momen-
tum for its contributions to neuronal development and neuro-
logical disorders. We have generated a SUMO1 transgenic
mouse model with overexpression in neurons to identify in vivo
conjugation targets and the functional consequences of their SU-
MOylation. Immunoprecipitation of SUMOylated proteins from
total brain extract and proteomic analysis revealed a number of
candidate proteins from a variety of functional classes, includ-
ing a number of synaptic and cytoskeletal proteins. SUMO1
modification of synaptotagmin 1 was found to be elevated as
compared to non transgenic mice. This observation was associ-
ated with an age dependent reduction in basal synaptic trans-
mission and impaired presynaptic function as shown by altered
paired pulse facilitation, as well as a decrease in spine density.
The changes in neuronal function and morphology were also as-
sociated with a specific impairment in learning and memory
while other behavioral features remained unchanged. These
findings indicate a significant contribution of SUMO1 modifica-
tion on neuronal function which has implications for mecha-
nisms involved in mental retardation and neurodegeneration.
2-S-01-2 Translational Pharmacology
and Zebrafish Based Drug Discovery
Toshio Tanaka 1, Yuhei Nishimura 1,2,3,4,
Yasuhito Shimada 1,2,3,4
1Dept. PGx., Mie Univ. Grad. Sch. Med, 2Dept. Sys. Pharmaco., Mie Univ. Grad.
Sch. Med, 3Mie Univ., Med. Zebra. R. C., 4Dept. Bioinfo., Mie Univ., Life Sci. R.
C.
The next generation discipline of systems pharmacology
aims to combine experimental analysis and computational
modeling of in vivo networks with quantitative pharmacology
approaches to drive the drug discovery processes, predict
rare adverse events, and catalyze the practice of personal-
ized medicine.Here, we introduce the strategy of zebrafish
based quantitative and systems pharmacology, which syner-
gistically combine the desirable features of systems pharma-
cology and emerging technology of zebrafish based screen-
ing system for functional omics and chemical biology. Ze-
brafish based systems pharmacology that analyze in vivo
regulatory networks involved in drug action can account for
a drug’s multiple targets and for the effects of genomic, epi-
genomic, and posttranslational changes on the drug efficacy.
Zebrafish based drug discovery has become a potential strat-
egy by its high throughput quantitative in vivo screening and
has already succeeded in several examples of phenotype
based drug discovery and personalized medicine.This new
translational pharmacology can drive drug discovery and
shape precision medicine.S42-S-01-1 Significant Role of
Pharmacology in Expected Outcomes
from Open Innovation
Toshiaki Akira 1,2
1Dept., Resear., Admin., Hyogo Col. Med., 2 Sohyaku. Innovative Research Dvision,
Mitsubishi Tanabe Pharma Corporation
The recent advances of medicine and medical care, accompa-
nied with development of high content technology and inven-
tion of revolutionary medical devices for diagnosis and treat-
ment, have been achieved by progression of medical sciences
including pharmacology. Above all, enhanced quality of medi-
cation is, in many cases, ascribed to discovery of innovative
drugs, thus at least partly based on pharmacological efforts
in open innovation, integrated and functional collaboration
between academia and industry. In spite of these efforts,
evaluating the general benefit of pharmacotherapy in treat-
ing patients, some diseases and symptoms, in contrast with
hypertension, hyperlipidemia or hyperglycemia, are given
limited benefits and still remained to treat enough in clinic.
Such dissatisfaction of medicating the disease (for instance,
stroke or diabetic complications) may be originated from in-
adequate or incomplete understanding of the nature of the
disease. We therefore need to exactly understand its pa-
thologic mechanism and to find adequate solution of the clini-
cal problems. Then, we will discuss how to overcome the cur-
rent situation and reach the goal to favorable medication
through playing significant roles of pharmacology upon open
innovation.
2-S-01-3 AMED Strategy of Drug
Discovery Support toAccelerate Delivery
of NewMedicines
Yoichi Kurebayashi
Japan Agency for Medical Research and Development
AMED Strategy of Drug Discovery Support to Accelerate
Delivery of New Medicines
Japan’s health and medical administration is facing chal-
lenges, such as changing medical needs due to rapidly aging
society, growing trade deficit due to increasing foreign im-
port of new drugs, and increasing global competition in
Pharma research and development. In this context, Depart-
ment of Innovative Drug Discovery and Development (iD3),
Japan Agency for Medical Research and Develoment
(AMED), has set broad, integrative strategies to boost, sup-
port and innovate drug discovery research in academic insti-
tutions and pharmaceutical industry. Drug Discovery Sup-
port Network is the core project of iD3 to accelerate transla-
tion of promissing basic researches into innovative new medi-
cines. In this presentation, recent development and chal-
lenges of the Drug Discovery Support Network project will
be outlined with other other new initiatives that iD3 has
started and pursued to date.2
2-S-01-4 Drug Discovery inAcademia
from the drug screening with new ideas
to the clinical trial in our university
hospital―
Masatoshi Hagiwara
Dept. Anat.＆ Dev. Biol., Grad. Sch. Med., Kyoto Univ.
Patients of congenital diseases have abnormalities in their
chromosomes and/or genes. Therefore, it has been consid-
ered that drug treatments can serve to do little for these pa-
tients more than to patch over each symptom temporarily
when it arises. Although we cannot normalize their chromo-
somes and genes with chemical drugs, we may be able to ma-
nipulate the amounts and patterns of mRNAs transcribed
from patients DNAs with small chemicals. Based on this sim-
ple idea, we have looked for chemical compounds which can
be applicable for congenital diseases and found INDY, TG003,
and SRPIN340, and RECTAS. These are promising as clinical
drugs for Down syndrome, Duchenne muscular dystrophy,
Denys Drash Syndrome, and Familial dysautonomia, respec-
tively. Through the development of these chemicals, we even-
tually succeeded to find candidate compounds available for
more common diseases such as viral infections, cancers, age
related macular degeneration, chronic pain, and Parkinson
disease. The preparation of the clinical trial of the ant virus
drug is under the way in our university hospital as an “Aca-
demia Drug”. We propose the strategy to maximize the seren-
dipity for the academic drug discovery with open innovation.
2-S-02-2 Effects of SGLT2 inhibitors on
blood pressure and renal function
Akira Nishiyama
Dept. of Pharmacy., Kagawa Med. Sch.
Accumulating clinical evidence has revealed that treatment
with SGLT2 inhibitors elicits a significant blood pressure re-
duction. However, the precise mechanism responsible for the
SGLT2 inhibitor induced blood pressure reduction is un-
clear. We have shown that treatment with selective SGLT2
inhibitors significantly decreased blood pressure with nor-
malization of its dipping pattern in salt treated obese rats
and metabolic syndrome rats. During treatment with SGLT2
inhibitors, blood pressure reduction was associated with an
increase in urinary excretion rate of sodium in these animals.
Interestingly, urinary osmolality was consistently decreased
by treatment with SGLT2 inhibitors. Furthermore, SGLT2
inhibitors induced natriuresis was not enhanced by the addi-
tion of hydrochlorothiazide or hydrochlorothiazide+fu-
rosemide. These data suggest that SGLT2 inhibitors elicit an
anti hypertensive effect with improvement of dipping pat-
tern of blood pressure through natriuresis in subjects with
obese or metabolic syndrome. Furthermore, SGLT2 inhibi-
tors induced natriuresis cannot be solely explained by os-
motic diuresis. Further studies are under way to examine the
effects of SGLT2 inhibitor on the regulation of renal sodium
transports.S42-S-02-1 Overview
Yoshikatsu Kanai
Dept. Bio system Pharmacol., Osaka Univ. Grad. Sch. Med.
SGLT2 inhibitors have been developed as anti diabetic
drugs. They target Na+/glucose cotransporter SGLT2 in the
renal proximal tubules responsible for the reabsorption of
glomerular filtered glucose. By inhibiting SGLT2, SGLT2 in-
hibitors increase glucose excretion into urine and decrease
blood glucose level in an insulin independent manner in pa-
tients with type 2 diabetes. By improving blood glucose level,
SGLT2 inhibitors ameliorate the symptoms and pathological
changes associated with diabetes. SGLT2 inhibitors dramati-
cally alter systemic glucose homeostasis because SGLT2 me-
diates massive glucose reabsorption. Renal tubular reabsorp-
tions, in general, by preventing urinary loss of low molecular
weight hydrophilic compounds and inorganic ions, play criti-
cal roles in the systemic homeostasis. Therefore, such trans-
porters can be the targets of drugs to recover homeostasis
disturbed in disease state. In this context, diuretics inhibiting
renal electrolyte transporters and uricosuric drugs inhibit-
ing urate reabsorption transporters have been used clini-
cally. This idea can be extended to developing new categories
of drugs to inhibit renal tubular transporters to recover ho-
meostasis in diseases.
2-S-02-3 Mechanism of SGLT2
Inhibitor induced Decrease in Serum
Urate Level
Ikumi Tamai
Fac. Pharm. Sci., Kanazawa Univ.
SGLT2 inhibitors commonly lower serum urate (SUA) level.
In clinical study, luseoglifrozin increased urinary excretion
of urate (UEua) and the extent of increase of UEua mostly ex-
plained the decrease of SUA level. In addition, the increase in
UEua was correlated with an increase in urinary D glucose
excretion, but not with the plasma luseogliflozin concentra-
tion. Furthermore, luseogliflozin had no direct effect on renal
urate transporters at clinically relevant concentration. Ac-
cordingly, SUA lowering effect was considered as the urico-
suric effect which is common to SGLT2 inhibitors and is asso-
ciated with the glycosuria. GLUT9 isoform 2 (SLC2A9b) is ex-
pressed at the apical membrane of the kidney tubular cells
and transports both urate and D glucose. By in vitro trans-
porter expressing cells, we observed trans stimulation of
urate efflux by 10 mM D glucose, a high concentration of glu-
cose that existed under SGLT2 inhibition. In addition, uptake
of urate by GLUT9 isoform 2 was cis inhibited by 100 mM D
glucose, a concentration assumed to exist in collecting ducts.
Accordingly, it was demonstrated that UEua could be in-
creased by SGLT2 inhibitor induced glycosuria with altera-
tions of urate excretory transport activity. Reference : Bio-
pharm Drug Dispos 35 : 391 404 (2014).3
2-S-02-4 A renal tubular transporter
mediating reabsorption of β
hydroxybutyrate: a potential target of
drugs increasing urinary ketone body
excretion
Shushi Nagamori
Dept. Bio sys Pharmacol., Osaka Univ. Grad. Sch. Med.
Ketone bodies are the important energy source particularly
when glucose is starved. Because they are filtered by
glomerulus in kidney, proximal tubules reabsorb them to re-
cover in blood. In diabetic condition, ketone body production
is increased so that its blood level is elevated, which causes
diabetic ketoacidosis. Although Na+ dependent monocaebox-
ylate transporters and H+ coupled monocaeboxylate trans-
porters have been proposed to mediate the reabsorption of a
ketone body β hydroxybutyrate (β HB), their contribution to
renal ketone body reabsorption has not been estimated. By
means of metabolomics to compare the urine of the OATN1
knockout mice and that of wild type mice, we have found that
an orphan transporter OATN1 mediates the reabsorption of
β HB. In alloxan induced diabetic mice in which blood β HB
is increased, we have confirmed that OATN1 homo knockout
mice exhibit much higher renal β HB excretion compared
with wild type mice. Furthermore, the inhibitors of OATN1
largely reduced the blood β HB level, suggesting that OATN
1 can be a target of drugs to increase urinary β HB excretion
and decrease blood β HB level, which may be beneficial for
the treatment of diabetic ketoacidosis.
2-S-03-2 Design of treatments for
cutaneous and visceral leishmaniasis
Simon. L. Croft, Katrien Van Bocxlaer, Karin Seifert
Fac. of Infectious and Tropical Diseases, London School of Hygiene＆ Tropical
Medicine
Leishmaniasis is a disease complex, with cutaneous (CL) and
visceral (VL) manifestations, caused by parasitic protozoa
that survive and multiply in host macrophages. The current
treatments for both forms of the disease are limited by cost,
toxicities, and variable efficacy. For CL, where there are few
acceptable treatments, variation in Leishmania species drug
sensitivity and pathology contributes to this variation
whereas for VL it is not understood why treatments that are
effective in India are significantly less so in East Africa.
We are using mouse models of infection of both CL, caused by
Leishmania major, and VL, caused by Leishmania donovani,
to explore novel formulations, both topical and nanoparticle,
to improve drug delivery and drug efficacy. The effect of the
disease status on drug distribution, drug disposition and
pharmacokinetics has been determined. In the mouse VL
model, PK PD analysis has helped determine dose and time
dependency of amphotericin B liposomes and miltefosine.
The data will be discussed in relation to design of improved
treatments.S42-S-03-1 Magic bullets for parasitic
diseases: drugs from Japan
Kiyoshi Kita
Dept. Biomedical Chem. Tokyo Univ.
Parasitologists in Japan have been trying to discover new
means to combat parasites and making significant contribu-
tions towards developing tools for global parasitic disease
control. In the early 1970s, Streptomyces avermectinius , the
source of ivermectin, was discovered by Prof. Satoshi
Omura, who is a winner of Nobel Prize 2015, and renewed
and vigorous screening of microbial metabolites in recent
years is discovering new antiprotozoals and anthelminthics.
Many people in developing countries still suffer from para-
sitic infectious diseases while, in developed countries, espe-
cially those caused by opportunistic infection due to the use
of immunosuppressants and HIV/AIDS are increasing. In ad-
dition, mergence of strains resistant to the current front line
drugs cannot be disregarded. Consequently, through the new
knowledge and understanding emanating from basic research
into parasitic adaptation and its development for clinical ap-
plication, Japanese scientists are retaining a significant role
at the forefront of the control of emerging and re emerging
parasitic diseases. In this presentation, past, now and future
of the discovery of the anti parasites drugs will be discussed.
These include ivermectin, nafuredin, atpenin A5, flutolanil
and ascofuranone.
2-S-03-3 Research＆ Development
and Distribution of medicines for
eliminatingTropical Diseases:
Introduction of our activities as an
example of the approach by
pharmaceutical industries
Makoto Asada
CINO, PC HQ, Eisai Co., Ltd.
Pharmaceutical industries are expected to play a crucial role
in combatting Neglected Tropical Diseases (NTDs) affecting
low income countries by providing effective medicines to pa-
tients in easy to access way. However in order to realize this
mission, various challenges ever unexperienced within the in-
dustry are required to be overcome. For examples, aside
from the issue of cost and benefit balance, knowledge and re-
search tools of tropical diseases, clinical study networks,
regulatory experiences and distribution logistics in the en-
demic countries are all sparse in existing pharma industries.
Recently, various international approaches for eliminating
tropical diseases have been initiated, which encourage and
support the activities for drug development to those diseases
by combining expertise of academia, PDPs (product develop-
ment partners) and industries. In this presentation, our expe-
riences on such collaboration activities for drug development
with DNDi (Drugs for Neglected Diseases initiative) and
other PDPs/academia will be introduced. Also, our efforts
for enhancing access to medicines for patients in developing
countries will be touched.4
2-S-03-4 Japan’s Global Health R＆D
Leadership
Kei Katsuno
Global Health Innovative Technology Fund
The first of its kind in Japan, the Global Health Innovative
Technology Fund (GHIT Fund) is a public private partner-
ship between seven Japanese pharmaceutical companies, the
Japanese Government, the Bill & Melinda Gates Foundation,
the Wellcome Trust, and UNDP. Launched in April 2013 with
an initial commitment of more than US$100 million, the or-
ganization taps Japanese research and development (R&D) to
fight neglected diseases. The GHIT Fund invests and man-
ages a portfolio of development partnerships aimed at ne-
glected diseases that afflict the world’s poorest people. GHIT
mobilizes Japanese pharmaceutical companies and academic
and research organizations to engage in the effort to get new
medicines and vaccines to people who need them most, with
Japan quickly becoming a game changer in global health. In
just two and a half years since it was formed, GHIT has in-
vested in the development of more than 40 new products,
with allocations totaling more than US $50 million. As of 2015,
GHIT is advancing six clinical trials in Burkina Faso, Ivory
Coast, Tanzania, Uganda, Thailand, Peru, and Bolivia, and
two more clinical trials will begin in 2016.
2-S-04-2 The involvement of NOX1/
NADPH oxidase in the emotional
behavior
Masakazu Ibi, Junjie Liu, Chihiro Yabe Nishimura
Dept. Pharmacol., Kyoto Prefectual Univ. Med.
Reactive oxygen species (ROS) have been implicated in the
development of psychiatric disorders. We presently report
NOX1/NADPH oxidase is the source of ROS that regulate the
emotional behavior demonstrated in murine models. When
anxiety like behaviors were evaluated, wild type mice (WT)
and mice deficient in Nox1 (NOX1 KO) showed similar anxi-
ety levels. However, increased anxiety like behaviors in WT
following acute restraint stress were markedly ameliorated
in NOX1 KO. Similarly, reduced sucrose preference demon-
strated in WT chronically administered with corticosterone
(CORT) was significantly suppressed in NOX1 KO. In WT
treated with CORT, the levels of brain derived neurotrophic
factor (BDNF) mRNA and of transcripts containing exon IV
of BDNF gene were significantly decreased, but they were
sustained in NOX1 KO. ROS production was significantly
elevated in the prefrontal cortex (PFC) of mice administrated
with CORT, while the level of NOX1 mRNA was up regu-
lated in the ventral tegmental area (VTA), not in PFC. Fi-
nally, selective silencing of NOX1 in VTA by AAVrh10 virus
expressing miRNA restored CORT induced depressive like
behaviors and reduced expression of BDNF mRNA. ROS de-
rived from NOX1 may therefore play a key role in the emo-
tional behavior induced by stress.S42-S-04-1 HSPs as potential therapeutic
targets in SCA14 associated with
amyloidogenic assembly of mutant PKCγ
Naoko Adachi 1, Hideyuki Takahashi 1, Aoi Nakazono 1,
Daizo Hamada 4, Takehiko Ueyama 1, Takahiro Seki 3,
Norio Sakai 2, Naoaki Saito 1
1 Biosignal Res. Ctr., Kobe Univ., 2Dpt. Mol. Pharm. Neurosci., Hiroshima Univ.,
3Dpt. Chemi. Pharm. Sci., Kumamoto Univ., 4Dpt Chem. Sci. Eng., Kobe Univ.
Amyloid assemblies are associated with a wide range of hu-
man neurological disorders, including Alzheimer’s and
Parkinson’s diseases. Here, we identify protein kinase Cγ
(PKCγ), a serine/threonine kinase mutated in the neurode-
generative disease spinocerebellar ataxia type 14 (SCA14), as
a novel amyloidogenic protein. We found that overexpression
of PKCγ in cultured cells, as well as in vitro incubation of pu-
rified PKCγ without heat or chemical denaturants, result in
amyloid like PKCγ fibril formation. We also observed that
SCA14 associated mutations in PKCγ greatly enhanced amy-
loid like fibril formation both in cultured cells and in vitro.
Furthermore, time lapse microscopic imaging in cultured
neuronal cells demonstrated that aggregates of mutant PKCγ
are highly toxic. In these cells, aggregates are co localized
with several heat shock proteins (HSPs), which physically in-
teract with mutant PKCγ. Overexpression of HSP70 and HSP
40 reduced aggregate formation and cytotoxicity of mutant
PKCγ in cultured cells. These findings demonstrate that
HSPs act directly to regulate amyloid like PKCγ fibril for-
mation, and thus identify HSPs as potential therapeutic tar-
gets in SCA14.
2-S-04-3 Molecular mechanisms of a
familial epilepsy caused by LGI1
mutations
Norihiko Yokoi 1,2, Yuko Fukata 1,2, Daisuke Kase 3,
Taisuke Miyazaki 4, Martine Jaegle 5, Keiji Imoto 2,3,
Dies Meijer 5, Masahiko Watanabe 4, Masaki Fukata 1,2
1Div. Membr. Physiol., Natl. Inst. Physiol. Sci., 2Dept. Physiol. Sci., SOKENDAI
(Grad. Univ. Adv. Studies), 3Div. Neural Signaling, Natl. Inst. Physiol. Sci.,
4Dept. Anatomy, Hokkaido Univ. Grad. Sch. Med., 5Dept. Cell Biol. Genet.,
Erasmus Univ. Med. Center
Mutations of LGI1, a neuronal secreted protein, are linked to
autosomal dominant lateral temporal lobe epilepsy (ADLTE).
Also, anti LGI1 autoantibodies are frequently detected in pa-
tients with limbic encephalitis characterized by seizures and
memory impairment. We have reported that LGI1 functions
as a ligand for an epilepsy related transmembrane protein,
ADAM22 ; LGI1 enhances AMPA type glutamate receptor
mediated synaptic transmission ; and loss of LGI1 in mice re-
duces AMPA receptor mediated synaptic transmission and
causes lethal epilepsy. However, the patho physiological
functions of LGI1 still remain unclear. Here, we classified
LGI1 missense ADLTE mutations as either secretion defec-
tive or competent, and generated two mouse models of
ADLTE harboring two representative LGI1 mutations. Both
mutations reduced synaptic LGI1 ADAM22 interaction in the
mouse brain due to protein conformational defects. A chemi-
cal chaperone restored the folding of the secretion deficient
mutant protein and its binding to ADAM22 and ameliorated
the increased seizure susceptibility of the mutant mice. This
study establishes an essential role of the LGI1 ADAM22 in-
teraction to regulate the brain excitability (Yokoi et al. Nat.
Med. 2015).5
2-S-04-4 The contribution of adult
born neurons in memory consolidation
during wake sleep cycles
Masanori Sakaguchi, Deependra Kumar,
Masanobu Hayashi, XiFang Hayashi,
Gopakumar Changarathil, Takeshi Sakurai
Sleep institute, Univ. Tsukuba
The process which affects memory consolidation during
wake sleep cycles has been unknown. We found that optoge-
netically silencing adult born neurons in the mice dentate
gyrus during specific wake sleep cycle impairs memory con-
solidation. The adult born neurons’ contribution to this proc-
ess depends on the maturation status of the neurons and the
nature of the memory. Furthermore, brain activity imaging
revealed that adult born neurons impact the hippocampal ac-
tivity of memory consolidation during sleep. These results
suggest that intervening specific neuronal circuits during
each wake sleep period could uncover its unique function.
2-S-05-2 An in vitro model for
studying repetition dependent memory
consolidation; Long lasting synaptic
enhancement in cultured hippocampal
slices and its suppression by a stress
mimicry.
Keiko Tominaga Yoshino, Shinichi Saito,
Akihiko Ogura
Osaka Univ. Grad. Sch. Front. Biosci.
We previously reported that the repeated inductions of
chemically induced LTP produced a long lasting enhance-
ment of synaptic strength in cultured hippocampal slices.
Naming this phenomenon RISE (Repetitive LTP Induced
Synaptic Enhancement), we assume this as an in vitro repro-
duction of repetition dependent memory consolidation since
it is long lasting, specific to input pathway and accompanied
by new synapse formation. RISE develops through stochastic
processes ; raised fluctuation of synapses (both generation
and retraction are increased) followed by biased fluctuation
(retraction returns to basal level earlier than generation). It
is shown that BDNF is involved in RISE production and that a
transient expression of Ca2+ permeable AMPA receptors is
critical. If RISE is the reproduction of memory consolidation,
RISE should also be affected by stress. Dexamethasone (Dex),
a stress mimicry, applied 12h after a RISE producing stimu-
lus blocked the development of RISE. However, Dex was inef-
fective when applied several days after the stimulus. RISE
should serve as a model for analyzing the cellular mecha-
nisms underlying stress induced memory defects.S42-S-05-1 Activity dependent
bidirectional regulation of terminal
neuronal maturation in the adult
hippocampus
Eri Segi Nishida 1, Katsunori Kobayashi 2
1Dept. Biol. Sci.＆ Tech., Tokyo Uni. of Sci., 2Dept. Pharm. Nippon Med. Sch.
Defects in the terminal maturation of central neurons have
been implicated in the pathophysiological basis of neuropsy-
chiatric disorders. However, the regulatory mechanism of
the terminal maturation remains largely unknown. Here we
show that neuronal activity bidirectionally regulates the ter-
minal maturation of adult mouse hippocampal granule neu-
rons. Neuronal excitation by electroconvulsive stimulation
(ECS) rapidly reduced expression of molecular markers for
mature granule neurons and induced immature neuron like
functional properties such as higher excitability. The pheno-
types of ECS treated neurons were maintained for more than
2 weeks after repeated ECS. Block of NMDA receptors after
the period of ECS counteracted maintenance of the immature
phenotypes and promoted rematuration, suggesting that the
enhanced excitability of ECS treated neurons autonomously
supports their immature state. These results demonstrate
that the terminal maturation of granule neurons is reversed
and advanced by excitation and inhibition, respectively. We
propose that cell stage specific regulation of neuronal matu-
ration by activity would be a novel strategy for treating neu-
ropsychiatric disorders via rescue of the defective neuronal
maturation.
2-S-05-3 Novel cognitive mechanism
by calcium/calmodulin dependent
protein kinase II activation
Shigeki Moriguchi, Kohji Fukunaga
Dept. Pharmacol., Tohoku Univ. Grad. Sch. Pharmaceut. Sci.
Calcium/calmodulin dependent protein kinase II (CaMKII) is
highly localized in the post synaptic densities of excitatory
synapses and becomes constitutively active through autophos-
phorylation following hippocampal LTP (Fukunaga et al.,
1993). CaMKII facilitates synaptic efficacy through direct
phosphorylation of post synaptic AMPA receptor subunit
GluA1 (Ser 831). Recently, we focus on CaMKII activation for
cognitive enhancement by Na+/Ca2+ exchangers (NCXs).
NCXs have three different isoforms (NCX1, NCX2, NCX3) en-
coded by distinct genes. We also found that mice lacking NCX
2 (NCX2 KO) exhibit impaired memory. NCX2 KO mice
showed significantly impairment of learning and memory re-
lated behaviors and hippocampal LTP. CaMKII autophospho-
rylation significantly decreased in the hippocampal CA1 re-
gion of NCX2 KO mice compared to wild type mice. The en-
hancement of CaMKII autophosphorylation following LTP
was also impaired in NCX2 KO mice. Furthermore, the de-
creased CaMKII autophosphorylation was closely associated
with the reduced GluA1 (Ser 831) phosphorylation in the hip-
pocampus. Taken together, the decreased CaMKII activity
with concomitant LTP impairment likely accounts for the
learning disability observed in NCX2 KO mice.6
2-S-05-4 Molecular Mechanisms and
Effects ofAging on Rewriting of Motor
Learning and Cerebellar Plasticity
Sho Kakizawa
Dept. Biol Chem., Kyoto Univ. Grad. Sch. Pharmaceu. Sci.
Rewriting of memory is essential for adaptation to new envi-
ronment. However, mechanisms of memory rewriting have
been largely unknown. Eyeblink conditioning, cerebellar de-
pendent motor learning, has acquisition and rewriting (ex-
tinction) phases. Although involvement of LTD at parallel fi-
ber (PF) synapse in acquisition process is well known, mecha-
nisms of extinction have yet to be examined.
Because LTP at PF synapse (PF LTP) is known to reverse
the saturation of PF LTD, involvement of PF LTP in the ex-
tinction of eyeblink conditioning is hypothesized. PF LTP is
also indicated to be induced by NO induced Ca2+ release
(NICR), a novel Ca2+ release mechanism, in PCs. Because
NICR is induced by S nitrosylation of C3636 in ryanodine re-
ceptor 1 (RyR1), a Ca2+ release channel, by NO, knockin mice
expressing RyR1 carrying C3636A mutation (RyR1C3636A mice)
was generated. In RyR1C3636A mice, as well as NICR and PF
LTP, extinction but not acquisition of eyeblink conditioning
was impaired. Therefore, NICR and PF LTP were suggested
as molecular and cellular basis for extinction of eyeblink con-
ditioning.
Another topic on memory rewriting is effect of aging. Effects
of aging on NICR and PF LTP were also investigated, and
will be shown in my talk.
2-S-06-2 Evidence, hypotheses and
significance of MAP kinaseTNNI3K
interacting with its partners
Hoichi Yorinaka
Dept. Pharmacol. Mol. Therap.＆ Grad. Sch. Med. Sci
TNNI3K plays important roles in promoting cardiac differen-
tiation, maintaining beating rhythm and contractual force.
The molecular structure of TNNI3K contains three kinds of
domains : a seven or ten NH2 terminal ankyrin repeat do-
main followed by a protein kinase domain and a COOH ter-
minal serine rich domain. There are many binding sites in
the structure of TNNI3K for binding to ATP, magnesium,
nucleotide, protein kinase C, antioxidant protein 1 and cTnI.
This review summarizes the evidence, hypothesis and signifi-
cance of TNNI3K interacting with TNNI3 and its other puta-
tive interaction partners. From the literature, the interaction
partners of TNNI3K are divided into 2 types : to increase or
suppress cardiac performances. Following their binding
sites, they are divided into other 2 types : binding to C termi-
nal domain or binding to both ankyrin repeat domain and C
terminal domains. To date, a well understood partner of
TNNI3K is cTnI, from the molecular structure, physiological
function, mechanisms and its significances in physiological
and pathophysiological conditions. There are many reasons to
believe that, with more understanding on the TNNI3K inter-
acting with its partners, we can understand more roles of
TNNI3K in some cardiac diseases.S42-S-06-1 Adenovirus Mediated
Overexpression ofTNNI3K Promotes
Cardiomyocyte Hypertrophy
Xian Min Meng
Cardiovascular Institute＆ Fu Wai Hospital, Chinese Academy of Medical Sciences
Cardiac troponin I interacting kinase (TNNI3K) is a novel
cardiac specific kinase gene. The aim of the present study
was to investigate the effects of TNNI3K on neonate rat car-
diomyocyte hypertrophy. Cardiomyocytes were infected
with either a control adenovirus carrying green fluorescent
protein (Ad GFP) or Ad TNNI3K. Compared with Ad GFP,
the Ad TNNI3K could increase in sarcomere organization,
cell surface area, 3H leucine incorporation and ν MHC re ex-
pression. This type of hypertrophic phenomenon is similar to
the observation in cardiomyocytes induced by ET 1. The
cells were further infected with Ad GFP or Ad TNNI3K in
ET 1 induced hypertrophic, Ad TNNI3K could also in-
crease in sarcomere organization, cell surface area and 3H
leucine incorporation.The results suggest that cardiomyo-
cytes hypertrophy could be induced and accelerated by TNNI
3K overexpression. Therefore, TNNI3K might be an interest-
ing target for the clinical treatment of hypertrophy.
2-S-06-3 CirculatingTNNI3K levels are
useful diagnosis biomarker for ischemic
myocardial diseases
Tianli Zhang
Dept. Microbiology, Grad Sch Med Sci, Kumamoto Uni
Availability of circulating TNNI3K level was investigated as
a new diagnosing biomarker for acuate ischemic cardiac dis-
eases by using anti TNNI3K poly or monoclonal antibodies in
patients diagnosed as AMI, chronic heart failure, acute renal
failure ; and in healthy volunteers groups. Our data showed
that circulating TNNI3K levels were significantly higher in
AMI when compared with other two groups (p<0.001), indi-
cating that measurement of circulating TNNI3K is a novel
and useful diagnosing tool for ischemic heart diseases includ-
ing AMI. Our data also showed that the sensitivity and speci-
ficity are higher, ROC curve is best than that of polyclonal
antibodies, indicating that measurement of circulating TNNI
3K level using the monoclonal antibodies may be a novel and
useful tool to diagnose AMI. In conclusion, using TNNI3K as
a molecular target is a new potential approach for developing
diagnostic agents for ischemic cardiac diseases.7
2-S-06-4 TNNI3K affects the cardiac
contractile function by cTnI
phosphorylation
Li Song
Cardiovascular Institute＆ Fu Wai Hospital, Chinese Academy of Medical Sciences
TNNI3K is a novel cardiac specific functional kinase that
could bind to cTnI in a yeast two hybrid screen. The phos-
phorylation of cardiac troponin I (cTnI) plays an important
role in the contractile dysfunction associated with heart fail-
ure. The purpose of this study was to investigate whether
TNNI3K could phosphorylate cTnI and the effect in cardiac
contractile function. The study first confirmed that TNNI3K
could interact with cTnI by Co Immunoprecipitation, and di-
rectly phosphorylated Ser43 and Thr143 in vitro. Further-
more, enhanced phosphorylation of cTnI correlated with
rTNNI3K (rat TNNI3K) overexpression, and phosphorylation
was reduced when rTNNI3K was knocked down in adult rat
cardiomyocytes. Finally, the contraction of cardiomyocytes,
modulated by TNNI3K mediated phosphorylation of cTnI, in-
creased with rTNNI3K overexpression and decreased with
rTNNI3K knockdown in adult rat ventricular myocytes. In
summary, TNNI3K may be a novel mediator of cTnI phos-
phorylation and contribute to the regulation of cardiac my-
ofilament contraction function.
2-S-07-1 Immunothrombosis in septic
ARDS
Hidenori Wake, Masahiro Nishibori
Dept. Pharmacol., Okayama Univ. Sch. Med., Dent.＆ Pharm. Sci.
The pathogenesis of sepsis includes the disturbance of blood
vascular homeostasis, which may cause multiple organ fail-
ure, circulatory shock, and DIC, leading to high mortality.
Neutrophil associated inflammation or microthrombus for-
mation (Immunothrombosis) in the lung resulted in ARDS,
the most important cause of death in sepsis. Histidine rich
glycoprotein (HRG) is an 80 kDa glycoprotein with high his-
tidine contents. HRG is known as the plasma factor to regu-
late coagulation/fibrinolysis, immune response and angio-
genesis. Our recent studies showed that plasma HRG levels
significantly decreased in CLP septic mice model and admini-
stration of HRG dramatically improved the survival rate of
CLP mice associated with the inhibition of immunothrombo-
sis and neutrophil extracellular trap (NET) formation in pul-
monary vasculatures by keeping neutrophils quiescent mor-
phologically and functionally. Supplementary therapy with
HRG may provide a novel strategy for the treatment of septic
patients by inhibiting immunothrombosis in blood vessels.S42-S-06-5 Dystrophin Deficient
Cardiomyocytes Derived From Human
Urine: New Biologic Reagents for Drug
Discovery
Yuanyuan Zhang
Wake Forest Institute Regener Med, Wake Forest Univ
The ability to extract somatic cells from a patient and repro-
gram them to pluripotency opens up new possibilities for per-
sonalized medicine. Induced pluripotent stem cells (iPSCs)
have been employed to generate beating cardiomyocytes
from a patient’s skin or blood cells. Urine was chosen as a
starting material because it contains adult stem cells called
urine derived stem cells (USCs). USCs express the canonical
reprogramming factors c myc and klf4, and possess high te-
lomerase activity. Pluripotency of urine derived iPSC clones
was confirmed by immunocytochemistry, RT PCR and tera-
toma formation. Urine derived iPSC clones generated from
healthy volunteers and a DMD patient were differentiated
into beating cardiomyocytes using a series of small molecules
in monolayer culture. Results indicate that cardiomyocytes
retain the DMD patient’s dystrophin mutation. Physiological
assays suggest that dystrophin deficient cardiomyocytes pos-
sess phenotypic differences from normal cardiomyocytes. Re-
sults demonstrate the feasibility of generating cardiomyo-
cytes from a urine sample and that urine derived cardiomyo-
cytes retain characteristic features that might be further ex-
ploited for mechanistic studies and drug discovery.
2-S-07-2 Uncontrolled
immunothrombosis as a basis of sepsis
associated DIC
Takashi Ito 1,2
1Dept. Emerg. Crit. Care Med., Kagoshima Univ., 2Dept. Systems Biology in
Thromboregulation, Kagoshima Univ.
Microvascular thrombosis is commonly considered to be
harmful because it compromises the blood supply to organs.
However, recent studies have suggested that microvascular
thrombosis might play a role in the early defense against in-
vading pathogens. This defensive role of thrombosis during
infection is now referred to as immunothrombosis. Detection
of pathogen associated molecular patterns (PAMPs) and
damage associated molecular patterns (DAMPs) triggers tis-
sue factor expression on monocytes and neutrophil extracel-
lular trap (NET) release by neutrophils, promoting immu-
nothrombosis. Sepsis associated disseminated intravascular
coagulation (DIC) is considered to be an uncontrolled state of
immunothrombosis, where the immune system is no longer
able to restrict spreading of pathogens, inflammation, and co-
agulation. In this state, widespread microvascular thrombosis
is detrimental because it causes ischemic damage to multiple
organs.
Recombinant thrombomodulin (rTM) is a therapeutic option
for the treatment of sepsis associated DIC in Japan. In addi-
tion to its anticoagulant effect, rTM has the ability to dampen
inflammation, in part through the sequestration of PAMPs
and DAMPs. Thus, rTM may be useful for resolving
PAMPs and DAMPs mediated DIC.8
2-S-07-3 Hemin induced NET
formation and the effects of iron
chelators on neutrophil functions
Katsuyasu Saigo 1, Mari Kono 2
1 Faculty Pharmacol., Himeji Dokkyo Univ., 2 Research Unit, Scientific Affairs,
Sysmex Corp
Transfusion related acute lung injury is serious adverse ef-
fect of transfusion. Although antibodies against leukocytes
are considered as major inducers of excessive neutrophil acti-
vation, red cell concentrate (RCC) is the main cause in Japan.
Then we have checked the effects of hemolysis using hemin
(ferri protoprphyrin IX).
Hemin increased CD11b expression, reactive oxygen species
(ROS) production, and induced surface minute process forma-
tion within 15min. The possibilities of the morphological
changes relating to neutrophil extracellular trap (NET) for-
mation has been studied. Sytox green method, immunofluo-
rescence using anti histone or myeloperoxidase, and electron
microscopy revealed that hemin induced NETs. These re-
sults suggested that hemin might be an inducer of acute lung
injury (ALI). RCC especially stored for long period contained
substantial concentration of hemin.
Deferasirox (DFS), new oral iron chelator, was reported to
suppress NF κB activation. Then we have checked the ef-
fects of DFS on NET formation. DFS was shown to decrease
ROS production induced by PMA or fMLP, and to inhibit
NET formation.
These results suggest the possible preventive effects of DFS
on over activation of neutrophil and relating pathophysiolo-
gies.
2-S-08-2 The effectiveness of the
curcumin on periodontal disease.
Tatsuya Akizuki
Div. Periodont., Kanagawa dental Univ.
Periodontitis is an infectious disease caused by periodonto-
pathic bacteria. Cytokines involved in the inflammatory re-
sponse activate osteoclasts, resulting in bone resorption. Con-
ventional periodontal treatment including plaque control
aims at removing these pathogens. Recently, controlling in-
flammation is important to reduce the risk of the periodontal
tissue destruction. It is known that curcumin possesses an
anti inflammatory effect and its effectiveness on periodonti-
tis has been clarified in animal and human experiments. In
this presentation, the effectiveness of the curcumin on peri-
odontitis will be discussed.S2-S-08-1 Prevention of diabetes using
curcumin via stimulation of gut
hormone secretion
Takanori Tsuda
College of Bioscience and Biotechnology
Glucagon like peptide 1 (GLP 1) is one of the incretins and
secreted from enteroendocrine L cells, which are present in
the lower small intestine and large intestine. Enhancing
GLP 1 action induces glucose dependent insulin secretion.
The preferable way for dietary factors to elevate GLP 1 ac-
tions is by stimulating the endogenous secretion of GLP 1.
Therefore, stimulation of GLP 1 secretion is recognized as
potential therapeutic targets in the prevention and treatment
of type2 diabetes. This presentation provides information as
to how dietary factors increase GLP 1 secretion. Concretely,
we present our findings on the GLP 1 secretion stimulating
functions of curcumin. Curcumin significantly stimulated se-
cretion of GLP 1 in vitro and in vivo. Our examination of
structure function relationships found that a β diketone
structure and at least one methoxy group on the aromatic
ring are necessary for a curcumin derivative to promote
GLP 1 secretion. The mechanism of action of by which cur-
cumin stimulates GLP 1 secretion is increase in intracellular
calcium and activation of Ca2+/calmodulin dependent kinase
II. These findings provide a novel biological function of cur-
cumin in regards to GLP 1 secretion.
2-S-08-3 Translational Research of
HighlyAbsorbable Curcumin for Heart
FailureTherapy
Yoichi Sunagawa 1,2,3, Yasufumi Katanasaka 1,2,3,
Atsushi Imaizumi 4, Koji Hasegawa 2,
Tatsuya Morimoto 1,2,3
1 Sch. Pharma. Sci, Univ of Shizuoka, 2 Cli. Res. Insti., Kyoto Med. Center,
3 Shizuoka General Hosp., 4 Proteomics Res. Center, Theravalues Corp.
Heart failure is the final stage of cardiovascular diseases. It is
necessary to find out the further medical therapy for heart
failure. We previously reported that cardiac p300 HAT activ-
ity is required for the development of heart failure and cur-
cumin, a natural p300 specific HAT inhibitor, has a thera-
peutic potency for heart failure. However, it is insufficient to
exert its bioactivities due to its low solubility and poor gas-
trointestinal absorption. We have produced highly absorbable
curcumin preparation, Theracurmin. In this session, we in-
troduce our recent study using Theracurmin and summarize
the translational research of Theracurmin for heart failure
therapy.49
2-S-08-4 Enhanced anti tumor effects
of the PD 1/PD L1 blockade by
combining a highly absorptive form of
NF κB/STAT3 inhibitor curcumin
Taeko Hayakawa 1, Juri Sugiyama 1,
Tomonori Yaguchi 1, Atsushi Imaizumi 2,
Yutaka Kawakami 1
1Div. Cell. Signal., Inst. Adv. Med. Res., Keio Univ. Sch. Med., 2 Theravalues
Corporation
The PD 1/PD L1 blockade is now recognized as one of the
effective standard therapy for some human cancers such as
melanoma and lung cancers, however clinical effect is still
limited because of tumor induced immunosuppression. Cur-
cumin has been reported to inhibit NF kB and STAT3 sig-
nals which have important roles for inducing immunosup-
pression. Here, we show not only that curcumin augments in-
duction of tumor antigen specific T cells via acting on both
cancer cells and immune cells, but also that combination of
curcumin and local PD 1/PD L1 blockade have synergistic
anti tumor activity. These results indicated that curcumin
enhanced effect of PD 1/PD L1 blockade and is an attractive
strategy for development of effective combination cancer im-
munotherapy.
2-S-09-2 The role of myeloid derived
suppressor cells in chronic airway
inflammation
Ichiro Horie, Yoichiro Isohama
Lab. Applied Pharmacol., Fac. Pharm. Sci., Tokyo Univ. of Sci.
Myeloid derived suppressor cells (MDSC), which are defined
as CD11b+ and Gr 1+ cells in mice, can directly suppress T
cells and macrophages, and negatively regulate immune re-
sponses. MDSC contribute to tumor immunity, chronic in-
flammation and autoimmune diseases, MDSCs may be a new
therapeutic target for these diseases. In this present study,
we examined whether MDSC contribute to chronic inflamma-
tion in airway, such as asthma and chronic obstructive pulmo-
nary disease (COPD). First, we prepared asthma model that
BALB/c mice were sensitized and challenged with ovalbu-
min (OVA). In OVA sensitized mouse, MDSC increased in pe-
ripheral blood, spleen and lung, according to progress of pa-
thology of airway inflammation. Interestingly, anti Gr 1 anti-
body, a typical inhibitor of MDSC, exacerbated inflammatory
pathology such as infiltrated cells and protein in bronchoal-
veolar lavage fluid (BALF), suggesting that MDSC play a pro-
tective role for chronic inflammation. In addition, we found
that dexamethasone, one of glucocorticoids, increased MDSC
in vitro, suggesting that glucocorticoid may exert anti in-
flammatory effect via up regulation of MDSC. Thus, our data
implicates that MDSC may be a therapeutic target in chronic
airway inflammation such as asthma and COPD.S52-S-09-1 Synergistic regulation of
biological molecules by the drugs for
COPD
Masanori Miyata 1,2, Seiko Susuki Miyata 1,2,
Jian Dong Li 2, Tsukasa Okiyoneda 1
1Dept. Biomed. Chem., Kwansei Gakuin Univ. Sch. Sci. and Tech., 2 CIII, IBMS,
GSU
COPD is the fourth leading cause of death worldwide and ex-
pected to become third in 2030. Anti inflammatory drugs,
such as steroids and phosphoriesterase 4 (PDE4) inhibitor,
have been approved for COPD. However, those efficacies
have been hampered by the development of adverse effects
and tolerance, and the underlying mechanism remains un-
clear. Here we found that the synergistic regulation of
IRAK M and PDE4B2 by those drugs. Our findings may lead
to further development of anti inflammatory therapeutic
strategies for COPD.
2-S-09-3 Abnormal expression of zinc
transporter ZIP2 in a novel mouse model
of obstructive lung diseases
Shunsuke Kamei 1,2, Tsuyoshi Shuto 1, Hirofumi Kai 1,2
1Dept. Mol. Med., Kumamoto Univ., Grad. Sch. Pharm. Sci., 2HIGO, Kumamoto
Univ.
Zinc ion (Zn2+) is an essential dietary metal ion that has pleiot-
ropic effects in many tissues including airway and lung. Pa-
tients with obstructive lung diseases like cystic fibrosis (CF)
and chronic obstructive pulmonary disease (COPD), refrac-
tory lung diseases characterized by mucus hypersecretory
and inflammatory phenotypes, have a defect in the regulation
of intracellular Zn2+ level. Here, we identified in a CF/COPD
murine model (βENaC Tg mice) that expression of a novel
splicing isoform of zinc transporter ZIP2 (ΔC ZIP2) is in-
creased in airway epithelial cells, which possibly results in
the production of C terminus deleted immature ZIP2 pro-
tein. Importantly, increased expression of ΔC ZIP2 tran-
script and inverse correlation between the expression of ΔC
ZIP2 transcript and WT ZIP2 protein or intracellular Zn2+
level were observed in human CF and COPD like airway epi-
thelial cells. Moreover, depletion of intracellular Zn2+ with
Zn2+ chelator up regulated the gene expression of mucus and
inflammatory cytokines in normal human airway epithelial
cells. Thus, our finding demonstrates that a novel splicing
switch of ZIP2 genes in airway epithelial cells possibly con-
trols the pathology of obstructive lung diseases.0
2-S-09-4 Development of the novel
therapeutic drug for COPD
Michiko Horiguchi
Dept. Pharmaceutics and DDS, Tokyo Univ. of Science.
Chronic obstructive pulmonary disease (COPD) is a chronic
respiratory disease characterized by cough, primarily dysp-
nea, sputum production, and other respiratory symptoms,
causes widespread and irreversible alveoli collapse. Recent
reports suggest that COPD mortality is increasing, and
COPD is estimated to emerge as the third leading cause of
death worldwide by WHO. However, a practically useful
compound for regenerating pulmonary alveoli is yet to be re-
ported. Regenerative medicine shows potential for address-
ing this intractable disease, but no regenerative treatments
for human alveoli have been described to date. The aim of
this study was to identify a treatment target molecule which
is able to regenerate collapsed alveoli. Previously, we have
elucidated that Akt phosphorylation is involved in elastase
induced COPD model mouse. In the present study, we di-
rected our attention to phosphoinositide 3 kinase (PI3K) Akt
signaling and examined whether PI3K inhibitors display the
pulmonary alveolus regeneration.
2-S-10-2 Mechanism of
immunopathology during malaria:
search for new drug targets
Cevayir Coban
IFReC, Osaka Univ.
Malaria caused by Plasmodium parasites is still one of the
most devastating infectious diseases of the world, killing ap-
proximately 1 million people each year. Efforts to eliminate
malaria have been compromised by the parasites’ rapid evo-
lution of drug resistance and the difficulty to develop effec-
tive vaccines. In my laboratory, we investigate the role of
both innate and adaptive immunity in response to Plasmo-
dium parasites and protective mechanism (s) elucidated by
host. To do that, we have utilized several imaging technolo-
gies such as ultra high field MRI and intra vital multi photon
microscopy to understand immunopathology caused by Plas-
modium parasites. We hope to develop novel therapeutics in
addition anti malarials to rescue host from the consequences
of immunopathology caused by parasites.S2-S-10-1 Regulation of a parasitic
disease by host innate immunity
Masahiro Yamamoto 1,2
1Dept. of Immunoparasitology, RIMD, Osaka Univ, 2Dept. of
Immunoparasitology, IFReC, Osaka Univ
p62 (also known as Sqstm1) is a selective autophagy adaptor
with a ubiquitin binding domain. However, the role of p62 in
the host defense against Toxoplasma gondii infection is un-
clear. Here, we show that interferon γ (IFN γ) stimulates
ubiquitin and p62 recruitment to T. gondii parasitophorous
vacuoles (PVs). Some essential autophagy related proteins,
but not all, are required for this recruitment. Regardless of
normal IFN γ induced T. gondii clearance activity and
ubiquitination, p62 deficiency in antigen presenting cells
(APCs) and mice diminishes the robust IFN γ primed activa-
tion of CD8+ T cells that recognize the T. gondii derived an-
tigen secreted into PVs. Because the expression of Atg3 and
Irgm1/m3 in APCs is essential for PV disruption, ubiquitin
and p62 recruitment, and vacuolar antigen specific CD8+ T
cell activation, IFN γ mediated ubiquitination and the subse-
quent recruitment of p62 to T. gondii are specifically re-
quired for the acquired immune response after PV disruption
by IFN γ inducible GTPases.
2-S-10-3 Potential of anti influenza
drug development targeting host
nuclear network
Yumiko Imai
Dept. Biological Informatics and Experimental Therapeutics, Akita Univ. Sch. Med.
The influenza virus is a single stranded RNA virus, and vi-
rus replication occur in the nucleus. Viral infection is associ-
ated with virus driven hijacking of the host factors. Cur-
rently licensed anti influenza drugs target viral NA proteins.
The strains have recently emerged that show resistance to
NA inhibitors. Thus, there is an urgent need to develop more
effective antiviral therapeutics against influenza virus infec-
tion. Virus host interaction could be novel targets for anti in-
fluenza drugs. Using lipid library screen and lipidomics
analysis we identified novel lipid mediators, which can sup-
press influenza virus replication via viral RNA nuclear ex-
port machinery, suggesting a link of host metabolic pathway
to nuclear virus replication mechanism. In addition, a glow-
ing body of work has shown that environmental stress can
control chromatin structures that closely correlate with tran-
scriptional regulation. We found that influenza virus dis-
rupted stable chromatin organization, which controls virus
replication mechanisms in the nucleus. These data suggest a
crucial role of dynamic nuclear virus host interaction in the
pathogenesis of influenza virus infection. Those pathways
could be potential targets for anti influenza drug develop-
ment.51
2-S-10-4 Recognition of mycobacteria
through C type lectin receptors
Sho Yamasaki
Div. Mol. Immunol., Med. Inst. Bioreg., Kyushu Univ.
C type lectin receptors (CLRs) comprise a large family of
proteins that share a common structural motif and are in-
volved in various immune responses. Among them, we found
that several ITAM coupled CLRs are pattern recognition re-
ceptors (PRRs) for mycobacteria. Characteristic glycolipids,
glycoproteins and lipoglycans were identified in mycobacte-
ria as ligands for these CLRs, such as Mincle, MCL and Dec-
tin 2. These findings shed light on CLRs as emerging im-
mune receptor family for wide spectrum of pathogens, par-
ticularly mycobacteria, and thus CLRs could be promising
targets for the development of novel adjuvant. In this semi-
nar, the recent progress and perspective on the function of
CLRs will be discussed.
2-S-11-2 Regulation of synaptic
plasticity in the cortico amygdala
synapse by dietary polyunsaturated
fatty acid balance
Masayuki Sekiguchi
Dept. Degen. Neurol. Dis., Natl. Inst. Neurosci., Ctr. Neurol.＆ Psychiat.
Converging evidence suggests that a balance of omega 3 to
omega 6 polyunsaturated fatty acid (PUFA) in the brain is in-
volved in emotion, and that imbalance of these PUFAs con-
tributes to mental illnesses, such as anxiety disorders. How-
ever, the underlying mechanism is unknown. We show that
auditory fear memory, a type of emotional memory, and
long term potentiation (LTP) of synaptic transmission in the
optogenetically isolated auditory cortico amygdala synapse,
which is one of the pathways transmitting conditioned stimu-
lus in auditory fear conditioning, were both reduced in mice
fed a high omega 3 to omega 6 PUFA ratio diet (3/6=0.97, a
high 3/6 diet) compared with mice fed a diet with a lower ra-
tio (3/6=0.14, a low 3/6 diet). These reductions were blocked
by a cannabinoid CB1 receptor antagonist. The cholesterol
content in brain tissues from mice fed a high 3/6 diet was
lower than in brain tissues from mice fed a low 3/6 diet. The
content of 2 arachidonoylglycerol did not differ in mice fed
these diets. These findings suggest that PUFA balance medi-
ated alteration of fear memory is accompanied by modulation
of LTP of neurotransmission in a synapse participating in
fear memory.S52-S-11-1 Cannabinoid functions in
amygdala contribute to conditioned fear
memory in diabetic mice
Junzo Kamei, Hiroko Ikeda
Dept. Pathophysiol. Therap., Hoshi Univ. Sch. Pharm. Pharmaceut. Sci.
The role of cannabinoid (CB) systems in conditioned fear
memory was investigated in streptozotocin-induced diabetic
mice (DM). The duration of freezing in DM was significantly
longer than that in non-diabetic mice (NDM). The injection of
WIN-55,212-2 after conditioning significantly prolonged the
duration of freezing in NDM, but not in DM. The injection of
CB1 receptor antagonist AM 251 after conditioning signifi-
cantly shortened the duration of freezing in DM, but not in
NDM. The injection of AM 251 before conditioning or before
testing did not significantly affect the duration of freezing in
DM. The protein levels of CB1 receptors, but not CB2 recep-
tors and diacylglycerol lipase α, an endocannabinoid 2-
arachidonoylglycerol synthase in amygdala were increased in
DM. The injection of AM 251 into basolateral amygdala
(BLA) significantly inhibited the duration of freezing in DM.
The injection of AMPA receptor antagonist NBQX into BLA
significantly inhibited the duration of freezing in DM. These
results suggest that CB functions in amygdala are increased
in DM and that enhanced glutamatergic function in the
amygdala of DM activates the endocannabinoid system,
which enhances fear memory via CB1 receptors.
2-S-11-3 Targeting the glutamatergic
system to develop novel therapeutics for
mood and anxiety disorders
Akiyoshi Saitoh, Mitsuhiko Yamada
Dept. Neuropsychopharmacol., NIMH. NCNP.
Growing evidence indicates that glutamatergic neurotrans-
mission plays important roles in the pathology and treatment
of mood and anxiety disorders. A nonselective NMDA R an-
tagonist ketamine, which is approved as a dissociative anes-
thetic, has been shown to induce rapid antidepressant effects
in patients and in rodent models. Riluzole, which is currently
used to slow the progression of amyotrophic lateral sclerosis,
is another candidate as an antidepressant or an anxiolytic
drug. Riluzole has been shown to inhibit glutamate release
and enhances glutamate uptake. We have previously reported
that riluzole rapidly attenuated hyperemotional responses in
olfactory bulbectomized rats, an animal model of mood and
anxiety disorders. More recently, we demonstrated that ri-
luzole shows clear anxiolytic like effects in behavioral tests
in rats. Drug approved for other uses has already passed a se-
ries of toxicity and other tests, its safety is known and the
risk of failure in clinical trials are reduced. We believe that
this strategy is practical to expedite the translation of pre-
clinical findings of drugs with novel mechanisms of action
such as glutamate transmission and related pathways into
clinical applications.2
2-S-11-4 Therapeutic potential of the
intranasally administered GLP 2
derivative for the treatment of
depression
Jun Ichiro Oka 1,3, Sachie Sasaki Hamada 1,3,
Michiko Horiguchi 2,4, Ryuji Nakamura 1,
Yusuke Nakao 2, Chikamasa Yamashita 2,4
1 Lab. Pharmacol., Fac. Pharmaceutical Sci., Tokyo Univ. Sci., 2 Lab. Pharmaceutics
DDS, Fac. Pharmaceutical Sci., Tokyo Univ. Sci., 3 TR Center, Res. Inst. Sci.
Technol., Tokyo Univ. Sci., 4Drug Deliv. Res. Center, Tokyo Univ. Sci.
Glucagon like peptide 2 (GLP 2) is derived from a progluca-
gon precursor in the gut and central nervous system (M.W.
3766.1), and used for the treatment of short bowel syndrome
because of its potent intestinotrophic effect. Gs coupled
GLP 2 receptors in the brain are distributed in the dorsome-
dial hypothalamic nuclei, nucleus solitary tract, amygdala,
thalamus, cerebellum, hippocampus, and cerebral cortex. In
our previous studies, GLP 2 (i.c.v., mice) significantly re-
duced immobility time in the forced swim test (FST) and tail
suspension test, and also showed antidepressant like effects
in treatment resistant depression model mice. In this sympo-
sium, we will give a talk on establishment of a new GLP 2 de-
rivative for the delivery of GLP 2 to the brain by the intrana-
sal administration and its antidepressant like effects. A new
nasal GLP 2 derivative was synthesized, and its brain perme-
ability, stability, and antidepressant like effects in the FST
were observed. We have applied for a national patent and the
patent cooperation treaty for the nasal GLP 2 derivative.
3-S-01-2 Observation and
manipulation of glia assembly
Kenji Tanaka
Keio Univ. Sch. Med. Dept. Neuropsychiatry
The development of gene encoded indicators and actuators
to observe and manipulate cellular functions is being ad-
vanced and investigated. Expressing these probe molecules in
glial cells is expected to enable observation and manipulation
of glial cell activity, leading to elucidate the behaviors and
causal roles of glial cells. The first step toward understand-
ing glial cell functions is to express the probes in sufficient
amounts, and the Knockin mediated ENhanced Gene Expres-
sion (KENGE) tet system provides a strategy for achieving
this. Here I will present the making history of KENGE tet
system and the expanding of the resource repertoire for the
glia assembly research.S3-S-01-1 Cortical astrocytes rewire
somatosensory synaptic circuits for
neuropathic pain mechanical allodynia
Sun Kwang Kim
Dept. Physiol., College of Korean Med., Kyung Hee Univ.
Although neuropathic pain such as mechanical allodynia is
known to be induced by glial activation within the spinal
cord, an effective treatment is still insufficient, indicating
that novel therapeutic targets are critically needed. One such
target may be the synaptic rewiring in the primary somato-
sensory (S1) cortex. However, its causal relationship to me-
chanical allodynia and its underlying cellular mechanisms re-
main unknown. Here, using in vivo two photon microscopy
imaging with genetic and pharmacological manipulations, we
show that partial sciatic nerve ligation (PSL) injury elicits
spontaneous somatic Ca2+ transients, thrombospondin 1 re-
lease in astrocytes, leading to synapse formation. Such activa-
tion of S1 astrocytes was evident only during a critical period
(~1w post injury), correlating with the temporal changes in S
1 extracellular glutamate levels and dendritic spine turnover
following PSL injury. Blocking this astrocytic signaling path-
way suppressed mechanical allodynia, while activating this
pathway in the absence of injury induced long lasting allo-
dynia. Thus, these synaptogenic astrocytes are a key trigger
for S1 synaptic circuit rewiring that causes neuropathic pain
mechanical allodynia.
3-S-01-3 Self organization strategy in
glial cells underlying diverse activity of
glia assembly
Hiroko Bannai
Dept. Biol. Sci., Grad. Sch. Sci., Nagoya Univ.
Astrocytes, the most numerous form of glial cell in the brain,
have an ability to respond to intercellular messengers with
Ca2+ signals allowing them to participate actively in the regu-
lation of local blood flow and of synaptic efficacy. Astrocytic
Ca2+ signals are diverse : some signals are localized in subcel-
lular compartments, while other signals widely spread
throughout the cell and even into neighboring cells. The mo-
lecular mechanisms enabling such a diverse Ca2+ dynamics in
single astrocyte, especially that confines Ca2+ signals in sub-
cellular compartments, remain to be elucidated. We report
here a unique self organization strategy that underlies local-
ized Ca2+ signals in astrocytes. Quantum dot single particle
tracking analysis revealed a membrane barrier that selec-
tively blocked the movement of mGluR5 between astrocyte
soma and their processes. We also showed that this barrier
contributed to maintain compartmentalized mGluR5 distribu-
tion and the localized Ca2+ signal. Our results demonstrate an
mGluR5 selective diffusion barrier between processes and
soma that compartmentalized mGluR Ca2+ signaling in astro-
cytes and may allow control of synaptic and vascular activity
in specific subcellular domains.53
3-S-01-4 In vivo calcium imaging
analysis using a transgenic mice
expressing an ultrasensitive calcium
sensor
Kazunori Kanemaru 1, Hiroshi Sekiya 1,
Nami Kitajima 1, Miki Takagi 1, Kenji Tanaka 2,
Masamitsu Iino 1
1Dept. Pharmacol., Grad. Sch. Med., Univ. Tokyo, Tokyo, Japan, 2Dept.
Neurospychiat., Sch. Med., Keio Univ.
Astrocytes show dynamic changes in the intracellular Ca2+
level (Ca2+ signals) that are thought to regulate various brain
functions. In vivo Ca2+ imaging with high spatiotemporal reso-
lution may pave the way to uncover enigmatic functions of as-
trocytes. Here we report such method using transgenic mice
expressing an ultrasensitive Ca2+ sensor protein, YC Nano50,
in astrocytes. This method allowed us to analyze the Ca2+ dy-
namics in individual astrocytes including their fine proc-
esses. We found a previously unidentified pattern of sponta-
neous Ca2+ signals (Ca2+ twinkles), which are preferably dis-
played in the fine processes. Upon sensory stimulation, astro-
cytes in the somatosensory cortex initially responded with
Ca2+ signals at the fine processes, and the Ca2+ signal subse-
quently propagated to the cell body. Ca2+ twinkles and evoked
Ca2+ signals were partially and fully dependent on the type 2
IP3 receptor, respectively. These results suggest that astro-
cytic fine processes function as a high sensitivity detector of
neuronal activities, and indicate involvement of intracellular
Ca2+ stores in the astrocytic activities. Thus, our present
method provides a useful tool to uncover the astrocytic func-
tions.
3-S-02-2 The answers to various
questions of when to apply theWilliams’
multiple comparison test for
Pharmacology test
Nobuhiro Nakanishi
Dept. Data Science. Div. Sohyaku. Corp.: Mitsubishi Tanabe Pharma CO., LTD.
Williams’ test is the multiple comparison method that has the
advantage of higher power than other multiple comparison
methods such as Dunnett’s test. However, adoption of the Wil-
liams’ test in the actual use of pharmacological test is not ap-
preciated enough. One of the reason is that there are the fol-
lowing questions to Williams’ test.
1. Interpretation when the dose response of the observation
result is not monotonic
2. Imbalance of each group sample size due to accidental re-
moval
3. Sample size estimation method
I report the knowledge obtained in solving the above ques-
tions in order to promote the Williams’ test at pharmaceutical
company.S53-S-02-1 Introduction of analytical
methods for data of nonclinical
pharmacological studies
Shinsuke Kurosu
Biostatistics., Taisho Pharmaceutical CO., LTD.
Nonclinical pharmacological studies are conducted for vari-
ous purposes and, therefore those data have many different
characteristics. Furthermore, many analytical methods are
applicable to those data and sometimes it would be difficult to
choose an appropriate method. In this presentation, I’d like to
show several analytical methods using dummy data sets
which are based on the studies actually conducted in our labo-
ratory and then, make comparisons with and consideration of
the results focusing on which method is ’good’ (that is, fit
with each data). I hope this presentation would be of some
help to pharmacologists carrying out their experiments effi-
ciently.
3-S-02-3 Parallelism as its premise
parallel line assay for efficacy
comparison of pharmacological effect
Jun Harada, Michiharu Yoshiike
Dept. Data Science. Div. DAIICHI SANKYO CO., LTD.
Previously, the approach of the parallel line test for potency
ratio, have been variousy studied. This situation arises when
comparing drug potencies, when studying the action of an-
tagonists, and in numerous other applications in pharmacol-
ogy and other branches of science.
Today, we will introduce a method that has been taken up in
the U.S. Pharmacopeia (USP) bioassay guidance (e.g. Chapter
1032 ). In addition, we will introduce a sample case.4
3-S-02-4 In house statistical training
for scientists in drug discovery
Chikara Honda
Operations Management, Research Headquaters, Ono Pharmaceutical CO., LTD.
Statistical education should be needed for pursuing good re-
search with rational study designs and appropriate analyses.
In the presentation, I’m going to talk examples of in house
practical statistical training for nonclinical pharmacologists
and the other scientists. I want to show the knowledge of sta-
tistical analysis contribute to progress of drug discovery re-
search.
3-S-03-2 Mechanism of striatal
circuitry underlying behavioral
sensitization
Kazuto Kobayashi 1, Kayo Nishizawa 1, Nobuyuki Kai 2,
Shuichi Ueda 2
1Dept. Mol. Genet., Fukushima Med. Univ. Sch. Med., 2Dept. Histo. Neurobiol.,
Dokkyo Med. Univ. Sch. Med.
Behavioral sensitization, enhanced motility by repetitive psy-
chostimulant administration, is a model of drug addiction.
The nucleus accumbens (Nac) receives dopaminergic affer-
ents from the ventral midbrain and is divided into the shell
and core subregions. Each of these contains two subtypes of
medium spiny neurons (MSNs), which express either
dopamine D1 (D1R) or D2 (D2R) receptor. However, func-
tional diversity between the two subtypes in psychostimulant
response has not been fully understood. We carried out selec-
tive elimination of each subtype in the Nac shell in mice using
immunotoxin mediated cell targeting and examined the be-
havioral sensitization evoked by repeated administration of
methamphetamine. The D1R cell targeting exhibited delayed
induction of sensitized locomotion, whereas the D2R cell abla-
tion showed a mildly enhanced rate of induction of sensitiza-
tion. In vivo microdialysis indicated a marked blockade of
drug induced dopamine release in the Nac of D1R cell ab-
lated mice, revealing that the observed delay in behavioral
sensitization involves an impairment in accumbal dopamine
release. Our results reveal distinct roles of D1R and D2R
containing accumbal shell MSNs in the development of behav-
ioral sensitization to psychostimulants.S53-S-03-1 Functional analysis of
changes in the mesolimbic
dopaminergic system under drug
addiction
Masahiro Shibasaki 1, Minoru Narita 1,2
1Dept. Pharmacol., Hoshi Univ., 2 L StaR, Hoshi Univ.
Long lasting usage of abused drugs is considered to induce
the functional change in the mesolimbic dopaminergic system
projecting to the nucleus accumbence and prefrontal cortex
from the ventral tegmental area. We have demonstrated that
chronic treatment with abused drugs induces amenability to
excitation of the mesolimbic dopamine system associated
with an increase in activity of Leucine rich repeat kinase 2
(LRRK2), which is known to multiply modulate lysosomal po-
sitioning and autophagy, synaptic vesicle endocytosis, synap-
togenesis, cytoskeleton and neurite outgrowth, protein syn-
thesis, golgi sorting, and retromer function in the ventral teg-
mental area. Additionally, it up regulates the down stream
of LRRK2, such as FOXO1, α synuclein and 4E BP, which
are well known as regulators of energy metabolism, neurode-
generation and protein synsesis, respectively. Thus, chronic
treatment with abused drug may induce the functional
change in the mesolimbic dopaminergic system through the
modulation of the LRRK2 dependent system. In this sympo-
sium, we will discuss the multi modification of the mesolim-
bic dopaminergic system by chronic treatment with abused
drugs.
3-S-03-3 Dopaminergic network
mechanism in cognitive learning and
drug addiction
Takatoshi Hikida
MIC, Kyoto Univ. Grad. Sch. Med.
The basal ganglia are key neural substrates that control not
only motor balance but also cognitive learning and decision
making. Dysfunction of the basal ganglia leads to neurodegen-
erative diseases (e.g. Parkinson’s disease and Huntington’s
disease) and psychiatric disorders (e.g. drug addiction,
schizophrenia, and depression). In the basal ganglia circuit,
there are two important pathways ; the direct and indirect
striatal pathways. We have developed a reversible neuro-
transmission blocking technique, in which transmission of
each pathway is selectively blocked by specific expression of
transmission blocking tetanus toxin, and revealed that the ac-
tivation of D1 receptors in the direct pathway is critical for
reward learning/drug addiction, and that the inactivation of
D2 receptors is critical for aversive learning/learning flexi-
bility. We also showed that postsynaptic D2L receptors are
necessary for cognitive learning and learning flexibility. We
propose a new circuit mechanism that the dopaminergic in-
put from ventral tegmental area can switch the direct and in-
direct pathway in the nucleus accumbens. These basal gan-
glia circuit mechanisms will give us insights into the patho-
physiology of mental diseases.5
3-S-03-4 Imaging of dopamine
metabolism by mass spectrometry
Yuki Sugiura 1,2
1Dept. Biochemistry., Keio Univ. Sch. Med., 2 JST PRESTO
Rationale : Highly sensitive neurotransmitter imaging is an
important technique for neurodegenerative disease research.
So far, positron emission tomography is used for this pur-
pose ; however, it only provides information on specific re-
ceptor/ligand interaction. Objective : To develop and vali-
date matrix assisted laser desorption/ionization (MALDI)
imaging mass spectrometry (IMS) as a sensitive technique for
in situ imaging of neurotransmitters in awaked mouse brain.
Methods and Results : Awake mouse brains were fixed in
vivo by focused microwave irradiation (FMW). Mapping of
amino acid neurotransmitters, glutamate, GABA and glycine
were achieve by IMS coupled with recently our developed
on tissue derivatization method (Toue and Sugiura et al.,
2014). Furthermore, this imaging technique was proven to be
sensitive enough to identify spatial distribution of trace
monoamines (e.g., dopamine) on same brain section.Conclu-
sions : Our results highlight the utility and high sensitivity
of MALDI IMS combined with FMW for visualizing neuro-
transmitters just as they were in vivo in awaked mouse
brains.
3-S-04-2 Neurochemical aspects of
obstructive sleep apnea syndrome―
Medullary serotonergic system―
Mitsuko Kanamaru, Masahiko Izumizaki
Dept. Physiol., Showa Univ. Sch. Med.
The treatment of continuous positive airway pressure
(CPAP) is used for moderate to severe obstructive sleep ap-
nea syndrome (OSAS). Although drug therapies can be valu-
able in mild to moderate OSAS, neurochemical pathophysiol-
ogy is not clear. Brain serotonergic neurons are CO2/pH sen-
sors and can be a target of drug therapies in OSAS. The role
of medullary serotonin (5 HT) in chemoreceptive airway
ventilatory responses was investigated in the present study
using microdialysis and a double chamber plethysmograph
in mice. Mice with a perfusion of a 5 HT2 antagonist through
a probe in the dorsomedial medulla oblongata, a part of the
respiratory network, inhaled hypercapnic (5, 7, and 9%CO2 in
O2), hypoxic (7%O2 in N2), or hypercapnic hypoxic gases (7%O2
+5%CO2 in N2). Early onsets of hypercapnic or hypoxic air-
way ventilatory responses, but not hypercapnic hypoxic re-
sponses, were delayed by a perfusion of the 5 HT2 antago-
nist. These results suggest that chemoreceptive input of CO2
is compensatory to medullary 5 HT activities in chemorecep-
tive airway ventilatory responses. A therapeutic target in
mild to moderate OSAS can be 5 HT antagonists, not ago-
nists, although further studies, such as 5 HT’s role in CO2 in-
duced arousal, are needed.S3-S-04-1 Current issues in the
development of disease modifying
drugs forAlzheimer’s disease
Nobuyuki Okamura
Dept. Pharmacol., Tohoku Univ. Sch. Med.
Alzheimer’s disease (AD) is the most common cause of de-
mentia. AD is neuropathologically characterized by the depo-
sition of amyloid β (Aβ) and tau proteins. Excessive accumu-
lation of Aβ and hyperphosphorylation of tau play a vital role
in the pathogenesis of AD. Aβ has been believed as the most
promising target of anti dementia drugs. Many Aβ targeted
therapies such as β and γ secretase inhibitors and Aβ immu-
notherapy have been developed and tested on humans. How-
ever, none of these anti Aβ drugs has yet to reach success so
far. Phosphorylation of tau protein decreases its ability to
bind to microtubules, leading to neuronal death. The inhibi-
tion of abnormal tau phosphorylation and aggregation ap-
pears to be another promising strategy. To facilitate the de-
velopment of these drugs, it is important to measure the pa-
thologic time course of protein accumulation in the human
brain. Recent progress in molecular imaging allows us to
visualize both Aβ and tau accumulation in the human brain
using positron emission tomography. In vivo Aβ and tau im-
aging would be useful in monitoring treatment outcomes and
for selecting patients for anti dementia drugs. In this sympo-
sium, strategies for successful development of anti dementia
drugs will be discussed.
3-S-04-3 Therapeutic strategies for
intractable digestive diseases
Koichiro Wada, Haruki Usuda
Dept. Pharmacol., Shimane Univ. Faclt. Med.
Various intractable digestive diseases, such as ulcerative coli-
tis (UC), Crohn’s disease (CD), eosinophilic gastroenteritis
(EGE), are important therapeutic targets, because the total
number of the patients is increased year by year. In addition
to such diseases, exponential increase in nonalcoholic steato-
hepatitis (NASH) is also serious issue in clinical practice.
Therefore, establishment of therapeutic strategies based on
pharmacological mechanisms for such intractable diseases
are really required. For the purpose, we have investigated
the potential mechanisms and mechanism based drug ther-
apy for many intractable digestive diseases. We found the
several important mechanisms involved in the pathogenesis
of NASH, and therefore, we reported the effective therapies
for NASH based on the mechanisms. In contrast, completely
mechanism based drug therapies about the UC, CD, and EGE
have not been established yet, although the several effective
drug therapies are performed in clinical sites. The reasons
may be still unknown mechanisms and lack of optimal dis-
ease models about the intractable digestive diseases. There-
fore, investigations using optimal animal models may be re-
quired to establish the mechanism based new therapeutic
strategies for the intractable digestive diseases.56
3-S-04-4 Development of therapeutics
strategy target for intracellular signaling
molecules responsible for the
pathogenesis of allergic rhinitis
Hiroyuki Mizuguchi
Dept. Mol. Pharmacol., Inst. Biomed. Sci., Tokushima Univ. Grad. Sch.
The expression level of an allergic disease sensitive gene is
correlated with the symptoms severity. Thus, suppression of
this gene expression should be good therapeutics. We demon-
strated that histamine H1 receptor (H1R) gene is an allergic
rhinitis (AR) sensitive gene. We also unveiled the signaling
pathway responsible for the up regulation of H1R gene ex-
pression. ( ) Maackiain was isolated as an anti allergic com-
pound that suppresses H1R gene up regulation, and PKCδ
and Hsp90 were identified as novel intracellular target mole-
cules for AR through the molecular pharmacological studies
to clarify the mechanism of action of ( ) maackiain. ( )
Maackiain and Hsp90 inhibitors suppressed up regulation of
H1R gene expression and alleviated nasal symptoms in al-
lergy model rats, suggesting the importance of H1R signaling
for pathogenesis of AR. However, the fact that decrease in
the H1R gene expression to the basal level could not com-
pletely resolve nasal symptoms led us to the discovery of the
2nd signaling pathway (Signaling X) responsible for the
pathogenesis of AR. Combination therapy suppressing both H
1R signaling and Signaling X markedly alleviated nasal
symptoms in allergy model rats.
3-S-05-2 The effective therapy of
dutasteride based on new evidence
Yoshihisa Matsukawa, Momokazu Gotoh
Dept Urology, Nagoya Univ. Sch. Med
Recently, the number of drugs used for treating benign
prostatic hyperplasia (BPH) has increased. At present, the
combination therapy using an alpha 1 blocker and 5 alpha
reductase inhibitor (5ARI) is recommended for patients with
a large prostate. However, many questions remain unsolved.
For example, how long the combination therapy should be
continued?Whether therapeutic effects decrease or not if the
combination therapy is changed to single drug therapy?
In this symposium, we would like to investigate the effective
therapy of dutasteride on BPH patients, based on new evi-
dences of dutasteride.S53-S-05-1 Alpha1 adrenoceptor
antagonist silodosin suppresses
prostatic hyperplasia through an
increase in prostatic blood flow
Shogo Shimizu, Takahiro Shimizu,
Youichirou Higashi, Motoaki Saito
Dept of Pharmacology, Kochi Med Sch, Kochi Univ
Chronic ischemia of the prostate could be associated with
lower urinary tract symptoms (LUTS). Alpha(α)1 adrenocep-
tor blockers are widely known that relax prostate smooth
muscle and decrease urethral resistance, thereby alleviating
benign prostatic hyperplasia related LUTS. We investigated
that whether α1 adrenoceptor blocker silodosin could im-
prove blood flow and hyperplasia in the ventral prostate of
the spontaneously hypertensive rat (SHR). Twelve week old
male SHRs were administered with silodosin (100 μg/kg/day,
p.o.) or vehicle once daily for 6 weeks. Wistar Kyoto (WKY)
rats were used as normotensive controls. The SHRs showed
significant increase in the blood pressure, prostate weight,
and tissue levels of oxidative stress (MDA), inflammatory cy-
tokines (IL 6, CXCL1/CINC1 and TNF α), growth factors
(TGF β1 and bFGF), and morphological abnormalities in the
ventral prostate compared to WKY rats. On the other hand,
the prostatic blood flow was decreased in the SHRs. Treat-
ment with silodosin significantly ameliorated the changes of
above parameters in SHRs excluding the blood pressure and
prostate weight. Silodosin can suppress the progression of
prostatic hyperplasia through an increase of prostatic blood
flow.
3-S-05-3 Effects of the
phosphodiesterase 5 inhibitorTadalafil
on bladder blood flow and bladder
function in rat models
Michiko Oka, Ryohei Yoshinaga, Yuko Kawai,
Yoshitaka Nakamura, Tomomi Fukui, Tatsuya Oyama
Research Laboratories, Nippon Shinyaku Co., Ltd.
In men with benign prostatic hyperplasia (BPH), prostate
growth leads to partial bladder outlet obstruction (BOO) and
makes urination difficult. Patients with BOO secondary to
BPH experience ischemia reperfusion episodes in the blad-
der during every micturition cycle, with increasing severity
of symptoms. There has therefore been a focus on the impair-
ment of bladder blood flow (BBF) as one of the putative
mechanisms of obstructive bladder dysfunction. In 2014, the
phosphodiesterase 5 inhibitor Tadalafil was approved in Ja-
pan for the treatment of lower urinary tract symptoms in pa-
tients with BPH. Here, we introduce our research on the ef-
fects of Tadalafil on BBF and bladder function in three rat
models of ischemia/reperfusion : bladder overdistension/
emptying, clamping/release of the abdominal aorta, and BOO
(Eur J Pharmacol 2015 754 : 92 ; Neurourol Urodyn 2015, in
press). In all rat models, Tadalafil improved BBF, and in
BOO rats, the increase in the number of micturitions and the
decrease in the average micturition volume were signifi-
cantly suppressed by Tadalafil. Taken together, these find-
ings suggest that improvement of BBF by Tadalafil may con-
tribute to Tadalafil’s amelioration of bladder function.7
3-S-05-4 Combination of α1 blockers
and anticholinergic agents for prostatic
hyperplasia and overactive bladder:
Effects and problems
Takako Shiota 1, Kazumasa Torimoto 2,
Kiyohide Fujimoto 2
1Dept. of Urology, Saiseikai Nara Hospital, Nara, Japan, 2Department of Urology,
Nara MedicalUnivercity
In prostatic hyperplasia, obstruction of the lower urinary
tract causes voiding symptoms. In addition, bladder ischemia
associated with this obstruction leads to storage symptoms in
50 75% of cases. Initial drug therapy for prostatic hyperpla-
sia employs α1 blockers, regardless of the presence of stor-
age symptoms. Monotherapy with α1 blockers reduces detru-
sor overactivity and is thus effective for overactive bladder
symptoms ; however, this improvement is observed in only
65% of cases. In cases in which α1 blocker monotherapy is in-
effective, anticholinergic agents are recommended, yielding
an improvement in 73% of cases. However, anticholinergic
agents present a risk of adverse events, and therefore should
be administered carefully. Drug therapy for prostatic hyper-
plasia, a disease among the elderly, requires consideration of
individual differences in pharmacokinetics, drug interac-
tions, and tolerability. In particular, anticholinergic agents
easily cause side effects such as dry mouth and constipation.
Furthermore, although rarely, anticholinergic agents can
also impair cognitive function. In addition, drug combination
therapy involves an increased dose of drugs, putting the pa-
tient at risk of polypharmacy.
3-S-06-2 Analysis of mechanisms
underlying mental and
neurodegenerative disorders using the
human disease specific iPS cell
technique
Naoko Kuzumaki 1, Hideyuki Okano 2, Minoru Narita 1,3
1Dept. Pharmacol., Hoshi Univ.,
2Dept. Physiol., Keio Univ. Sch. Med., 3 L StaR, Hoshi Univ.
Dopamine neurons are key regulators of emotional and motor
coordination. Great efforts are in place to understand the mo-
lecular mechanisms that trigger psychiatric and neurodegen-
erative disorders, taking advantage of human genetics and
animal modeling. It has been recognized that most psychiat-
ric and neurodegenerative diseases are sporadic in etiology,
arising from what appear to be the complex interactions of
genetic and environmental risk factors. Since neuronal dys-
function and degeneration as a result of the neurodegenera-
tive process probably occurs much earlier than the initial
neurological manifestations that characterize disease, it may
be difficult to fully model these conditions in rodents. Consid-
ering these backgrounds, it is useful to apply iPS cells tech-
nology for understanding the initiating process of neurologi-
cal diseases. In the recent study, we found the dopaminergic
cell vulnerability associated with dynamic changes in epige-
netics of differentiated dopaminergic neurons derived from
Parkinson disease specific iPS cells. In this symposium, we
will discuss the importance of epigenomic landscape for
dopaminergic cell vulnerability under mental and neurode-
generative disorders.S53-S-06-1 Mechanisms of neurogenesis
and gliogenesis to understand
pathogenesis of brain diseases
Noriko Osumi
Dept. Devel. Neurosci., Tohoku Univ. Sch. Med.
Generation of neurons starts from the early embryonic stage
and continues throughout life in certain brain regions such as
the subventricular zone (SVZ) of the lateral ventricle and the
subgranular zone (SGZ) of the hippocampal dentate gyrus
(DG). Gliogenesis, i.e., generation of astrocytes and oligoden-
drocytes, follows neurogenesis in the perinatal stage. It is of
note that proliferation of oligodendrocyte precursor cells
(OPCs) takes place in the healthy brain, while massive pro-
duction of astrocytes occurs typically in the injured brain.
Extensive studies have been done to elucidate significance of
neurogenesisis on various animal behaviors such as learning
and memory, but generation of glial cells should deserve to
be paid more attention if we consider great impact of recent
works on how human astrocytes improve neural functions in
the mouse and on how OPCs contribute to mouse cognitive
functions. Impairment in neurogenesis seems to be related
with mental disorders such as autism, schizophrenia, Al-
zheimer disease, etc, and so is gliogenesis independently from
or synergistically with neurogenesis. Needless to say, there
are many molecules and pathways that govern neurogenesis
and gliogenesis.
3-S-06-3 Generation of blood brain
barrier (BBB) model derived from iPS
cells
Kohei Yamamizu
Lab. Stem Cell Diff. CiRA. Kyoto Univ.
The blood brain barrier (BBB) is a network of vessels of
brain endothelial cells (BECs) and are ensheathed by peri-
cytes, neurons, and astrocytes. The BBB has the barrier func-
tion by forming tight junction and expressing the various
transporters for protection of brain homeostasis. We success-
fully established the efficient differentiation systems of iPS
cells into endothelial cells, pericytes, neurons, and astrocytes.
The BECs are generated by co culturing with these four line-
ages derived from an iPS cell line. The BECs formed the
tight junction and highly expressed BBB specific transport-
ers such as GLUT1, PGP, BCRP, and MRP. About 99% of new
drugs in development for brain diseases are hampered be-
cause these drugs cannot go through BBB. Our technology of
BBB would contribute the drug discovery before clinical
tests. Furthermore, the extent of BBB impairment in
neurodegenerative diseases and how it affects the bioavail-
ability of therapeutics remains unclear. Our BBB models
would investigate the molecular mechanisms of progression
the neurodegenerative diseases related BBB by using pa-
tient specific iPS cells. Therefore, this technology of BBB
model would have a great potential for drug discovery and fu-
ture therapy of neurodegenerative diseases.8
3-S-06-4 Non human primate as
human disease model
Hirotaka James Okano
Div. Regen Med., Jikei Univ. Sch. Med.
Good animal model will play a key role in a significant break-
through that will greatly impact studies for neurodegenera-
tive diseases aimed at understanding their pathophysiology.
The value of Common marmoset (Callithrix jacchus), a small
non human primate, for human disease modeling is well
documented during last 15 years, because of its advantage for
translation to genetically close human systems. Marmosets,
by having smallest ranged body size and high reproduction
rate among primates, are suitable for transgenic modifica-
tion. Recently, transgenic marmoset was successfully pro-
duced by gene transduction into embryos, which creates
greatly advantageous animal models to study human neurode-
generative diseases such as Parkinson’s disease. Recently, we
generated marmoset Parkinson’s disease model and con-
ducted MRI analysis. Voxel based morphometry and diffu-
sion tensor imaging showed decrease of the density in sub-
stantia nigra and of projection of nigrostriatal pathway. Fur-
thermore, we established the auditory brainstem response
test for study of hearing loss in marmoset. The clinical and
pathologic similarities between marmoset disease models and
their human counterpart make the non human primate mod-
els potentially valuable for studies on the pathogenesis and
treatment of human diseases.
3-S-07-2 Functional coupling and Ca2+
signaling between SR and mitochondria
in smooth muscles
Hisao Yamamura, Keisuke Kawasaki,
Yoshiaki Suzuki, Yuji Imaizumi
Dept. Mol. Cell. Pharmacol., Grad. Sch. Pharmaceut. Sci., Nagoya City Univ.
The Ca2+ signaling microdomain is recognized as a spatiotem-
poral platform for functional protein assembly and efficient
signal transduction in plasmalemmal and subplasmalemmal
regions. In smooth muscle cells, depolarization induced Ca2+
influx caused a local [Ca2+]cyt transient (Ca2+ hotspot) mediated
by Ca2+ release from the SR (CICR) at several discrete sites in
subplasmalemma areas. Subsequently, the high [Ca2+]cyt within
localized area triggered Ca2+ uptake of neighboring mitochon-
dria. TIRF imaging revealed that subsets of mitochondria
fragments closely localized with RyRs and VDCCs. These re-
sults suggest that Ca2+ hotspots promote ATP production by
the activation of respiratory cycle and the produced ATP is
supplied to the coupling SR. Alternatively, confocal fluores-
cent imaging showed that mitofusin proteins tethered a part
of SR and mitochondria each other. In addition, mitofusins
were involved in mitochondrial Ca2+ uptake following ago-
nist induced [Ca2+]cyt increase. In conclusion, discrete mito-
chondria have efficient functional coupling with colocalized
SR fragments and plasma membrane as a local Ca2+ microdo-
main and, thereby, substantially contribute to the [Ca2+]cyt
regulation in smooth muscles.S53-S-07-1 Role of mitochondrial
ubiquitin ligase MITOL in mitochondrial
dynamics and quality control
Shigeru Yanagi
Dept. Mol. Biochem., TUPLS. Life Sci.
We have previously identified mitochondrial ubiquitin ligase,
MITOL (also known as March5), which regulates mitochon-
drial dynamics through the ubiquitination of mitochondrial
fission factor Drp1 (EMBO J, 2006). Subsequently, we re-
ported that MITOL ubiquitinated and attenuated cell toxicity
of unfolded proteins accumulated in mitochondria such as
mutant SOD1 and expanded polyglutamine proteins which
cause neurodegenerative disorders (Mol. Biol. Chem. 2009,
Mitochondrion 2010), suggesting the involvement of MITOL
in mitochondrial quality control and pathogenesis of neurode-
generative diseases. To further understand the role of MI-
TOL in mitochondria, we searched for physiological sub-
strates for MITOL and succeeded to identify microtubule as-
sociated protein 1B light chain 1 (MAP1B LC1) and mito-
fusin2 (Mfn2). Recently, we report that MITOL plays a pro-
tective role against nitrosative stress induced mitochondrial
dysfunction mediated by MAP1B LC1 in neuronal cells
(PNAS. 2012), and that MITOL is required for ER mitochon-
dria interaction via Mfn2 (Mol. Cell 2013). In this meeting, by
analyzing MITOL deficient MEFs and mice, we provide evi-
dence for a critical role of MITOL in mitochondrial quality
control through regulation of mitochondrial dynamics.
3-S-07-3 The analysis of stress
responses in mitochondria
Shiori Sekine, Hidenori Ichijo
Cell Signaling, Grad. Sch. of Pharmaceut. Sci., Univ. of Tokyo
Mitochondria not only serve as cellular energy stores but also
function as platforms of various stress responses. In this sym-
posium, we will talk about two mitochondrial proteins,
PGAM5 and SARM1, both of which are originally identified
as activators of ASK1, a MAP3K in the stress responsive
MAPK cascades. The first main character of this talk, SARM
1, is a member of TIR domain containing adaptor molecules.
Recently, we found that SARM1 acquires a capacity to acti-
vate ASK1 when SARM1 is localized in mitochondria. Our re-
sults provide one example that mitochondria can serve as a
location for the activation of specific kinase in order to trig-
ger the subsequent proper stress responses. PGAM5, the sec-
ond main character, is a member of the PGAM family, an evo-
lutionarily conserved enzyme family. Although the amino
acid sequence of the catalytic core of other PGAM family
members are conserved in PGAM5, we previously reported
that PGAM5 lacks mutase activity and instead acts as a Ser/
Thr specific protein phosphatase. Recently, we generated
whole body knockout mice of PGAM5 and found that PGAM5
deficiency confers resistance against several metabolic per-
turbations. In the second part, we will introduce the novel
link between mitochondria resident protein and whole body
metabolism.9
3-S-07-4 Eco pharma of approved
drugs focused on inhibition of
mitochondrial fission
Tsukasa Shimauchi 1,2, Tatsuya Ishikawa 2,3,
Motohiro Nishida 1,2,4
1Division of cardiocirculatory signaling, Okazaki Institute for Integrative
Bioscience (NIPS), 2Department of Translational Pharmaceutical Sciences,
Graduate School of Pharmaceutical Sciences, Kyushu Univerisity, 3Ajinomoto
Pharmaceuticals Co., Ltd., 4 PRESTO, JST
Mitochondrial abnormal metabolism is attracted attention as
a major cause of several diseases. We noticed that mitochon-
drial division was induced prior to cardiomyocyte senescence
in the peri infarct region of myocardium after myocardial in-
farction in mice. We also found that hypoxic signals were ac-
tivated in this region, and confirmed that mitochondrial fis-
sion was actually induced by 1% hypoxia in rat neonatal car-
diomyocytes. Although hypoxic stress induced neither cardi-
omyocyte cell death nor senescence, reoxygenation of cardio-
myocytes significantly induced senescence. Mitochondrial fis-
sion was induced by the activation of dynamin related GTP
binding protein (Drp) 1, and reoxygenated cardiomyocytes
showed intracellular ATP accumulation. We performed a
drug screening, and found that an ion channel blocker (ICB 1)
completely suppressed cardiomyocyte cell senescence in-
duced by hypoxia/reoxygenation. ICB 1 suppressed Drp1 ac-
tivation and significantly improved heart failure and diabetes
in mice. These results strongly suggest that Drp1 activation
triggers induction of muscle senescence, and that a novel
pharmacological action by ICB 1 has a potency to be addition-
ally applied to mitochondrial excess fission related intracta-
ble diseases.
3-S-08-2 The Development of Drugs
for Natriuretic Peptide System in
Cardiovascular Diseases―Bench to
Bedside
Tomoko Ichiki, John Burnett
Division of Cardiovascular Diseases, Mayo Clinic
Heart failure (HF) and hypertension (HT) are major health
burdens worldwide characterized with impaired neurohu-
moral systems including reduced activity of natriuretic pep-
tides (NP) with decreased cGMP activation in association
with renin angiotensin aldosterone system activation.
Stimulation of the NPs receptors GC A or GC B has been
considered an optimal therapeutic target. Short term use of
NP replacement therapy for acute HF has improved symp-
toms, while controversy remains regarding improvement of
outcomes. LCZ676 (ARNi), which can enhance the endoge-
nous NP system, is approved in the US for chronic stable HF.
LCZ676 significantly improved prognosis ; however, ARNi
may not be efficacious in patients with endogenous NP defi-
ciencies. Thus, endogenous NP deficiency states require di-
rect NP receptor agonists. Our group has been developing
chronic NP therapy with subcutaneous (SQ) administration of
novel NPs for HF and HT. Because of the challenge of oral
peptide delivery, NP therapy requires the half life and ap-
propriate absorption from subcutaneous area. I will review
our experience from bench to bedside the development of
CD NP, a novel dual GC A/GC B agonist for HF and MANP,
an innovative GC A agonist for resistant HT.S63-S-08-1 Significance of endogenous
and exogenous NO production systems
in the pathogenesis of cardiovascular
and metabolic diseases
Masato Tsutsui 1, Hiroaki Shimokawa 2, Yutaka Otsuji 3,
Nobuyuki Yanagihara 4
1Dept. Pharmacol., Ryukyu Univ. Grad. Sch. Med., 2Dept. Cardiovascular Med.,
Tohoku Univ. Grad. Sch. Med., 3 2nd Dept. Int. Med., Univ. Occup. and Environ.
Health, 4Dept. Pharmacol., Univ. Occup. and Environ. Health
Nitric oxide (NO) is synthesized by three different NO syn-
thases (nNOS, iNOS, and eNOS). We previously generated
mice in which all NOS genes are completely disrupted. The
triple NOSs / mice manifested metabolic syndrome, myocar-
dial infarction, and diastolic heart failure. Long term high
cholesterol diet markedly increased plasma LDL cholesterol
levels in the triple NOSs / mice, and these levels were similar
to those in apoE / mice. It has been shown that NO is pro-
duced from its inert metabolites, nitrite (NO2 ) and nitrate
(NO3 ). We examined the effect of low nitrite/nitrate diet on
metabolic phenotypes in wild type mice. The long term low
nitrite/nitrate diet resulted in visceral obesity, hypercholes-
terolemia, impaired glucose tolerance, and insulin resistance
in the mice. These results suggest that long term dietary ni-
trite/nitrate deficiency causes metabolic syndrome in mice,
identifying a specific dietary ingredient that gives rise to
metabolic syndrome even in the absence of excess calorie in-
take. Our findings demonstrate that not only the endogenous
NO production system, but the exogenous NO production sys-
tem also plays a role in the pathogenesis of cardiovascular
and metabolic disorders.
3-S-08-3 Sigma 1 receptor mediates
depressive behaviors induced by
cardiovascular diseases
Kohji Fukunaga, Yasuharu Shinoda
Dept. Pharmacol., Tohoku Univ. Grad. Sch. Pharm. Sci.
Cardiovascular diseases are risk factors to cause the depres-
sion in human. Since cardiac hypertrophy and heart failure
induced by transverse aortic constriction (TAC) was closely
associated with the marked reduction of Sigma 1 receptor
(Sig 1R) in the brain, we here hypothesized that the impair-
ment of Sig 1R in brain triggers the depressive behaviors in
cardiovascular disease patients. Oral administration of a spe-
cific Sig 1R agonist SA4503 (0.3 1.0mg/kg) significantly im-
proved TAC induced depressive behaviors with restoration
of Sig 1R expression in both hippocampal CA1 and DG re-
gions. Indeed, the plasma corticosterone levels were signifi-
cantly elevated in 6 weeks after TAC concomitant with de-
pression like behavior expression. The chronic corticoster-
one administration for 3 weeks caused depressive behaviors
with the reduction of Sig 1R expression in the hippocampus.
Consistent with the improvement of depression behaviors,
heart failure was also ameliorated by SA4503 (0.3 1.0mg/kg)
administration. Taken together, Sig 1R stimulation with SA
4503 is attractive therapy to improve not only depressive be-
haviors but also heart failure following cardiovascular dis-
eases.This work is supported by Grants in Aid for Scientific
Research (Kakenhi 24659024).0
3-S-08-4 G protein coupled receptor
mediated responses on myocardial
infarction
Hitoshi Kurose
Dept. Pharmacol. Toxicol., Grad. Sch. Pharm. Sci., Kyushu Univ.
Myocardial infarction occurs by thrombotic occlusion of coro-
nary artery and results in death of cardiac myocytes. During
myocardial infarction, it has been known that extracellular
pH decreases, that is the concentration of proton increases.
Proton is ion but can activate several signaling molecules
such as ion channels and G protein coupled receptors. There
are reports that ion channels are activated and play an impor-
tant role in myocardial infarction induced cardiac injury.
However, the roles of G protein coupled receptors in myocar-
dial infarction have not been examined so far. There are four
members of the receptors that are regulated by proton.
These are named as proton sensing G protein coupled recep-
tors. Each receptor has unique cellular distribution and acti-
vates distinct signaling pathways to cause detrimental or pro-
tective changes in the cells. In this presentation, I would like
to introduce the roles of the proton sensing receptors in myo-
cardial infarction, and suggest proton sensing receptors are
a promising target for treatment of myocardial infarction.
3-S-09-2 Cardiactoxicity Prediction of
drug usingThree dimensional Heart
Simulator
Jun ichi Okada 1,2, Takashi Yoshinaga 3,
Junko Kurokawa 4, Takumi Washio 1,2,
Tetsushi Furukawa 4, Kohei Sawada 3,
Seiryo Sugiura 1,2, Toshiaki Hisada 2
1GSFS, Univ. Tokyo, 2UT Heart Inc., 3 Eisai Co. Ltd., 4 Tokyo Med. Dent. Univ.,
M.R.I.
We will show a novel cardiotoxicity testing system combin-
ing in vitro ion current measurements using the patch clamp
technique and a three dimensional, multi scale, multi phys-
ics heart simulator (UT Heart). This simulator implements
the excitation propagation and excitation contraction cou-
pling process, based on a finite element method with parallel
computation. Because the heart model, torso model, and con-
duction system model are coupled by a multi scale algorithm
we can analyse the changes in the electrocardiogram caused
by modification of ion channels by drug effects. To evaluate
the pro arrhythmic risk of drugs, the guideline for drug
safety testing (ICH S7B) recommends measurement of IKr
through the hERG channel, as well as an in vivo QT assay and
examination of the QT interval for drug development. Our
heart simulator more accurately predicted the pro arrhyth-
mic risk than the QT interval and the HERG test. The inhibi-
tory effects of drugs are analysed for the six or seven ion
channels, and the effects of drugs under various plasma con-
centrations are reproduced by changing parameter values of
22 million cell models implemented in the heart model.S63-S-09-1 Prediction method of
cardiotoxicity triggered by kinase
inhibition
Yoshiaki Kariya
Dept. Pharm., Univ. Tokyo Hosp.
Although tyrosine kinase inhibitors (TKIs), belonging to
molecularly targeted drugs, have been designed to inhibit
particular kinases, adverse drug reactions (ADRs) by TKIs
are difficult to predict since they are considered to be associ-
ated with off target inhibition. Therefore, for predicting
ADRs, clarification of comprehensive inhibition profile of
kinases by TKIs and identification of kinases highly relevant
to ADRs are important. The former is evaluable by compre-
hensive affinity measurement method reported previously.
To address the latter, systems biological analyses are
adopted here. In this study, cardiotoxicity has been focused
due to its clinical severity. Since some TKIs are reported to
cause cardiac cell apoptosis leading to cardiotoxicity, the in-
formation of intracellular signaling pathways from various
kinases to apoptosis in cardiac cells were collected from
knowledge bases and was integrated into a large single map.
With applying dynamic simulation based analysis, risks of
various kinases on apoptosis are evaluated. The calculated
risks show good correlation with viability of primary cul-
tured cardiomyocytes under knockdown of several kinases,
suggesting that our method could be helpful in identification
of high risk kinases for cardiotoxicity.
3-S-09-3 In silico study for meeting the
needs of safety pharmacological
evaluation: Models of the rapid
pharmacological evaluation and the
induced pluripotent stem cell derived
myocardium
Takashi Ashihara
Dept. Cardiovasc. Med., Shiga Univ. Med. Sci.
To improve the cost efficiency of drug development and to
decrease the number of animal testing, both human induced
pluripotent stem cell derived cardiomyocytes (hiPSC CM)
and in silico approach (computer simulation) are attempted
to be used for the evaluation of safety pharmacology in the
process of drug development. However, whether such novel
approaches properly evaluate the clinical pharmacological ef-
fects is still unclear. Indeed, it has been known that the elec-
trophysiological properties of hiPSC CM differ in some re-
spects from those of the original human heart. Moreover,
there is a limited number of specialists in the field of in silico
pharmacology (or arrhythmology), and thus in some cases in
silico models are not handled properly. The purposes of this
talk are to give an overview of some of in silico studies appli-
cable to the cardiac safety pharmacology testing (including
the analysis of a gap between the hiPSC CM and the real hu-
man heart) and to comment on the possible future direction of
the in silico safety pharmacology.1
3-S-09-4 Significance of
comprehensive and quantitative
proteomics of membrane transport
proteins in drug discovery
Shushi Nagamori, Yoshikatsu Kanai
Dept. Bio Sys. Phrmacol., Grad. Sch. Med. Osaka Univ.
More than 60% of approved drug targets are membrane pro-
teins. Among membrane proteins, membrane transport pro-
teins, such as transporters or channels, play critical roles for
living cells. While number of membrane transport protein as
a target of the existing drugs is limited, most of the drugs tar-
geting transport proteins are quite important. Moreover, it is
predicted that more membrane transport proteins would be
targets of new drugs. Thus, it is very meaningful to obtain
comprehensive expression profiles of the membrane trans-
port proteins in various cells or tissues and quantitate the
proteins accurately. However, due to hydrophobic properties
of the transport proteins, comprehensive expression analysis
of the proteins is difficult and the quantification is performed
rarely. Recently, we have developed a proteomic procedure
that allows us to analyze transport proteins comprehensively
and quantitatively. The comprehensive and quantitative pro-
teomics lead us to the new stage of drug discovery targeting
transport proteins as well as that of in silico modeling.
3-S-10-2 Ryanodine receptor/Ca2+
release channel linked diseases in
skeletal muscle
Takashi Murayama
Dept. Pharmacol., Juntendo Univ. Sch. Med.
The type 1 ryanodine receptor (RyR1) is a Ca2+ release chan-
nel in the sarcoplasmic reticulum of skeletal muscle and is
mutated in several diseases, including malignant hyperther-
mia (MH) and central core disease (CCD). Most MH and CCD
mutations cause accelerated Ca2+ release, resulting in abnor-
mal Ca2+ homeostasis in skeletal muscle. However, how spe-
cific mutations affect the channel to produce different pheno-
types is not well understood. We have recently developed a
method to quantitatively evaluate the CICR activity of RyR1
channels using [3H]ryanodine binding and ER luminal Ca2+
measurements (Murayama T, Kurebayashi N et al., PLoS
ONE, 10 : e0130606, 2015). Using this method, we analyzed
RyR1 channels carrying different MH and CCD mutations in
the amino terminal and central regions by expressing them
in HEK293 cells. The mutations divergently affected two pa-
rameters for CICR, i.e., the gain that determines the attain-
able maximum activity and the sensitivity to activating Ca2+
in a site specific manner. The CICR activity of the mutants
well correlated with the severity of diseases. Our method can
also be applied to diagnosis and treatment of the diseases. I
will talk about recent progress of our research and approach
toward diagnosis and therapy.S63-S-10-1 Regulation of excitation
contraction coupling by junctional
membrane associated proteins
Tsutomu Nakada, Toshihide Kashihara,
Mitsuhiko Yamada
Dept. Mol. Pharmacol., Shinshu Univ. Sch. Med.
Skeletal muscle L type calcium channels (LTCC) are specifi-
cally localized to the junctional membrane (JM) where the
sarcolemma are closely apposed to the sarcoplasmic reticu-
lum. Although the targeting of LTCC is critical for efficient
excitation contraction coupling, its molecular mechanism has
not been clarified. Junctophilins (JPs) are known to stabilize
the JM complex by bridging the plasma membrane and sarco-
plasmic reticulum. We explored structural and functional
consequences of JP knockdown (KD) in C2C12 and GLT myo-
tubes. JP1 or JP2 KD significantly inhibited the JM targeting
of LTCC whereas JP2 but not JP1 KD significantly decreased
the current density of LTCC. Calcium imaging assay showed
that JP1 or JP2 KD significantly decreased the number of
myotubes exhibiting calcium transient in response to electri-
cal stimulation. Co immunoprecipitation and GST pull down
assay showed that JP binding domain (JPD) exists and is lo-
cated in the proximal C terminus of CaV1.1. Immunocyto-
chemical analysis revealed that the JM targeting rate of the
JPD mutated CaV1.1 was significantly reduced compared
with the wild type. These results suggest that interaction of
CaV1.1 with JPs via JPD is important for the proper localiza-
tion and function of LTCC.
3-S-10-3 Mouse models for myopathy
associated with nuclear envelopathy
Yukiko Hayashi
Dept. Pathophysiol., Tokyo Medical Univ.
Mutations in the genes encoding nuclear envelope proteins
cause several diseases, so called nuclear envelopathy. Defi-
ciency of emerin, an inner nuclear membrane protein, cause
Emery Dreifuss muscular dystrophy (EDMD), which is clini-
cally characterized by slowly progressive muscular dystro-
phy, cardiomyopathy with conduction defects, and early joint
contractures. Mutations in the LMNA gene, which encodes
A type lamins, cause variable diseases including EDMD,
limb girdle muscular dystrophy, partial lipodystrophy, and
premature aging. To date, several mouse models for nuclear
envelopathy have been developed, but there is no good model
mimicking myopathy observed in EDMD. We produced a new
mouse model (EH) by crossing Emd knockout (Emd) and
Lmna H222P knock in (H222P) mice.EH mice show promi-
nent degeneration of skeletal muscle is seen together with
cardiac fibrosis in EH mice. Surprisingly, cardiac fibrosis in
EH mice is milder than H222P mice, which died by promi-
nent dilation of heart with plural effusion.This new animal
model is useful to elucidate the different roles of nuclear en-
velope proteins in both skeletal and cardiac muscles.2
3-S-10-4 Molecular mechanism of
sarcopenia―Adaptive changes in
negative regulators modulating muscle
mass
Kunihiro Sakuma 1, Akihiko Yamaguchi 2
1Health Science Center, Toyohashi University of Technology, 2 Schhol of
Rehabilitation Sciences, Health Science University of Hokkaido
Sarcopenia, the age related loss of skeletal muscle mass, is
characterized by a deterioration of muscle quantity and qual-
ity leading to a gradual slowing of movement, a decline in
strength and power, increased risk of fall related injury, and
often, frailty. Since sarcopenia is largely attributed to vari-
ous molecular mediators affecting fiber size, mitochondrial
homeostatis, and apoptosis, the mechanisms responsible for
these deleterious changes present numerous therapeutic tar-
gets for drug discovery. Muscle loss has been linked with sev-
eral proteolytic systems, including the ubuiquitin protea-
some, lysosome autophagy, and TNF a NF kB (nuclear fac-
tor kappaB) systems. Although many factors are considered
to regulate age dependent muscle loss, this gentle atrophy is
not affected by factors known to enhance rapid atrophy (den-
ervation, hindlimb suspension etc). In addition, defects in
SRF (serum response factor) dependent signaling have been
found in sarcopenic muscle. Intriguingly, more recent studies
indicated an apparent functional defect in autophagy and
myostatin dependent signaling in sarcopenic muscle. In this
symposium, we summarize the current understanding of the
adaptation of many regulators in sarcopenia.
3-S-11-2 Effects of early life stress on
the brain
Mayumi Nishi, Takayo Sasagawa,
Noriko Horii Hayashi
Dept. Anatomy＆ Cell Biol., Nara Med. Univ.
Many studies have shown that daily repeated maternal sepa-
ration (MS), an animal model of early life stress, can regulate
the hypothalamic pituitary adrenal axis (HPA axis) and af-
fect subsequent brain function and behavior during entire
life including puberty and adulthood. However, the molecular
basis of the long lasting effects of early life stress on brain
function has not been fully elucidated. In this symposium, we
will present various cases of MS in rodents and illustrate the
alterations in HPA axis activity by focusing on corticoster-
one (CORT). We then show a characterization of the brain re-
gions affected by various patterns of MS, including repeated
MS and single time MS at various stages before weaning, by
investigating neuronal activity marker, c Fos. These CORT
and c Fos studies suggest that repeated early life stress may
affect neuronal function in region and temporal specific
manners, indicating a critical period for habituation to early
life stress. Next, we introduce how early life stress can im-
pact behavior, namely by inducing depression, anxiety or eat-
ing disorders, and alterations in gene expression in adult
mice subjected to MS.This study was supported by Grants
in Aid for Scientific Research from the JSPS.S3-S-11-1 Early weaning increased
emotional behavior in mice
Takefumi Kikusui
School of Veterinary Medicine, Azabu University
We examined the developmental effects of early weaning on
anxiety and the extinction of fear memory in male C57BL/6
mice. Early weaning led to increased freezing behaviors af-
ter fear conditioning via the foot shock method both during
extinction training and in a test of extinction retrieval. In ad-
dition, we found that the levels of brain derived neurotrophic
factor (BDNF) protein and mRNA transcripts for BDNF exon
III in the medial prefrontal cortex (mPFC) at the time of ex-
tinction retrieval were lower in early weaned mice than nor-
mally weaned mice. Furthermore, BDNF expression was
negatively correlated with the duration of freezing behaviors
during extinction training. Together, these findings suggest
that early weaning impaired fear extinction, and this was cor-
related with a decrease in BDNF protein levels in the mPFC
that was caused by disrupted BDNF protein synthesis from
its mRNA transcripts with or without reduced transcription
of BDNF Exon III. These data suggest that early weaning of C
57BL/6 mice might provide a reliable animal model for stud-
ies of the pathogenesis of post traumatic stress disorder.
3-S-11-3 Impact of environmental
factors in early life on brain development
and emotional behaviors
Kazuhiro Takuma 1,2, Yukio Ago 3, Shigeru Hasebe 1,
Hitoshi Hashimoto 2,3, Toshio Matsuda 4
1Dept. Pharmacol., Grad. Sch. Dent., Osaka Univ., 2United Grad. Sch. Child Dev.,
Osaka Univ. Kanazawa Univ. Hamamatsu Univ. Sch. Med. Chiba Univ.＆ Univ.
Fukui, 3 Lab. Mol. Neuropharmacol., Grad. Sch. Pharm. Sci., Osaka Univ., 4 Lab.
Med. Pharmacol., Grad. Sch. Pharm. Sci., Osaka Univ.
Epidemiological researches of neurological and psychiatric
disorders have provided the importance of environmental
factors, especially during early life, in mental health. Accord-
ingly, there are a growing number of animal studies to imply
the involvement of environmental factors in brain and mental
development. We have previously demonstrated environ-
mental enrichment (EE), which is considered to enhance mo-
tor, sensory and cognitive stimulation (Nat. Rev. Neurosci.,
2006), during early developmental period attenuates abnor-
malities of emotional behaviors in adult pituitary adenylate
cyclase activating polypeptide knockout (PACAP KO) mice
(Behav. Brain Res., 2010 ; 2014). Furthermore, we have re-
cently revealed that factors other than mortar stimulation
are important in the improvement of behavioral abnormali-
ties by EE in PACAP KO mice via a BDNF independent in-
crease in dendritic spine density in the hippocampal CA1.
The present review summarizes the roles of environmental
factors in early life on brain development and emotional be-
haviors, focused on our findings on regulation of the expres-
sion of behavioral abnormalities by early life EE in mouse
models of psychiatric disorders.63
3-S-11-4 Early life stress produces
stress vulnerability and affects chronic
pain
Takashi Nishinaka, Kazuo Nakamoto,
Shogo Tokuyama
Dept. Clinic. Pharm., Fac. Pharmaceu. Sci., Kobe Gakuin Univ.
Clinical studies have demonstrated that adversity in early
life increases the risk of developing a chronic pain in adult-
hood, suggesting that early life stress increases the vulner-
ability to development of chronic pain. Neuropathic pain
leads to impairment of the neuronal function in multiple
brain regions which contribute to the maintenance of pain
and development of emotional dysfunction. Therefore, early
life stress induced abnormalities of neuronal function in
brain may negatively affect the pain modulation system dur-
ing neuropathic pain condition. In the present study, we in-
vestigated the behavioral and molecular effect of early life
stress on the model mice of neuropathic pain. In our model,
early life stress exacerbated the hyperalgesia and emotional
dysfunction after neuropathic pain in adult mice. Transient
alteration of brain derived neurotrophic factor (BDNF) levels
in the brain was observed immediately after early life stress
but not nerve injury. Furthermore, early life stress increased
p ERK, a neuronal activation maker, expression in the multi-
ple brain regions of adult mice. These findings suggest that
early life stress negatively affect the neuropathic pain
through the abnormalities of neuronal function in brain.
3-S-12-2 Supplemental indication
approval by an application based on
public knowledge for a currently
approved drug: history and current
status in Japan
Shinichi Kawai
Div. Rheumatol., Dept. Intern. Med., Toho Univ. Sch. Med.
History and current status of the supplemental indication ap-
proval by an application based on public knowledge for a cur-
rently approved drug will be introduced in this symposium.S3-S-12-1 Anti atrial fibrillatory effect of
anti influenza drug oseltamivir
Yuji Nakamura, Takeshi Wada,
Hiroko Izumi Nakaseko, Kentaro Ando,
Atsushi Sugiyama
Dept. Pharmacol., Fclt. Med., Toho Univ.
Oseltamivir is a potent and selective neuraminidase enzyme
inhibitor. The drug has been recently shown to more selec-
tively delay the intra atrial conduction than the intra ven-
tricular conduction in the halothane anesthetized dogs,
which was less selective for pilsicainide. We assessed the
anti atrial fibrillatory effect of oseltamivir by using recently
developed persistent atrial fibrillation model of beagle dogs.
Class I drugs (3 mg/kg of disopyramide, aprindine, ciben-
zoline and pilsicainide), IKur blocker (6 mg/kg of AVE0118),
and 3 and 30 mg/kg of oseltamivir were intravenously admin-
istered to the model over 10 min (n=6 for each drug).
Disopyramide, aprindine, cibenzoline, pilsicainide and AVE
0118 terminated the atrial fibrillation in 1, 0, 2, 2 and 2 out of
6 animals in each group, respectively. The low and high doses
of oseltamivir terminate the atrial fibrillation in 2 and 5 out
of 6 animals, respectively. It should be noted that disopyra-
mide induced torsade de pointes following remarkable QT
interval prolongation in 1 dog without terminating the atrial
fibrillation. Thus, oseltamivir may become a efficacious and
safe strategy for treating atrial fibrillation.
3-S-12-3 Drug Repositioning based
Drug Development:―From
Pharmaceutical Industry’s viewpoints―
Masanori Osakabe
Nobelpharma, R＆D Division
Drug Repositioning (DR) is a new methodology to apply
known drugs and failed investigational products to new indi-
cations different from their original indications. Nobel-
pharma is a new company established in 2003, targeting nec-
essary but neglected drugs and medical devices that are usu-
ally indicated for rare diseases with small market sizes. Con-
sequently, Nobelpharma has been applying DR approach to
get approvals.In this symposium, I will introduce some of our
drugs developed by DR approach and will try to give careful
consideration to DR based approach to promote a better un-
derstanding of the obstructive factors against developing
new drugs for rare diseases.64
3-S-13-1 Toxicity evaluation on a
bioartificial liver using 13C glucose
breath test
Tomokazu Matsuura
Dept. Labo. Med., Jikei Univ. Sch. Med.
The major cause of candidate compounds dropout in drug dis-
covery is toxic effects in the liver caused by hepatic drug me-
tabolism and pharmacokinetics. We are developing the pre-
diction system on human drug metabolism and pharmacoki-
netics using a bioartificial liver (BAL), which is contracted
by high density human liver cells cultured in a 3 D radial
flow bioreactor (RFB). This system is useful in studying drug
interactions during induction of human CYP3A4. The CYP3
A4 mRNA after rifampisin treatment in the BAL was 100
times higher than in a monolayer culture of a human cell line,
FLC 5.We also made a 3 D reconstructed liver organoid us-
ing RFB, and evaluated viability of the organoid by 13C glu-
cose breath test (GBT). The liver organoid was constructed
by co culture with immortalized mouse hepatocytes, sinusoi-
dal cells. Exhaust gas was sampled in gas bags from the
closed circuit of RFB system. Firstly we observed transition
of 13CO2 in exhaust gas along culture time. Glucose metabo-
lism was enhanced by not only hepatocyte growth, but co cul-
ture of non parenchymal cells. We also examined ischemia/
reperfusion injury model in the reconstructed liver organoid.
13C GBT clearly showed depressed metabolism by ischemic
effect to the liver organoid.
3-S-13-3 A rodent model of impaired
gastric motility resulting from gastric
low grade inflammation induced by allyl
isothiocyanate, a pungent ingredient of
wasabi, for drug evaluation: the stable
isotope labeled compound [13C] acetic
acid breath test
Kimihito Tashima 1, Kenjiro Matsumoto 2,
Kazuki Hashimoto 1, Noriyuki Oshi 1, Taku Imai 1,
Syunji Horie 1
1 Lab. Pharmacol., Fac. Pharm. Sci., Josai International Univ., 2Dept. Pharmacol.
Exp. Ther., Kyoto Pharm Univ.
We have shown the gastrointestinal pharmacological effects of a
wasabi ingredient allyl isothiocyanate (AITC), which induced
the low grade inflammation in rat stomachs. This study is to es-
tablish a mouse model of impaired gastric motility induced by
AITC, which is reliable produce to evaluate prokinetic agents
by detecting the stable isotope [13C] in the breath. Male ddY mice
were used after 15 h fasting. Gastric motility was measured by
[13C] acetic acid breath test in conscious mice. AITC was given
p.o. 30 min before the measurement of motility. Prokinetic
agents including itopride, mosapride, and neostigmine were
given s.c. 40 min before the measurement. AITC impaired gas-
tric motility in dose dependent manner in mice, yet gastric
damage was not observed by AITC. Decreased gastric motility
induced by AITC was restored by the pretreatment of itopride,
mosapride, and neostigmine. These results demonstrate that im-
paired gastric motility induced by AITC was reversible by
prokinetic agents in conscious mice, which might be a useful
animal model for drug evaluation of prokinetic agents.S63-S-13-2 Evaluation of various
pathophysiological functions by the
breath test using 13C labelled
compounds in small animals
Orie Kobayashi, Masayuki Uchida
Food Science Institute, Division of Research and Development, Meiji Co., Ltd.
In the present study, we introduce the methods evaluating
various physiological functions by the breath test using 13C
labelled compounds in small animals. This method has a
merit to be able to evaluate in course of time without sacrific-
ing animals and in the non anesthetized and non restraint
state. A desiccator was employed so that the rats could move
freely within the chamber, and the expired air could be col-
lected effectively in the breath sampling bag using pump.
POCone was chosen to measure the expired 13C labelled air
simply and effectively (Uchida et al . J Pharmacol Sci. 2005).
Gastric emptying and gastrocecal transit time were evalu-
ated by using 13C acetic acid or 13C octanoic acid and lactose
13C ureide, respectively. N Benzoyl L tyrosyl 1 13C L
alanine sodium was used for studying pancreatic exocrine
function. The metabolism of 13C labelled carbohydrate, lipid,
amino acid and peptide was also estimable. Pathophysiologi-
cal functions and drug’s effects could be evaluated. With the
use of another or newly synthesized 13C labelled compounds,
further physiological function, pathopysiological state or
drug’s effects would be clarified by using the present
method.
3-S-13-4 Current status and
perspective in clinical application of
biological function test uing 13C breath
test
Koji Nakada 1,2, Masahiko Kawamura 1,2, Hideo Konishi 2,
Taizo Iwasaki 2, Keishiro Murakami 2, Atsuo Shida 2,
Norio Mitsumori 2, Tomokazu Matsuura 3,
Nobuyoshi Hanyu 2, Katsuhiko Yanaga 2
1 Kawamura Hospital, 2Dept. of Surgery, The Jikei Univ. School of Med., 3Dept. of
Laboratory Medicine, The Jikei Univ. School of Med.
Basic and clinical medical research using 13C breath tests
have been performed over four decades, however, clinical ap-
plication of these useful biological function tests are not yet
widely prevailing and these tests are still remain under con-
sideration of covered by insurance. 13C breath test has sev-
eral advantages including non invasiveness, simplicity and
safety and may contribute to investigate the pathophysiology
of various disease and to evaluate the severity of the disease
by obtaining new dimensional data about biological function.
In current status, 13C breath test is used to evaluate several
biological function such as gatric emptying, fat absorption,
exsocrine pancreatic insufficiency, liver metabolism, insulin
resistance, small intestinal bacterial overgrowth, colonic mu-
cosal injury in inflammatory bowel disease as clinical re-
search, then, more expansion of the clinical application of 13C
breath test in dairy practice is anticipated. For this purpose,
to standardize the method, to fix the standard, to disperse the
usefulness of the tests and to be covered by insurance are vi-
tal. In the presentation, the current status of several biologi-
cal function tests using 13C breath test and perspective of
those will be shown.5
3-S-14-1 Optogenetic control of
central serotonergic neurons affects
impulse control and model based
decision making
Yu Ohmura
Dept. Neuropharmacol., Hokkaido Univ. Sch. Med
It has been speculated that serotonin release in the forebrain
is involved in impulse control and model based decision mak-
ing. However, there is so far no direct evidence proving this
hypothesis. To obtain the direct evidence, we developed
transgenic mice expressing channelrhodopsin 2 (ChR2) mu-
tant (C128S) or Archaerhodopsin T (ArchT) only in central
serotonergic neurons. A 3 choice serial reaction time task (3
CSRTT) was used to assess impulsive action. A lithium de-
valuation task was used to assess model based decision mak-
ing. In this paradigm, a mouse is first trained to poke its nose
to illuminated holes to get a food pellet, and then the food is
devalued by pairing it with lithium induced illness. Optoge-
netic activation of serotonergic neurons suppressed impul-
sive action without affecting other cognitive/motor parame-
ters in the 3 CSRTT. Although inconclusive, preliminary re-
sults indicated that optogenetic silencing of serotonergic neu-
rons impaired model based decision making. Thus it is likely
that central serotonergic activity has a pivotal role in impulse
control and model based decision making.
3-S-14-3 Dynamic encoding of
appetitive and aversive information in
the primate dorsal raphé nucleus
Kae Nakamura, Kazuko Nakao, Kazuko Hayashi,
Atsushi Noritake
Dept. Physiol. Kansai Medical Univ. Sch. Med
There have been inconsistent hypotheses about whether and
how the central serotonergic system is involved in positive or
negative emotional information processing. The dorsal raphé
nucleus (DRN) is the major source of serotonin in the fore-
brain, and despite neurochemical variability, measurement of
single DRN neurons’ activity would provide significant un-
derstandings of such opposing information processing. We
therefore performed single unit recording from the DRN
while monkeys were conditioned in a Pavlovian procedure
with two distinct contexts : an appetitive context where a re-
ward was available and an aversive one where an airpuff was
delivered. We found that the DRN neurons discriminate appe-
titive and aversive contexts by tonic modulation in activity.
Using the eye movement tasks, we also found that the same
neurons further kept track of moment to moment changing
expected reward value in the appetitive, but not in the aver-
sive context. Such temporally distinct DRN neuronal activi-
ties may provide the neural basis of information processing
required for decision making in different emotional contexts.S63-S-14-2 Neural computation
mechanism of prediction and decision
making by dorsal raphe serotonin
neurons
Katsuhiko Miyazaki, Kayoko Miyazaki, Kenji Doya
Okinawa Institute of Science and Technology
Recently we showed that optogenetic activation of the sero-
tonin neurons in the dorsal raphe nucleus (DRN) enhanced
the mice’s patience in waiting for reward. Here we test if the
probability of future rewards affects promotion of patience.
Mice were trained a task with a 75% probabilistic food pellet
after 3 s delay. We focused on the waiting time of 25% of
omission trials. In half of the trials, DRN serotonin neurons
were optogenetically activated during waiting for rewards.
In the omission trials, the waiting time with serotonin neuron
activation was significantly longer than that without activa-
tion. Next, the mice performed a with a 25% probabilistic
food reward after waiting for 3 s. In the omission trials, the
waiting time with serotonin activation was not significantly
different from that without activation. Finally we introduced
a 25% reward test with three pellets, in which the expected
reward value was equated with that in the 75% reward test.
The waiting time in the omission trials with serotonin activa-
tion was not significantly different from that without sero-
tonin activation. These results suggest that serotonin’s effect
on promoting patience depends on a high probability, but not
expected value, of future reward.
3-S-14-4 A role of the dorsal raphe
serotonin neurons in the regulation of
emotion
Kazuki Nagayasu 1,2, Shuji Kaneko 2
1Drug Innov. Ctr., Grad. Sch. Pharm. Sci., Osaka Univ., 2Dept. Mol. Pharmacol.,
Grad. Sch. Pharm. Sci., Kyoto Univ.
Serotonin (5 HT) have been thought to play an important role
in regulation of emotional states. Indeed, a variety of thera-
peutic agents for mood disorder modulate the 5 HT signal
transmission. We have previously reported that the activity
of the 5 HT neurons in the dorsal raphe nucleus (DRN) can
be increased by ketamine and olanzapine, promising thera-
peutic agents for treatment resistant depression, as well as
conventional antidepressants such as selective serotonin re-
uptake inhibitors and tricyclic antidepressants. It is, how-
ever, still unclear whether the activation of the DRN 5 HT
neurons is sufficient for eliciting antidepressant like effects.
Furthermore, identification of responsible 5 HT circuits for
a variety of behaviors and disorders has been hampered by
wide ranging projection of 5 HT neurons. To address these
issues, we developed lentiviral vectors capable of optogenetic
manipulation of 5 HT neurons specifically. In this sympo-
sium, we would like to show our recent findings on the role of
5 HT neurons in the regulation of depression and anxiety.6
3-S-15-1 Economic evaluation of team
care―Pharmacological impact of
pharmacist participation in a
multidisciplinary team―
Shunya Ikeda
International Univ. Sch. Pharm.
There are many foreign studies which directly or indirectly
demonstrated the economic impact of clinical pharmacy serv-
ices. Viswanathan et al. reviewed 44 studies which assessed
the effect of Medication Therapy Management (MTM) inter-
ventions among outpatients with chronic illnesses. MTM in-
terventions improved medication appropriateness and adher-
ence, and reduced medication dosing. They also reduced
health plan expenditures on medication costs and hospitaliza-
tion costs.
Based on the evidence from the foreign studies, I will present
the pharmacological impact of the pharmacist participation
in a multidisciplinary team and the possibility of its economic
benefit in the Japanese clinical setting.
3-S-15-3 New pharmacy practice
based on interprofessional work is
developing in Kobe University Hospital
Midori Hirai
Dept. Hosp. Pharm., Kobe Univ. Sch. Med.
Today, to achieve optimal patient outcomes, the focus in
healthcare has been shifted towards patient centeredness ap-
proaches to achieve optimal patient outcomes. Pharmacists
are at the forefront of patient pharmaceutical care which im-
proves pharmacological and therapeutic outcomes with by
minimizing adverse events of induced by drug use. In our
hospital, pharmacists are working as active members of
many care teams developing interprofessional work. Pharma-
cists should promote take leadership in pharmacotherapy for
patient outcome and safety as well as reduction of incidence
of adverse drug reactions. I will introduce the pharmacists’
activity activities in the interprofessional education for un-
dergraduate students, in outpatient clinics as a member of in-
terdisciplinary teams, and in medication assessment using
STOPP/START criteria for avoiding inappropriate pre-
scribing.S63-S-15-2 From the standpoint of
pharmacists working for medical
insurance pharmacies focusing on
improvement of adherence
Yuko Doi
Ain Holdings Inc.
Since Japan has become super aged society, pharmacists
need to consider drug therapy that is appropriate for elderly
people. Reconsideration of conventional drug therapy is re-
quired to deal with problems specific to elderly people, such
as bone fractures, swallowing disorders and dementia, all of
which cause decreases in the level of QOL. Pharmacists must
give attention also to various aspects of living environments
of elderly patients.In this symposium, I will present several
cases of patients, who are subjected to home medical care,
and discuss about effectiveness and problems of home medi-
cal care provided by a regional medical network from a phar-
macological point of view. As a result of examining the cases
in detail, I reached a conclusion that one solution to the prob-
lems might be obtained by sharing information about patients
and their living conditions among pharmacists and other
medical professionals working in the same regional medical
network. Under these conditions, pharmacists should propose
drug therapies that are most suitable for elderly patients.
3-S-15-4 Characteristics of effective
interprofessional medical teams and
usefulness of team training to promote
effective health care
Tomohiro Taguchi
Dept. Family Medicine, Mie Univ. Sch. Med.
Recently, the importance of interprofessional medical team(s)
(IMT) has been recognized widely due to such factors as in-
creasing complexity and specialization of medical care, the
increasing incidence of chronic disease, shortage of global
workforce and initiatives for safe working hours, etc.
According to many studies, it has been proven that effective
IMTs can provide better quality of medical care at the or-
ganization level such as reduced hospitalization time and
costs, the patient level such as improved health outcomes and
reduced medical errors, the team level as a whole such as im-
proved coordination of care and the individual team member
level such as enhanced job satisfaction.
Effective IMTs are never formed by accident, therefore we
need first to understand characteristics of successful teams
and to know how they function and maintain their effective-
ness, and, secondly, to carry out training programs essential
to promote effective health care.
Based on the evidence obtained from various medical studies
and some cases under Japanese clinical settings, I demon-
strate characteristics of effective IMTs and usefulness of
team training to make excellent IMTs.7
3-S-16-1 Disruption of gap junction as
the therapeutic target in sensorineural
hearing impairment
Taro Yamaguchi, Masanori Yoneyama,
Kiyokazu Ogita
Dept. pharmacol., Setsunan Univ.
Most of sensorineural hearing impairment, which causes the
inner ear dysfunction, is irreversible and has become a social
problem because there is no treatment of sensorineural hear-
ing impairment. Under physiological conditions, maintenance
of the potassium ion concentration in the endolymph by gap
junction in the cochlear lateral wall is important for hearing.
We found using in vivo and in vitro experiments that intense
noise exposure produced disruption of gap junction through
oxidative stress induced connexin degradation prior to hair
cell damage. Therefore, the collapse of ion balance in the in-
ner ear through degradation of connexin is one of the causes
of hair cell damages. In addition, calpain inhibitors prevented
noise induced hearing loss and disruption of gap junction in-
duced by connexin degradation. Taken together, the disrup-
tion of gap junction by oxidative stress is involved in one of
the pathogenesis of sensorineural hearing impairment and
could be a new target of pharmacotherapy for sensorineural
hearing impairment.
3-S-16-3 Protection and regeneration
of cochlear hair cells using IGF1 and its
downstreammolecule
Norio Yamamoto
Dept. ORL, Head＆ Neck Surg, Kyoto Univ. Grad Sch. Med.
We have demonstrated that insulin like growth factor1 (IGF
1) protected cochlear hair cells (HCs) of neonatal mice against
aminoglycoside (AG) through the inhibition of apoptosis and
the induction of cell cycle promotion. Moreover, we have con-
firmed its effectiveness to idiopathic sudden sensorineural
hearing less in the clinical trial. As effectors of IGF1 signal-
ing during hair cell protection against AG, we have identified
two candidate genes, Gap43 and Ntn1 (netrin 1) using mi-
croarray and quantitative RT PCR. The netrins constitute a
conserved family of secreted proteins that are involved in
axon guidance and cell migration. Recent studies reported
other roles of NTN1 including tissue morphogenesis or an
anti apoptotic survival effect. To examine the effect of NTN1
on cochlear hair cells, we utilized cochlear explant culture es-
tablished from P2 mice and found that NTN1 protected HCs
from AG damage through inhibition of apoptosis. This effect
of NTN1 was mediated by UNC5B, one of the six canonical
NTN1 receptors. Moreover, we confirmed that the effect of
IGF1 was attenuated by blocking NTN1 or UNC5B. These re-
sults suggest that NTN1 is one of the effectors of IGF1 in the
cochlea.S63-S-16-2 Generation of a newmouse
model for deafness by optogenetic
approach
Hiroshi Hibino 1, Mitsuo Sato 1, Fumiaki Nin 1,
Kenji Tanaka 2
1Dept. Mol. Physiol., Niigata Univ. Sch. Med., 2Dept. Neuropsy., Sch. Med., Keio
Univ.
More than 10% of world population currently suffer from
hearing loss, which is primarily caused by disorders in the in-
ner ear in both congenital and acquired conditions. In the lat-
ter, some cases that show reversibility at the early stage be-
come irreversible and finally result in refractory hearing
loss. To develop new drugs and therapeutic strategies for the
disease, creation of model animals that mimic reversible sen-
sorineural hearing loss in human is crucial. For such pur-
pose, in this study we have characterized the transgenic mice
that expressed channelrhodopsin 2 in the stria vascularis.
This epithelial tissue maintains a highly positive potential of
+80 mV in the cochlear endolymph, a K+ enriched extracellu-
lar solution essential for audition. Hearing threshold of the
mice was increased by ~20 dB when their cochleae were ex-
posed to blue light. Electrophysiological experiments showed
that the illumination sharply reduced the endolymphatic po-
tential by 25 mV in a few seconds. Upon cessation of the light
exposure, the EP was completely recovered within 5 minutes.
The extent of the EP reduction depended on duration and in-
tensity of the illumination. The mice may serve useful tools to
study reversible or transient hearing disorders.
3-S-16-4 Analysis of hearing loss
causing from failed maintenance of
auditory hair’s integrity
Takehiko Ueyama, Naoaki Saito
Lab. of Molecular Pharmacol., Biosignal Research Ctr., Kobe Univ
Cochlear hair cells (CHCs) have specialized structures, called
stereocilia (auditory hairs) which are composed of hundreds
of actin filaments, on the apical surface. Stereocilia are
graded in length and organized into a characteristic staircase
patterns. Each stereocilia bundle displays a tightly regulated
size and shape : a narrow base and almost cylindal upper
part. High sensitivity of CHCs depends on the coordinated
movement of stereocilia ; thus, the length and shape of
stereocilia are determined precisely. Moreover, as CHCs are
usually not replaced, turnover of stereociliary components is
a lifetime requirement.Cdc42 is a member of Rho family
small GTPases. We reported HC specific conditional KO
mice whose CHCs normally developed but progressively de-
generated after maturation, resulting in progressive hearing
loss. Cdc42 is localized and active at stereocilia for their
maintenance, but not development. We further developed our
study based on the hypothesis that other Rho family small
GTPases may play important roles in development of stereo-
cilia. We also investigated downstream molecules of Cdc42
signaling. In this symposium, we will show and disscuss our
current results about development/maintenance of stereo-
cilia.8
3-S-17-1 Central regulation of hepatic
metabolism by leptin
Licht Miyamoto
Dept. Med. Pharmacol., Inst. of Biomed. Sci. Tokushima Univ.
Leptin is an adipocytokine which enhances glucose and lipid
metabolism as well as suppresses appetite. Especially, leptin
administration demonstrates the striking beneficial effects
against metabolic disturbances in lipodystrophy, which is a
disease due to lack of adipose tissue, characterized by multi-
ple severe metabolic abnormalities including diabetes and
fatty liver. Thus leptin is clinically applied to treat the meta-
bolic disorders in lipodystrophy. We have recently found that
leptin administration activates hepatic AMPK, which is a key
molecule controlling energy metabolism, while AMPK de-
pendent signals are suppressed in the liver in lipodystrophy.
Central injection of leptin also increased hepatic AMPK ac-
tivities, but leptin stimulation did not activate AMPK in pri-
mary hepatocytes. Furthermore, the hepatic AMPK activa-
tion by leptin was completely inhibited by chemical sympa-
thectomy or alpha1 blockers, while neither hepatic vagotomy
nor beta blockers affected the activation. Therefore, leptin is
suggested to centrally regulate hepatic metabolism using
AMPK through alpha adrenergic effects of sympathetic
nervous system. The suppression of hepatic AMPK depend-
ent signals is supposed to be a cause of metabolic disorders in
lipodystrophy, which could be ameliorated by leptin.
3-S-17-3 Elucidation of the
pathophysiological mechanisms and
drug targets for leptin resistance in the
CNS
Toru Hosoi, Koichiro Ozawa
Dept. Pharmacotherapy., Grad. Sch. of Biomed. and Health Sci., Hiroshima Univ.
Obesity is one of the risk factor of diseases such as diabetes,
hypertension and hyperlipidemia. Leptin is an anti obesity
hormone, which was discovered in 1994 by Dr. Friedman’s
group. Leptin exerts its anti obesity effect through Ob Rb
leptin receptor expressed in hypothalamic neurons. Although
leptin has anti obesity effect, recent evidence suggested that
most of the obese patients are in the state of leptin resistance.
Therefore, elucidation of the pathophysiological mechanisms
of leptin resistance may give us the useful information for the
treatment. Previously, we found that ER stress may be in-
volved in the development of leptin resistance and flurubipro-
fen may be able to ameliorate the resistance (Mol. Pharm.,
2008, 74 : 1610 9 ; EMBO Mol. Med., 2014, 6 : 335 46). In the
present symposium, we are planning to show other new possi-
ble mechanisms of the development of leptin resistance in the
CNS. Furthermore, we will show the role of glial cells on the
leptin’s action in the CNS, which may help to understand the
mechanisms of the pathophysiology of leptin resistance.S3-S-17-2 Orexin system regulating
glucose homeodynamics: a potential
target for chronotherapy of type 2
diabetes
Hiroshi Tsuneki, Tsutomu Wada, Toshiyasu Sasaoka
Dept. of Clin. Pharmacol., Univ. of Toyama
Glucose metabolism is dynamically regulated to maintain
whole body glucose homeostasis, according to daily sleep/
wake cycle. The hypothalamus is the central region to regu-
late the glucose homeodynamics, although their mechanisms
had long been uncertain. We found that orexin, a hypotha-
lamic neuropeptide, plays central role in this regulation of
blood glucose, in addition to the well established role in stabi-
lization of wakefulness. In this process, orexin bidirectionally
regulated hepatic glucose production by changing autonomic
nerve balance, thereby promoting generation of daily rhythm
in blood glucose in mice. This daily rhythm in blood glucose
was beneficial for preventing endoplasmic reticulum stress
in the liver, thereby preventing hepatic insulin resistance un-
der pathophysiological conditions, such as aging, obesity, and
depression. Moreover, when daily rhythmic action of orexin
was amplified by an awake state administration of nicotine, a
stimulator of the orexin system, or a sleeping state admini-
stration of suvorexant, an orexin antagonist, in type 2 dia-
betic db/db mice, the abnormal glucose tolerance was amelio-
rated. Therefore, hypothalamic orexin system appears to be a
target for chronotherapy against type 2 diabetes.
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Our clinical study has shown that brown rice improves obe-
sity and glucose dysmetabolism in middle aged men (Br J
Nutr 111 : 310, 2014). However, the underlying molecular
mechanism remains unclear. We discovered that γ oryzanol
(Orz), a major bioactive component of brown rice, decreases
hypothalamic endoplasmic reticulum (ER) stress in high fat
diet (HFD) fed mice, thereby attenuating preference for the
dietary fat (Diabetes 61 : 3084, 2012). We recently demon-
strated the metabolically beneficial impact of Orz on pancre-
atic islet function (Endocrinology 156 : 1242, 2015, Br J Phar-
macol 172 : 4519, 2015). In murine isolated islets, Orz en-
hanced glucose stimulated insulin secretion (GSIS) via sup-
pression of local dopamine D2 receptor (D2R) signaling. We
demonstrated that D2R is confined to β cells and decreases
cAMP levels, thereby decreasing GSIS. In islets from HFD
fed mice, expression levels of D2R signaling molecules were
significantly increased, which reciprocally decreased by Orz.
HFD induced ER stress in β cells aggravates GSIS, leading
to apoptosis. We also found that Orz reduced ER stress in is-
lets from HFD fed mice. Taken together, our data provide
rationale of Orz as a potential anti obesity and anti diabetic
agent.69
